Reversible assembly and amyloidogenesis of the
staphylococcal biofilm protein, Aap
A dissertation submitted to the
Graduate School
of the University of Cincinnati
In partial fulfillment of the
requirements for the degree of
Doctor of Philosophy
In the Department of Molecular Genetics,
Biochemistry and Microbiology
of the College of Medicine
2019
Alexander E. Yarawsky
B.S. Biological Sciences and Chemistry
Northern Kentucky University 2013
Committee Chair: Andrew B. Herr, Ph.D.
Abstract
The human skin commensal, Staphylococcus epidermidis, is the bacterium most commonly responsible for hospital-acquired infections. This microbe has a very strong capacity for forming bacterial communities known as biofilms. These communities are well-structured and often involve a slime-like matrix of extracellular polysaccharide which assists in bacterial accumulation. A well-known protein factor, the accumulation- associated protein (Aap), can also mediate intercellular adhesion, contributing the biofilm formation. Interestingly, Aap has been shown to be critical for infection in a rat catheter model, whereas the extracellular polysaccharide was irrelevant in infection.
Aap is a large, multi-functional, cell wall-anchored protein expressed by S. epidermidis. The N-terminus of the protein contains a region of short repeats called the
A-repeats, followed by a globular lectin domain. The lectin domain can mediate attachment of bacteria to a surface. A proteolytic cleavage site downstream of the lectin domain leads to the release of the A-repeats and lectin domain, allowing Aap to function in accumulation. There are 5 - 17 B-repeats downstream of the cleavage site, which can assembly with Aap on adjacent cells in the presence of Zn2+. At the C-terminus of Aap lies a region of low complexity, which is rich in proline and glycine residues. After this region is a cell wall-anchoring motif that results in the covalent attachment of Aap to the bacterial cell wall.
Much of the progress made toward understanding the structure and biological function of the B-repeats has utilized a minimal construct containing one and a half B- repeats (Brpt1.5). Previous members of the Herr Lab have determined that Brpt1.5 can
ii assemble into an anti-parallel dimer in the presence of Zn2+. Interestingly, while the
Brpt1.5 dimer would disassociate in the presence of Zn2+-chelator, mature biofilms were unaffected by addition of the chelator. This led members of the Herr Lab to express and characterize longer B-repeat constructs, which more closely resemble the number of B- repeats observed in Aap and show Zn2+-dependent assembly beyond dimer, eventually forming amyloid-like fibers. Amyloid fibers are often associated with toxicity, however, the fibers formed by Aap's B-repeats are utilized by the bacterium in a functionally beneficial way. In several other bacteria, functional amyloids have been shown to provide added strength to the biofilm structure. In the work presented here, we show
Aap forms fibers in S. epidermidis biofilms and are responsible for the biofilm's resistance toward Zn2+-chelator. We also characterize a recently discovered protein, small basic protein (Sbp), which is able to reduce the amount of Zn2+ required for B- repeat aggregation. We propose that Sbp is a nucleating or accessory protein for Aap- amyloidogenesis.
Finally, a secondary interest of this dissertation work is to characterize the structure of the proline/glycine-rich stalk-like region of Aap and other cell wall-anchored proteins. Interestingly, several of these regions have a very high propensity to remain extended in solution, primarily due to the high polyproline type II helix propensity.
Overall, this dissertation work has led to an increased understanding of the mechanism of Aap-dependent accumulation in biofilm formation.
iii
iv
Acknowledgements
I would like to thank my advisor, Dr. Andrew Herr for always being enthusiastic about my data and inspiring me to continue down the path of biophysics. I thank my fellow lab members for constant discussions about various aspects of my research, as well as for entertaining outings. I also owe the previous lab members who had set the stage for my projects, especially Deb Conrady and Stefanie Johns. I would also like to thank my undergraduate advisor at Northern Kentucky University, Dr. Heather Bullen, for showing me the excitement of research and being an inspirational mentor.
I am grateful for my many trips to the Gibbs Conference on Biological
Thermodynamics, which are always inspiring me to maintain a high degree of rigor in my work, and have led to me reading many papers from the influential biophysicists that are or once were associated with this meeting.
I would like to thank Beckman Coulter for awarding me a full travel grant to attend the 23rd International Analytical Ultracentrifugation Workshop and Symposium
(AUC 2017) where I learned a great deal from many experts in the field, particularly in regards to Walter Stafford's SEDANAL software.
I must acknowledge my family and friends as well, especially my wife Danille, who have supported my journey and who have encouraged me to pursue the highest of goals.
v
Table of Contents
Title Page ...... i
Abstract ...... ii
Acknowledgements ...... v
Table of Contents ...... vi
List of Figures and Tables ...... x
Chapter I. Literature Review ...... 1 A. The importance of staphylococcal biofilms in the healthcare industry ...... 1 B. Molecular pathways of staphylococcal biofilm formation ...... 2 i. Steps of biofilm formation ...... 3 ii. PNAG-dependent accumulation ...... 8 iii. Protein-dependent accumulation ...... 10 C. The accumulation-associated protein ...... 13 i. Aap domain architecture ...... 14 ii. Role of Aap in attachment ...... 14 iii. Zn2+-mediated self-assembly of Aap (role in accumulation) ...... 17 D. Considerations in Protein Folding and Stability ...... 21 i. The hydrophobic effect ...... 22 ii. Solvent-solute interactions ...... 23 iii. Solute-solute interactions ...... 27 E. Protein misfolding and natively unfolded proteins ...... 31 i. Protein aggregation and amyloid formation ...... 31 a. Amyloid stability ...... 32 b. Pathogenic vs. functional amyloid ...... 33 ii. Intrinsically disordered proteins ...... 34 a. Factors determining conformational propensities ...... 34 b. Functional roles of IDPs ...... 36 F. Goals of dissertation work...... 39 References ...... 42
Chapter II. The biofilm adhesion protein Aap from Staphylococcus epidermidis forms zinc-dependent amyloid fibers ...... 54 Abstract ...... 55 Author Summary ...... 57 Introduction ...... 58 Solution characterization of tandem B-repeats from Aap ...... 62 Tandem B-repeats assemble into multiple higher-order species in the presence of Zn2+ ...... 64 2D size-and-shape sedimentation analysis indicates formation of fiber-like species . 67 Tandem B-repeats form amyloid fibers in the presence of Zn2+ ...... 71 vi
B-repeat fiber assembly is time- and temperature-dependent ...... 76 B-repeat fibers are resistant to acid and chelator treatment ...... 79 Amyloid fibers are structural components in S. epidermidis biofilms ...... 80 S. epidermidis amyloid fibers are composed of processed Aap ...... 84 Amyloid fibers form early in biofilm formation and correlate with DTPA resistance of biofilms ...... 86 Discussion ...... 89 Methods ...... 94 Supporting Information ...... 103 References ...... 110
Chapter III. Tandem B-repeats from Aap show reversible zinc-dependent assembly beyond dimer ...... 120 Abstract ...... 121 Introduction ...... 123 Brpt5.5 exhibits monomer-dimer-tetramer equilibrium ...... 127 Analysis of linked equilibria indicates a similar mechanism of Brpt5.5 dimerization to shorter constructs ...... 130 Formation of the tetramer requires additional Zn2+ ions ...... 130 Chemical modification and sequence mutation to define tetramer assembly ...... 133 Tetramer assembly is required for Zn2+-dependent amyloidogenesis ...... 137 Discussion...... 141 Materials and methods ...... 145 Supplementary Figures ...... 150 References ...... 151
Chapter IV. Defining the basis of the interaction between Sbp and the B-repeats of Aap in Staphylococcus epidermidis biofilms ...... 153 Abstract ...... 154 Introduction ...... 155 The secondary structure of Sbp is strongly dependent on electrostatic interactions 158 Sbp undergoes compaction upon electrostatic screening ...... 160 Probing for Sbp:B-repeat interactions at low and high NaCl concentrations ...... 160 Sbp enhances Zn2+-dependent Brpt5.5 assembly ...... 165 Sbp cannot interact with the Brpt5.5 monomer or dimer ...... 168 The ability for Sbp to reduce the Zn2+ requirement for B-repeat assembly is biologically relevant ...... 170 Discussion...... 173 Materials and methods ...... 176 Supplementary Figures ...... 180 References ...... 182
Chapter V. The proline/glycine-rich region of the biofilm adhesion protein Aap forms an extended stalk that resists compaction ...... 184 Abstract ...... 185 Introduction ...... 186 vii
The proline/glycine-rich region shows aberrant mobility ...... 190 PGR sediments as an elongated monomer ...... 193 Determination of the hydrodynamic radius of PGR in solution ...... 194 Predicted disorder based on PGR primary sequence ...... 197 PGR contains polyproline type II helix content ...... 198 Hydrodynamic behavior as a function of temperature ...... 200 Effects of cosolvents on PGR conformation ...... 203 Electrostatic interactions do not affect local or global PGR conformations ...... 207 Predicting PPII propensity and Rh from PGR primary sequence ...... 210 Discussion...... 212 Materials and methods ...... 218 Supplementary Figures ...... 228 Supplementary Tables ...... 231 References ...... 235
Chapter VI. Comparing intrinsically disordered regions of Staphylococcus surface proteins ...... 248 Abstract ...... 249 Introduction ...... 250 All constructs are predicted to be disordered ...... 255 AUC indicates highly elongated monomers ...... 262 CD confirms random coil/PPII secondary structure content ...... 264 Cosolvents perturb secondary structure to varied degrees ...... 267 Discussion...... 272 Materials and methods ...... 276 Supplementary Tables ...... 279 References ...... 283
Chapter VII. Future Directions ...... 289 A. The importance of Aap higher-order assembly and amyloidogenesis in Staphylococcus epidermidis biofilm formation and virulence ...... 289 B. Biological significance of the role of Sbp in Aap amyloidogenesis in Staphylococcus epidermidis biofilms ...... 294 C. Investigating the mechanism of B-repeat amyloidogenesis ...... 300 D. Biophysical and structural insights from endogenously expressed full-length Aap ...... 305 E. Defining spatial and temporal parameters of Staphylococcus epidermidis biofilm formation ...... 308 F. Differentiating infectious and commensal S. epidermidis colonization ...... 310 References ...... 313
Appendix I. Biophysical insights into the mechanism of Bap-dependent biofilm formation in Acinetobacter baumannii ...... 317 Abstract ...... 318 Introduction ...... 319 Bap is rich in beta-sheet secondary structure content and highly elongated ...... 323 viii
Bap dimerization occurs in the presence of Zn2+ ...... 323 Zn2+-induced dimerization of Bapice2 results in no significant secondary structural changes ...... 328 Testing for heteroassociation between the Bap ice-repeat regions ...... 328 Discussion...... 331 Materials and methods ...... 333 References ...... 336
ix
List of Figures and Tables
Chapter I Figure I-1: Biofilm formation ...... 2 Table I-1: Summary of components involved in attachment ...... 6 Table I-1: Summary of components involved in accumulation ...... 7 Figure I-2: Domain arrangement of Aap ...... 14 Figure I-3: B-repeat Zn2+-coordination ...... 19 Table I-3: Gibbs free energy of transfers from water to other solvents ...... 25 Table I-4: Component contributions to Gibbs free energy of transfers ...... 26
Chapter II Figure 1: Characterization of tandem B-repeats from S. epidermidis Aap ...... 63 Figure 2: Sedimentation behavior of tandem B-repeats in the presence of Zn2+ ...... 66 Figure 3: AUC c(s,ff0) analysis of early-stage HMBP-Brpt3.5 amyloidogenic intermediates ...... 68 Figure 4: Amyloid properties of tandem B-repeat constructs in the presence of Zn2+ 72 Figure 5: HPLC and turbidity assays to monitor time and temperature dependence of amyloidogenesis...... 77 Figure 6: Amyloid fibers composed of Aap are important structural components in S. epidermidis biofilms ...... 82 Figure 7: The formation of amyloid fibers is well correlated to DTPA resistance in S. epidermidis biofilms ...... 88 Figure S1: Sequence identity comparison of the tandem Brpt domains of Aap ...... 103 Figure S2: Secondary structure analysis of Brpt3.5 ...... 104 Figure S3: B-repeat fibers are resistant to acid and metal chelator treatment ...... 105 Figure S4: Stability of HMBP-Brpt3.5/Zn2+ fibers after incubation with HCl or the metal chelator DTPA ...... 106 Figure S5: Initial assembly of Brpt5.5 is sensitive to acidification and the metal chelator DTPA ...... 107 Figure S6: Mass spectrometry results of SDS-resistant aggregate present in S. epidermidis RP62A biofilms ...... 108 Table S1: Mass spectrometry results of SDS-resistant aggregate present in S. epidermidis RP62A biofilms ...... 109
Chapter III Figure 1: Brpt5.5 exhibits a monomer-dimer-tetramer equilibrium in the presence of Zn2+ ...... 129 Figure 2: Analysis of linked equilibria reveals the number of Zn2+ ions bound during each assembly event ...... 132 Figure 3: Chemical modification targets and potential Zn2+-binding residues are highlighted on a structure of Brpt1.5 (PDB: 4FUN) ...... 134 Figure 4: Chemical modifications and H85A mutations inhibit tetramer formation ... 136 Table 1: Measured equilibrium constants from sedimentation equilibrium experiments shown in Figure 4C and 4D ...... 136
x
Figure 5: Inhibiting tetramer formation results in weaker aggregation propensity .... 138 Figure 6: Models of tandem B-repeat reversible assembly ...... 143 Figure S1: Circular dichroism of Brpt5.5 assembly states ...... 150 Figure S2: Secondary structure and thermal denaturation of Brpt5.5 H85A ...... 150
Chapter IV Figure 1: Sbp is partially folded under standard conditions ...... 159 Table 1: Thermodynamic parameters calculated from thermal denaturation experiments shown in Figure 1C ...... 159 Figure 2: Sbp requires high NaCl concentrations to become fully compacted ...... 163 Table 2: Hydrodynamic parameters from AUC experiments in Figure 2A ...... 163 Figure 3: Interactions between Sbp and Brpt5.5 require the presence of Zn2+ ...... 164 Figure 4: Sbp induces Brpt5.5 assembly and aggregation at lower Zn2+ concentrations ...... 166 Figure 5: Sbp shows a weaker effect toward Brpt5.5 H85A aggregation and does not affect Brpt5.5 H85A assembly ...... 169 Figure 6: Sbp lowers the Zn2+ required for biofilm formation ...... 172 Figure S1: AUC indicates no Sbp:Brpt1.5 assembly ...... 180 Figure S2: Investigation the turbidity behavior of Brpt5.5 ...... 181 Figure S3: Effect of retroSbp on Brpt5.5 turbidity ...... 181
Chapter V Figure 1: PGR shows aberrant mobility and exists as an elongated monomer in solution ...... 191 Figure 2: Size exclusion chromatography (SEC) confirms an extended conformation in solution ...... 195 Figure 3: PGR contains polyproline type II helix ...... 199 Figure 4: PGR shows weak temperature dependence of Rh ...... 202 Figure 5: The local conformation of PGR shows resilience against chemical perturbants ...... 204 Figure 6: Coulombic effects do not play a role in local or global conformations ...... 209 Figure 7: Model of Aap on the surface of S. epidermidis ...... 217 Table 1: Summary of hydrodynamic parameters determined in this study ...... 217 Figure S1: PGR is predicted to be intrinsically disordered ...... 228 Figure S2: The sequence of PGR is highly conserved among S. epidermidis strains ...... 230 Table S1: Concentration dependence of sedimentation velocity AUC data ...... 231 Table S2: Temperature dependence of sedimentation velocity AUC data ...... 231 Table S3: Salt dependence of sedimentation velocity AUC data ...... 232 Table S4: Comparison of hydrodynamic properties for PGR to a dataset of studied IDPs ...... 233 Table S5: Folded proteins and hydrodynamic measurements from literature ...... 234
xi
Chapter VI Figure 1: Sequences of constructs ...... 251 Figure 2: Predictions of disorder and classification of constructs ...... 256 Table 1: Parameters calculated by CIDER ...... 257 Table 2: Calculated and predicted parameters of IDP constructs ...... 260 Figure 3: AUC indicates each construct is highly elongated and monomeric ...... 263 Table 3: Sedimentation velocity AUC parameters ...... 263 Figure 4: Circular dichroism wavelength scans show constructs have primarily random coil and PPII helix content ...... 265 Figure 5: Constructs respond to denaturants to different extents ...... 268 Figure 6: Comparing the response to TMAO and TFE ...... 270 Table S1: Sequence-based parameters of IDP dataset ...... 279 Table S2: The sequence of IDPs used in PPII and Rh predictions ...... 280
Chapter VII Table VII-1: S. epidermidis Aap B-repeat mutations and the predicted effects on biofilm formation ...... 293 Figure VII-1: Dot blot assay performed on Brpt5.5 samples using the amyloid- detecting antibody OC ...... 301 Figure VII-2: Predictions of amyloidogenic regions ...... 303 Figure VII-3: Analysis of Aap by AUC ...... 307
Appendix I Figure 1: Bap domain arrangement ...... 320 Figure 2: Secondary structure analysis reveals beta-sheet and random coil content ...... 322 Table 1: Secondary structure analysis by DichroWeb ...... 322 Figure 3: Bapice2 is highly extended in solution ...... 324 Table 2: Hydrodynamic parameters determined by AUC ...... 324 Figure 4: Zn2+ induces dimerization of Bapice2 ...... 326 Table 3: Hydrodynamic parameters determined by AUC in the presence of Zn2+ .... 324 Figure 5: No evidence for heteroassociation of Bap ice-repeat regions is observed 330 Table 4: Sw analysis of AUC data from Figure 5 ...... 324
xii
Chapter I. Literature Review
A. The importance of staphylococcal biofilms in the healthcare industry
The gram-positive bacterium, Staphylococcus epidermidis, is typically beneficial to the human host. S. epidermidis colonizes the skin and mucous membranes, preventing colonization by pathogenic bacteria. Unfortunately, S. epidermidis' ubiquity on the surface of the skin makes it a likely source of contamination during insertion of indwelling medical devices [1, 2]. In fact, S. epidermidis is the most common microbe responsible for hospital-acquired infections [1, 3]. There is a significant cost to the US healthcare system due to intravascular catheter infections caused by S. epidermidis and other coagulase-negative strains [4]. Such infections are very problematic, due primarily to the ability of the bacteria to form biofilms - a community of bacterial cells which form a three-dimensional structure typically encased in an extracellular polysaccharide-rich matrix. These biofilms confer a degree of chemical and physical resistance to the bacteria, often resulting in the need for prolonged antibiotic treatment and removal of the contaminated device [5].
1
B. Molecular pathways of staphylococcal biofilm formation
The ability to form biofilms is considered S. epidermidis' most important virulence factor, as opposed to the toxins and more traditional virulence factors Staphylococcus aureus possesses [6]. Biofilm formation by staphylococci is composed of several distinct phases, depicted in Figure 1. First, bacteria must attach to a surface, whether it be biotic (e.g. human cells, extracellular matrix) or abiotic (e.g. medical devices). Once a cluster of bacteria attaches to a surface, maturation occurs, where intercellular attachment holds bacteria together and a build-up of the trademark 3-dimensional structure occurs. Following maturation, bacteria periodically undergo cycles of shedding or detaching from the community, which can lead to the distribution of bacteria to other sites, where new biofilms may form [6].
Figure I-1. Biofilm formation is initiated by the attachment of planktonic bacteria to a surface. Accumulation and maturation of the biofilm can involve various factors, such as polysaccharide intercellular adhesion (PNAG - poly-N-acetylglucosamine), proteins, extracellular DNA and teichoic acids. Bacteria may then be shed during dispersal of the biofilm.
2
i. Steps of biofilm formation
Attachment: The first step of biofilm formation may be mediated by a variety of proteins which are capable of recognizing and binding to human matrix proteins, carbohydrates, or abiotic surfaces. These proteins, responsible for attachment, are classified as MSCRAMMs (microbial surface components recognizing adhesive matrix molecules), which typically contain the relevant "surface-binding" domain, a (usually) repetitive region leading back to the cell wall, and a motif which mediates attachment to the peptidoglycan layer of the bacterial cell wall [6]. Specific attachment of bacteria to a biotic surface or human matrix proteins is extremely relevant to infection. Indwelling medical devices become coated in proteins such as fibronectin, collagen, fibrinogen, and vitronectin [7, 8]. A number of MSCRAMMs have been demonstrated to bind one of more of these human proteins, initiating biofilm formation [7-10].
The serine-aspartate repeat (Sdr) family of proteins is one class of MSCRAMMs which have been well-studied. These proteins are composed of a ligand-binding region, repeat domains, serine-aspartate repeats, a cell wall-spanning region, and an LPXTG anchoring motif [11]. The LPXTG anchoring motif is a signal sequence that results in the covalent linkage of the protein to the peptidoglycan layer of the cell wall via a Sortase A family member [12]. The S. epidermidis Sdr family includes SdrG, SdrF, and SdrH.
SdrG, previously Fbe, binds strongly to fibrinogen, with a slow dissociation rate
[13]. Furthermore, the abundance of SdrG on the surface of S. epidermidis correlates with the affinity for surfaces coated with the human matrix protein. Together, these characteristics mean SdrG is well-suited to plant S. epidermidis on the surface of
3 indwelling medical devices and resist the shear forces experienced on many such surfaces [14].
SdrF has been well-characterized in its binding to type I collagen [7, 15].
Interestingly, the mechanism of binding differs from that of SdrG and fibrinogen - which uses a 'dock, lock, and latch' mechanism [16]. SdrF actually utilizes strong and weak forces across both the A and B regions of the protein in order to bind collagen [15]. In addition to the protein's role in infection, SdrF has also recently been shown to be important in S. epidermidis' ability to colonize skin, through binding keratin and therefore mediating attachment to human epithelial cells [17].
SdrH differs in its domain organization from SdrG and SdrF. It has a very short putative ligand-binding region, an extra region (termed a C region), and it lacks the
LPXTG sortase, cell wall-anchoring motif [18]. Nonetheless, SdrH and SdrG were present in 16/16 strains from patients experiencing S. epidermidis infections, while SdrF was absent from 4 of these strains. Importantly, all patients had developed antibodies against the ligand binding A regions of SdrH and SdrG, implicating these in S. epidermidis infection [18].
Outside of the Sdr family of surface proteins, autolysin E (AtlE) and autolysin/adhesion (Aae) can also bind matrix proteins. AtlE binds vitronectin, while Aae shows binding to vitronectin, fibronectin, and fibrinogen [9, 10]. Both proteins retain their namesake bacteriolytic activity, but also share adhesive properties towards host matrix proteins. This is a well-defined example of a surface protein exhibiting multiple functions.
4
While specific attachment is mediated by cell wall-associated proteins, nonspecific attachment of bacteria to abiotic surfaces depends on the cell surface hydrophobicity and the hydrophobicity of the abiotic surface itself [19]. Surface- associated proteins, such as autolysin E (AtlE) in S. epidermidis or Atl from S. aureus increase the hydrophobic nature of the cell (simply by their presence on the cell surface), and therefore affect the ability of strains to form biofilms on abiotic surfaces
[9]. The S. aureus biofilm-associated protein (Bap) and S. epidermidis Bap homologue protein (Bhp) have also been shown to afford the ability to form biofilms on polystyrene, although the mechanism is unclear [20]. Other key components in nonspecific attachment are teichoic acids. Teichoic acids are negatively charged or zwitterionic, linear polymers present at the cell wall of gram-positive bacteria and serve to bind cations to be used by the cell [21, 22]. The charged nature of these compounds has been shown to be a strong determinant of whether or not a strain of S. aureus can colonize polystyrene or glass. A mutant synthesizing teichoic acids with a stronger negative charge was unable to colonize the abiotic surfaces, suggesting electrostatic repulsion could be a valuable means to combat infection of indwelling medical devices
[23]. It should also be noted that molecules involved in the next phase of biofilm formation, accumulation, can also play a role in attachment.
Examples of proteins which function in both attachment and accumulation are the accumulation-associated protein (Aap) and small basic protein (Sbp). While the mechanism of Aap-mediated surface attachment is becoming more and more well- understood (discussed in Section C-ii), there is very limited data on how Sbp mediates attachment. Evidence suggests that Sbp is a necessary co-factor for establishing
5 sustained attachment. Given the positively-charged nature of Sbp, this protein could be enhancing attachment to slightly negative glass surfaces via electrostatic interactions.
This could explain the abundance of Sbp observed at the base of the biofilm [24].
Table I-1. Summary of components involved in attachment Component Target Mechanism Ref(s) SdrG (previously Fibrinogen Direct binding [14] Fbe) SdrF Type I collagen, keratin Direct binding [7, 15-17] SdrH Unknown Unknown [18] AtlE Vitronectin Direct binding [9] Polystyrene Hydrophobicity [9] Aae Vitronectin, fibronectin, fibrinogen Direct binding [10] Bhp (Bap) Polystyrene Unknown [20] Aap (N- Polystyrene Protease-induced [25] terminus) Corneocytes Lectin-binding [26] Polystyrene Unknown [27] Polystyrene N-terminus-based [28] Tissue culture-treated SepA-protease [29] polystyrene plates, glass or activity polycarbonate Sbp Polystyrene Unknown [24] Keratinocytes Unknown [24] Teichoic acid Polystyrene, glass Electrostatic [23]
Accumulation: Once attachment has occurred and a monolayer of bacterial cells has been formed on a surface, the next critical step is intercellular aggregation of bacteria. The canonical pathway of accumulation in S. epidermidis utilizes a polysaccharide intercellular adhesin (PIA), specifically poly-N-acetylglucosamine
(PNAG) [30, 31]. However, protein components may also be used in accumulation, namely the accumulation-associated protein (Aap) [32]. The redundancy for accumulation in biofilm formation is not totally understood. It has been reported that
6 biofilms formed by both protein and PNAG are more robust than protein-dependent biofilms [33]. This observation suggests both components play an important role in building a strong, effective biofilm. Furthermore, switching between PNAG- and protein- dependent biofilm formation has been observed, suggesting the environment is an important factor, but more importantly, redundancy suggests biofilm formation is a critical ability for this bacterium [34]. Additionally, PNAG- and protein-dependent biofilms differ in their abilities to resist shear stress and virulence [28]. The accumulation phase will be expanded upon in Section ii and Section iii.
Table I-2. Summary of components involved in accumulation Component Target Mechanism Reference(s) PNAG Bacterial surface Electrostatic [35] Aap Aap B-repeats Zn2+-mediated assembly [36, 37] Bhp (Bap) Unknown PNAG-independent, Aap- [20] independent Sbp Aap B-repeats, PNAG Direct binding [24]
Dispersal: Biofilm detachment, or dispersal, is an important factor in the spread of bacteria to other sites, whether for colonization or for infection. In this phase of biofilm formation, single cells or clusters of cells can be released from the mature biofilm structure via mechanical forces, decreased production of accumulation-related factors, and production of matrix-degrading factors [6]. Well-controlled regulation of factors involved in biofilm detachment is crucial for maintaining a well-structured biofilm. The most well-understood mechanism of dispersal regulation is the quorum-sensing system, agr [38, 39]. Mutating the agr system results in a thicker biofilm, suggestive of 7 decreased detachment. Expression of agr is focused at the biofilm surface (as opposed to the biofilm interior), where it could be better utilized in detachment regulation [39].
The agr system in S. aureus seems to function similarly [40].
Several proteases are produced by S. epidermidis which could contribute to detachment by degrading surface proteins involved in intracellular attachment, although more work needs to be completed in this area [41-43]. In addition to the degradation of protein factors involved in intercellular aggregation, degradation of PNAG could also be a useful mechanism of dispersal. While, no S. epidermidis or S. aureus enzymes responsible for PNAG hydrolysis have been found, the hydrolase, dispersin B, from
Acinetobacillus actinomycetemcomitans, can indeed disperse S. epidermidis biofilms via this mechanism [33, 44]. PNAG is slightly positively charged, while the bacterial surface is highly negatively charged. Therefore, in a PNAG-dependent biofilm, disruption of the electrostatic attraction between the cells and PNAG could lead to the release of cells. Likely candidates for this role are the phenol-soluble modulins (PSMs).
PSMs are under the control of the agr quorum-sensing system, and they are peptides ranging from 20 residues (α- and δ-types) to ~45 residues (β-type) and contain an amphipathic α-helix which could act as a detergent-like molecule to disrupt hydrophobic and electrostatic interactions [1].
ii. PNAG-dependent accumulation
The synthesis of PNAG is under the control of the intercellular adhesion operon, icaADBC [30, 45]. The specific role of each component in this system was determined using a xylose-inducible expression vector transformed into Staphylococcus carnosus.
8
Inactivation of any single component led to loss of cellular aggregation, PNAG production, and biofilm formation on various surfaces [30, 45]. The catalytic enzyme,
IcaA, showed a low level of N-acetylglucosaminyltransferase activity when presented with the substrate, UDP-N-acetylglucosamine. However, when co-expressed with IcaD,
IcaA activity was significantly increased and synthesis of a 20 residue oligomer occurred. With the co-expression of IcaC, a putative integral membrane protein, synthesis of full-length PNAG (≥130 residues) could occur [30]. IcaB does not appear to be directly involved in PNAG biosynthesis, yet it is an essential part of the icaADBC operon for biofilm formation [30]. IcaB is anchored to the surface of S. epidermidis, where it partially deacetylates PNAG. The bacterial surface itself is negatively charged, likely due in part to teichoic acid, so the positive charge on PNAG allows for intercellular attachment based on electrostatic interactions, whereas neutral, non-deacetylated
PNAG (synthesized by a mutant strain lacking icaB) could not support intercellular attachment. The ability of the icaB mutant strain to persist in a murine infection model was diminished compared to the icaB-expressing strain [35]. As PNAG synthesis is closely tied to biofilm formation, the regulation of the icaADBC operon is crucial. In addition to regulation by substrate availability [6], environmental factors can also regulate the system. For instance, a decrease in oxygen concentration increases icaADBC mRNA expression and PNAG synthesis. It is well understood that oxygen and other resources are increasingly depleted in the inner depths of a biofilm, therefore,
PNAG synthesis would be increased in cells experiencing lower oxygen concentrations within the biofilm, potentially creating a positive feedback loop [46]. Interestingly, some antibiotics have also been shown to increase transcription of the ica operon [47]. There
9 are also several internal regulators, in addition to these outside influences. Sigma factor
SigB upregulates PIA production when induced through the RsbU regulator via NaCl or ethanol [48]. The sarA gene in S. aureus is known to control the production of many virulence factors, and the sarA homolog in S. epidermidis was recently shown to regulate PNAG production leading to biofilm formation [49]. The luxS quorum-sensing system represses PNAG production via a pathway involving autoinducer 2 secretion
[50].
iii. Protein-dependent accumulation
Despite the classical connection between biofilm formation and secretion of intercellular adhesins such as PNAG, there is ample evidence for PNAG-independent biofilm formation in S. epidermidis. Early evidence came from an analysis of strains isolated from prosthetic infections [33]. Of the isolates, 89% were aap-positive, while
62% were icaA-positive. In the cases where biofilm formation could occur, 27% lacked the ica operon, and the ability to form biofilms was contributed to Aap [33]. More recently, further evidence has pointed toward the significance of PNAG-independent
(and more specifically, Aap-dependent) biofilm formation. Using a flow cell which exposes a glass surface to fluid shear, Schaeffer et al. found that strains lacking aap produced only limited amounts of biofilm mass on the glass surface compared to aap- positive strains. In a rat catheter infection model, strains lacking Aap had a significant decrease in bacterial recovery from the catheter and blood, compared to Aap- expressing strains. Importantly, there was no difference in improvement of bacterial recovery when the ica operon was present [28]. These results suggest that in the
10 context of infection inside a body, where fluid shear is present, Aap is critical in maintaining the intercellular aggregation necessary for mature biofilm formation.
In addition to Aap, the Bap homologue protein (Bhp), can also be responsible for biofilm formation. In the ica-negative, aap-negative, biofilm-forming strain C533, when bhp is deleted, the ability to form biofilms on a polystyrene surface is lost, but can be regained via complementation [20]. Bap (biofilm-associated protein) has been well- studied in S. aureus and other staphylococcal strains, however, the S. epidermidis homologue, Bhp (Bap homologue protein) is less well-understood. According to the previously mentioned study of S. epidermidis prosthetic joint infections, bhp was present in 46% of all isolates, compared to aap found in 89% of all isolates, regardless of biofilm formation capability [33]. A more recent study by Giomerzis, et al. examined S. epidermidis and S. haemolyticus isolated from patients suffering from bloodstream infections or prosthetic-device-associated infections [51]. S. epidermidis comprised nearly 75% of the strains isolated and tested. Of the total strains tested, 40% contained aap compared to a total of 20% containing bhp. Considering biofilm-producing isolates only, there is an enrichment of aap-containing isolates to 43%, whereas bhp sees a drop to just 16% [51]. Another report investigated a S. epidermidis isolate which switched from PNAG-dependent biofilm formation to protein-dependent biofilm formation. Interestingly, aap transcription was up-regulated after the switch to protein- dependent biofilm formation, while bhp was down-regulated [34]. These results seem to further emphasize the role of Aap in biofilm formation and clinical infections.
As was previously alluded to, Sbp (small basic protein) has also been implicated in the accumulation phase of biofilm formation. Sbp was initially discovered and isolated
11 from crude S. epidermidis biofilm mixture via its affinity toward sepharose beads tagged with the B-repeat superdomain of Aap. Aap-dependent biofilms were still formed in a
1457Δsbp strain, the addition of recombinant Sbp recovered biofilm thickness and volume to levels similar to the parent 1457 strain. Expression of Sbp in the biofilm- negative S. carnosus TM300 strain did not result in biofilm formation, indicating Sbp is not sufficient for biofilm formation, but may still be an important co-factor. By confocal microscopy, co-localization of Sbp and B-repeats was observed, while there was also co-localization of Sbp and PNAG. Expression of PNAG correlated with sbp expression levels [24]. In all, Sbp seems to play a role in multiple aspects of biofilm formation, and further studies will be needed to address its mechanisms of action.
12
C. The accumulation-associated protein
The accumulation-associated protein, Aap, was first observed by Timmerman, et al. in 1991 [52]. Studies leading up to this work had shown that proteases could reduce biofilm formation [53, 54]. This pointed toward protein factors being responsible for biofilm formation. Timmerman, et al. utilized a monoclonal antibody (mAb) raised against surface proteins cleaved from the surface of a strong biofilm-producing strain of
S. epidermidis. They observed a 220 kDa protein recognized by the mAb. When the mAb was used to pretreat a polystyrene surface, biofilm formation was greatly inhibited.
Further, they used the mAb for immunogold labeling and electron microscopy to show this protein was forming fibril-like appendages protruding outward from the cell surface
[52]. The next major characterization of Aap came several years later, when
Schumacher-Perdreau, et al. isolated a mitomycin mutant of S. epidermidis RP62A, termed M7. This mutant was unable to form a biofilm, whereas the RP62A parent strain is a strong biofilm producer. Further comparison of these two strains revealed only a loss of 115 kDa and 18 kDa extracellular proteins. Other characteristics remained unchanged, such as growth rate, initial adherence to the surface, antimicrobial susceptibility, and others [55]. Using the same M7 mutant, Hussain, et al. specifically attributed the accumulation phase of biofilm formation to Aap. The extracellular proteins were collected, and the 140 kDa protein (an unprocessed form of the 115 kDa protein above) had antiserum raised against it. The resulting antiserum was able to inhibit biofilm accumulation in RP62A and clinical strains [32], demonstrating an important role for Aap in biofilm formation, as well as clinical infections.
13
i. Aap domain architecture
Aap is a multi-domain, cell wall-anchored protein. The N-terminus of the protein is composed of 11 short, 16 residue A-repeats and a putative lectin domain. Following the lectin domain is a proteolytic cleavage site and 5-17 B-repeats (strain-dependent), containing 128 residues each. Immediately following the B-repeats is a 135-residue long region comprised mostly of AEPGKP repeats, referred to as the Proline/Glycine-rich region. This region leads into the LPXTG motif, which becomes covalently attached to
Lipid II of the peptidoglycan layer of the cell wall.
Figure I-2. Domain arrangement of Aap from S. epidermidis RP62A. Scissors represent the primary SepA cleavage site at Leu 602 and a secondary SepA cleavage site at Leu 336. The anchor marks the LPXTG Sortase A cell wall-anchoring motif, which covalently links Aap to the peptidoglycan layer of the bacterial cell wall (green half-oval).
ii. Role of Aap in attachment
As was previously mentioned, Aap has a role in the attachment phase of biofilm formation, as well as in accumulation. Given the multi-domain architecture of the protein, it is not surprising that the protein supports different functions. The N-terminus has been attributed to attachment to surfaces, both biotic and abiotic, and may be an important regulator of biofilm formation.
14
Rohde, et al. [25] investigated the presence of a 140 kDa isoform of Aap (220 kDa) in the clinical strain 5179. Expression of the 140 kDa isoform in the aap-negative strain
1585, led to biofilm formation, while expression of the full-length form of Aap did not result in biofilm formation in strain 1585. This result indicates that Aap can only induce biofilm formation after the N-terminus is proteolytically removed. The addition of α2- macroglobulin, a staphylococcal protease, was able to induce biofilm formation through proteolytic cleavage of Aap. Host-derived proteases, including trypsin, elastase and cathepsin G also could induce biofilm formation. These results suggest that the host immune response could induce Aap-dependent biofilm formation, which may very well have been evolved as a method of immune evasion [25].
S. epidermidis attachment to human corneocytes was shown to be mediated by the N-terminus of Aap. Adhesion to corneocytes could be inhibited using recombinant
AapArpt+Lectin, but not by AapArpt, indicating the ability for the lectin region to block adhesion when exposed to cells before addition of bacteria [26]. Additional evidence for the attachment role of Aap came from a S. epidermidis mutant CSF41498 and its mutant lacking sortase A - the protein responsible for Aap's attachment to the cell wall of S. epidermidis. The sortase A mutant showed diminished biofilm forming capacity compared to the parent strain, due to lower levels of Aap anchoring to the cell wall.
Antibodies raised against the N-terminus of Aap were able to specifically inhibit attachment on polystyrene [27]. Schaeffer, et al. produced genetic mutants of strain
1457 to better understand the role of Aap and the processing event. On plastic surfaces, complementing an aap-negative mutant with full-length aap enhanced initial attachment. However, complementing with the B-repeat region showed no effect on
15 attachment [28]. In 2016, Paharik, et al.[29] identified a staphylococcal protease, SepA
(controlled by SarA) that seems likely to be S. epidermidis' native mechanism of Aap processing. In strain 1457, a sepA-negative mutant resulted in biofilms which were able to attach to a surface, but unable to mature into well-structured biofilms. The sepA mutant resulted in a lack of processed Aap, which prohibited intercellular accumulation by the B-repeats. Therefore, processing of the A-repeats and lectin away from the B- repeat superdomain actually allows for the accumulation to occur, presumably by exposing the B-repeats in such a way that they can then interact with B-repeats on adjacent cells, rather than being sterically inhibited by additional protein at the N- terminus.
After identifying SepA, Paharik, et al. [29] proceeded to identify the specific cleavage sites in Aap. Fragments of recombinant Aap were expressed and purified, then incubated with concentrated culture supernatants from strain 1457ΔicaΔsarA, which showed higher expression of the SepA and greater processing of Aap. When a fragment containing the lectin and B-repeat superdomain was exposed to the culture supernatant, there was a slight change in the size of the protein by SDS-PAGE, indicative of a cleavage event. N-terminal sequencing of the shifted fragment identified residues 601-608 (residues just before the B-repeat superdomain begins) indicating the removal of the lectin region at a site between the lectin and B-repeats. This is consistent with the expected region of the cleavage site based on previous work by Rohde, et al.
[25]. Interestingly, the smaller cleaved fragment containing the lectin region was difficult to observe without slowing kinetics by keeping samples on ice before western blot analysis. This suggests the possibility that the cleaved fragment resulting from Aap
16 processing is rapidly degraded. Another recombinant fragment contained the A-repeats and lectin region. This fragment also was processed by supernatant from strain
1457ΔicaΔsarA. N-terminal sequencing of the larger, processed fragment identified residues corresponding to the beginning of the lectin region, after the A-repeats. The other resulting fragment (containing the A-repeats) was not detected, suggesting rapid degradation of the A-repeats. Performing experiments in strain 1457ΔicaΔsarAΔecp and 1457ΔicaΔsarAΔesp, which lack the respective secreted proteases, Ecp and Esp, showed slowed processing of the lectin/B-repeat fragment, indicating these two proteases contribute to SepA processing at the cleavage site between the lectin region and B-repeat superdomain. These two proteases had no effect on processing of the A- repeat/lectin fragment [29].
iii. Zn2+-mediated self-assembly of Aap (role in accumulation)
After processing of Aap, the absence of the A-repeats and lectin region allow for exposure of the B-repeat superdomain. Depending on the strain of S. epidermidis, there may be 5-17 B-repeats within the superdomain. Each B-repeat contains a G5 domain and a spacer region, with the exception of the C-terminal half-repeat, which contains only a G5 domain. The N-terminal-most B-repeat is consistently the most divergent repeat, with only 81-90% identity to other B-repeats, while the other B-repeats have a very high identity to one another (84-100%) [37, 56]. Biophysical characterization of the
B-repeat superdomain of Aap has been performed by the Herr Lab [36, 37, 56, 57], primarily utilizing a minimal, Brpt1.5 construct containing the full, most C-terminal B- repeat and the C-terminal half B-repeat, which contains only the G5 domain.
17
Based on the presence of G5 domains in Zn2+ metalloproteases, Conrady, et al. evaluated the ability of recombinant Brpt1.5 to assemble in the presence of Zn2+.
Analytical ultracentrifugation was used to show Brpt1.5 dimerized in the presence of
Zn2+, with 1-2 Zn2+ ions required by each G5 domain. The functional relevance of this observation was evaluated using a biofilm formation assay. Interestingly, DTPA, a Zn2+- chelator, was able to prevent biofilm formation of S. epidermidis on polystyrene and S. aureus USA300 (a methicillin-resistant strain) on fibronectin-coated polystyrene.
Addition of Zn2+ could restore biofilm formation. Recombinant Brpt1.5 was able to inhibit biofilm formation in the presence of Zn2+, providing further evidence of the involvement of Aap's B-repeats in the accumulation phase of biofilm formation. Given these results,
Conrady, et al. proposed the zinc zipper model of accumulation, in which Zn2+ supports intercellular adhesion via overlapping, anti-parallel B-repeat superdomains [36].
After this initial study, Conrady, et al. [37] then determined X-ray crystallographic structures of Brpt1.5 as a dimer in the presence of Zn2+ (Figure 3). As was expected based on the initial biophysical study, dimerization involved a His, as well as Glu and
Asp residues, although several different arrangements were observed across structures indicating a pleomorphic mechanism of Zn2+-binding. Overall, the structures also confirmed that Brpt1.5 is a highly extended protein rich in β-sheets and random coil [37].
The B-repeats do not contain the typical globular architecture with a hydrophobic core of nonpolar residues. Instead, there is a hydrophobic stack at the intersection of each spacer and G5 domain, which was of high importance for protein stability [37]. Chaton, et al. [57] recently investigated the preference of Zn2+ over other divalent cations. The primary factor in metal specificity seemed to be the coordination number, with Zn2+
18 nearly always having a coordination number of 4, making it an ideal fit when also considering typical residue coordination distances. In addition to Zn2+, Cu was also able to induce assembly of Brpt1.5 (as well as a Brpt5.5 construct containing an additional four, C-terminal B-repeats). Mn, Co, and Ni can all competitively inhibit Zn2+-dependent assembly, suggesting they have the ability to bind the Zn2+-binding sites, but cannot support assembly. This study proposed that Aap may not only be able to respond to local Zn2+ concentrations, but also Cu, which is also elevated in areas of immune response [57].
(A)
(B) (C)
H75 D21 E19 H75 H75
Zn2+ Zn2+ 2+ Zn
E203 D149 D149 E203
Figure I-3. (A) A crystal structure of Brpt1.5 (PDB: 4FUN) with one protomer shown in magenta and the other shown in cyan. Two Zn2+ ions are shown as gray spheres. (B) A detailed view of the Zn2+-binding region shows H75 and D21 from the magenta protomer and E203 from the cyan protomer interacting with one Zn2+ ion. Panel (C) shows three different sets of residues involved in Zn2+-binding. See Conrady, et al. for additional details [37].
19
While there is a high degree of identity among the B-repeats, specifically, in terms of the G5 domains, there is a set of eight residues that tend to swap in or out as a
"consensus" or "variant" cassette. The cassettes contain residues spatially near the
Zn2+-binding site, dimer interface and hydrophobic stack. Shelton, et al. [56] expressed minimal, Brpt1.5 constructs containing consensus or variant G5 domains. Interestingly, the C-terminal G5 domain determined the thermal stability of the overall fold - with the variant G5 conferring 5-7°C in additional thermal stability over constructs having the consensus cassette in the C-terminal position. Conversely, the consensus cassette was required in the C-terminal G5 domain in order to support Zn2+-dependent dimerization.
A significantly lower affinity was observed when both G5 domains were the consensus type, indicating stronger dimerization ability. In summary, variant cassettes offered higher thermal stability to the protein fold, while the consensus cassettes sacrificed thermal stability in exchange for better Zn2+-assembly capacity [56].
20
D. Considerations in Protein Folding and Stability
Nearly 30 years after Emil Fischer and Franz Hofmeister, in 1902, determined the composition of proteins to be covalently linked amino acids, Hsein Wu proposed a critical theory of protein folding and denaturation. He was the first to define the native
(folded) state of a protein as compact and having regular folding patterns and non- covalent linkages. Upon denaturation, Wu states these non-covalent linkages are broken, and the protein becomes more diffuse and like a flexible chain. Prior to Wu's highly insightful theory on denaturation, the process was mistaken for depolymerization
(via hydrolysis) or protein dehydration [58].
The next leap in understanding protein folding did not happen until 1959, when the physical chemist Walter Kauzmann published his wide-reaching review on factors of protein denaturation [59]. Kauzmann impressively tied earlier mentions of hydrophobicity by Irving Langmuir and J.D. Bernal and a theoretical physics paper by
Henry Frank and Marjorie Evans, together to conceptualize the hydrophobic effect as we now know it [60].
Protein folding is a delicate balance between a variety of forces, both attractive
(favorable) and repulsive (unfavorable). The Gibbs free energy change between the folded, native state and the unfolded, denatured state is relatively small - usually about
5-20 kcal/mol of protein, so even "weaker" forces are important to consider [61]. While the hydrophobic effect is widely accepted as the primary driver of protein folding, electrostatic interactions, hydrogen bonding, and van der Waals forces all play essential roles in protein folding, and therefore, biological function [58, 62, 63]. The following sections are aimed at breaking down the variety of forces and types of interactions that
21 govern protein folding and stability. With this knowledge, one can begin to understand why some proteins might aggregate or form super stable amyloid fibrils, or in the case of intrinsically disordered proteins, lack a traditional folded native state.
i. The hydrophobic effect
The hydrophobic effect can be described as the tendency for nonpolar amino acid sidechains to avoid contact with water molecules in the solvent. The result of this effect is that nonpolar residues are buried in the "hydrophobic core" of the globular protein, where they do not make contact with the water in the solvent, but instead are in contact with other nonpolar residues. This leaves polar residues on the surface of the protein to make more favorable contact with water molecules in the solvent.
Additionally, if hydrophobic residues were exposed on the surface of the protein, water molecules would form ordered "cages" around them, resulting in an unfavorable loss of entropy [64]. In Kauzmann's seminal papers explaining the hydrophobic effect, he cites as evidence the ability of nonpolar solvents to denature proteins. We now understand the mechanism for why this occurs - the driving force (polar solvent) that kept the nonpolar residues buried in the hydrophobic core is now gone, and the nonpolar residues can form favorable interactions with the nonpolar solvent (recall "like dissolves like"). The other piece of evidence Kauzmann proposed supporting the major role the hydrophobic effect plays in folding is that the stability of proteins shows a similar temperature dependence to that of nonpolar solutes [58].
Much more evidence supporting the hydrophobic effect's role as a dominant force in protein folding has amassed since Kauzmann's seminal papers [58]. One piece
22 of evidence is the vast numbers of high-resolution protein structures showing nonpolar residues buried in hydrophobic cores [65]. Along similar lines, Pace, et al. [63] have measured the change in conformational stability of many mutants designed to query the impact of buried hydrophobic residues. They found, for example, that replacing an isoleucine in the hydrophobic core of a protein with the less hydrophobic valine reduces the stability of the protein by 1-2 kcal/mol. Across 22 proteins, the contribution of hydrophobic interactions was determined to be about 60% of the total contributions to protein stability [63]. Furthermore, Lim & Sauer made random mutations to the hydrophobic core of λ-repressor and found that the primary requirement allowing for a native fold and functional activity was for the residues to retain their hydrophobicity [66].
Rather than continuing individually into the variety of forces or interactions important in protein stability, we will examine different forces in the context of two perspectives - interactions between the solvent and solute (protein), and interactions occurring within the protein (solute-solute interactions). It is the combination of these two that is important in the consideration of overall protein folding.
ii. Solvent-solute interactions
Protein solubility was a major hurdle for early protein work [58], and is still a major problem in formulation of protein pharmaceuticals [67]. Proteins are typically not very soluble in pure water, but the presence of salt and buffer will greatly enhance the solubility. Furthermore, a variety of cosolvents are known to greatly stabilize or destabilize proteins. Hence, the solvent is a critical consideration in protein folding.
23
Much of the early work on understanding, and specifically quantitatively predicting protein stability and the importance of solvent-protein interactions comes from the work of Charles Tanford [68, 69]. The experimental approach (based on earlier work by
Thomas McMeekin, Edwin Cohn, and John Edsall [70]) of interest here is the use of solubility measurements for single amino acids and model compounds representing the protein backbone [68, 71]. To oversimplify the experiments, known amounts of the solute were placed into known amounts of solvent (pure water, urea, alcohol, etc.) and shaken in a constant temperature water bath for 24 hours. The mixture was then filtered and the soluble solute quantified either by dry weight or by titration. The free energies of transfer from water to urea, for example, were then calculated based on these solubility measurements at each specific concentration of urea [68]. A negative (i.e. favorable)
Gibbs free energy change of transfer (usually displayed as ΔGtr or ΔFt) indicates greater solubility in the urea solution than in pure water, while a positive ΔGtr results from lower solubility in the urea solution. Conceptually, this means a negative ΔGtr value is indicative of favorable interactions between the amino acid (or peptide backbone) and the solvent. Table 3 lists the ΔGtr from water to the specified solvent for the peptide group and the leucine sidechain as an example of a hydrophobic residue. Solubility experiments have mostly focused on residues with hydrophobic sidechains, which are mostly buried in the native state, but mostly accessible in the denatured state, creating the opportunity for a major impact on stability [69]. It should be noted that while it was originally believed that polar residues are sequestered to the surface of the protein, the abundance of high-resolution structures has allowed for re-evaluation of this idea. In
24 fact, 37% of polar charged residues and 57% of polar uncharged residues are buried in smaller proteins, while larger proteins can bury even higher percentages [62, 72].
Table I-3. Gibbs free energy of transfers from water to other solvents Solvent Peptide Leu side chain Urea (2 M) -70 -110 GdnHCl (2 M) -135 -210 Sarcosine (2 M) +90 +80 TMAO (2 M) +180 +20 Ethanol +1400 -1800 Cyclohexane +7600 -4900 Vacuum +9800 -2300 -1 See Pace, et al. 2004 for individual references [62]. Values are ΔGtr in cal mol .
While it is out of the scope of this discussion to elaborate on all of the above solvents, a detailed example of urea and TMAO (trimethylamine N-oxide) will be presented. Table 4 summarizes the breakdown of backbone and sidechain interactions and their relative contributions on stability. Urea, of course, is a denaturing osmolyte, causing proteins to unfold. The mechanism for this process is largely that the peptide backbone has a favorable transfer to urea, as evident by the negative value in Table 3, above. Therefore, the unfolded state, where there is more backbone solvent exposure, is preferred. However, while hydrophobic sidechains have largely favorable transfers as well, polar and charged residues show slightly unfavorable transfers [73]. Arguments have been made as to whether the backbone or the sidechains are most responsible for urea's denaturing ability, particularly based on the solvent-accessibility assumed in
25 different models [74, 75]. Urea may also affect water ordering around the protein, providing an indirect, entropic effect [76].
Table I-4. Component contributions to Gibbs free energy of transfers Solvent Net Peptide Sidechain Polar Polar Hydrophobic Total Group Total Charged Uncharged Urea ------+ ++ + -- TMAO ++ +++ ------"+" signs indicate strength of positive ΔGtr (unfavorable interaction) "-" signs indicate strength of negative ΔGtr (favorable interactions) Summarized from Auton, et al. 2011 [73].
TMAO is a well-known stabilizing osmolyte. In nature, TMAO can be found in organisms present in extreme environments, where the ability for proteins to maintain a folded state would be otherwise challenging [77, 78]. In fact, TMAO can counteract urea
[73, 79]. Like urea, the effect of TMAO is primarily governed by the TMAO-backbone interactions. However, there is a positive ΔGtr for the backbone into TMAO, meaning the transfer is unfavorable. Sidechains tend to have a slightly favorable transfer to TMAO, regardless of type [73]. Therefore, TMAO stabilizes proteins primarily by causing the protein to bury backbone to prevent unfavorable interactions, thereby shifting the equilibrium to the folded, often native and functional state [80].
Another solvent worth mentioning briefly is trifluoroethanol (TFE). Similar to
TMAO, the peptide backbone has a positive, unfavorable ΔGtr into TFE (see solubility measurements for ethanol [81]). Generally, this causes folding to be favorable due to
26 preferential exclusion of the alcohol from the backbone. However, TFE-protein hydrogen bonding is weaker than the water-protein hydrogen bonding, resulting in a preference for α-helix formation, which maximizes intramolecular hydrogen bonding, while also minimizing backbone solvent exposure [82].
iii. Solute-solute interactions
With the considerations from solvent-solute interactions in mind, we next turn to solute-solute interactions, specifically intramolecular protein-protein interactions such as those important in some secondary structure elements.
Electrostatics were identified early on as an important force in folding. As is now well- known, protein folding (and function) depends highly on pH and salt concentration of the buffer. The charged state of sidechains, and therefore overall protein net charge, change with pH. Protonation or deprotonation of sidechains may also result in the breaking of specific ion pairing (salt-bridges).
Protein solubility is also directly affected by electrostatics. A phenomenon known as "salting in" describes increased protein solubility at low salt concentrations. The electrostatic shielding effect of salt weakens the attractive electrostatic interactions that may form between adjacent protein molecules and result in non-specific aggregation.
"Salting out" describes the opposite effect occurring at high salt concentrations, where salt ions outcompete charged protein sidechains for solvent interactions. As a result, protein-protein interactions become more favorable than protein-solvent interactions, thereby causing aggregation or precipitation of the protein [64].
27
The isoelectric point, or pI, is defined as the pH at which a protein has no net charge, and therefore, the overall contribution to stability should be null. As the pH is shifted with the addition of acid, for example, the net charge increases with protonation of sidechains. Proteins generally exhibit lower stability outside the physiological pH range [83]. As the net charge increases, the charge density of the molecule also increases, and an increasing electrostatic repulsion will arise. It will then become more favorable for the protein to expand and unfold, thereby decreasing the effects of high charge density and electrostatic repulsion [58].
Electrostatic contributions also appear via specific ion pairing between charged sidechains. While such interactions were once thought to be the dominant folding force, they are now believed to contribute a free energy value 5- or 10-fold smaller than the contribution of the hydrophobic effect. The relatively low number of ion pairs observed in folded proteins, the low conservation of these residues, and the weak effect of mutating charged residues all offer evidence that electrostatics and specifically ion pairing are not the major driving force for folding [58]. Additionally, the formation of an ion pair causes a loss of entropy of the sidechains, and a loss of favorable solvent interactions, such that these will offset a portion of any benefit to folding [64].
Intramolecular hydrogen bonding was also once in the running for primary folding force, especially after Linus Pauling proposed α-helices and β-sheets as major structural elements of folded proteins [58, 62]. Nick Pace and co-workers have quite thoroughly investigated the contribution of hydrogen bonding and its effect on protein stability [62, 84, 85]. By making mutations to buried residues, they have shown that hydrogen bonding in the protein core increases the stability (favors folding), and the
28 burial of a polar residue could actually stabilize the protein greater than burial of a nonpolar residue (in certain situations) [62]. Not surprisingly, essentially all buried polar groups in known crystal structures are hydrogen bonded [86]. Hydrogen bonding is considered by others to play only a minor role, because while hydrogen bonding occurs in the folded state, it also occurs in the unfolded state, between the protein and water molecules [64]. Regardless of the magnitude of the stabilizing effect of hydrogen bonding on protein folding, hydrogen bonding has been suggested to contribute specificity, leading to a unique native structure [64, 87]. This is in contrast to the hydrophobic effect, which may lack specificity [88].
While transfer free energy estimations and hydrophobicity contributions provided useful estimates for predicting protein stability, the resulting Gibbs free energy change for unfolding values were in the range of 100-200 kcal/mol - about 10-fold larger than the observed Gibbs free energy change, ΔG, of unfolding [58]. It turns out the major missing force was a force which strongly opposes folding - entropy. Entropic effects can be classified as local or nonlocal. The local entropic forces deal with translational, rotational, and vibrational entropies expected for any small molecules. Specific ion pairing and secondary structure formation are features of the folded state which result in unfavorable entropic contributions, because they reduce the ability of those sidechains or backbone to sample additional configurations [58]. The nonlocal entropic contribution is due to excluded volume or steric restrictions, which are apparent when one considers a protein as a polymer chain, rather than individual amino acids. The nonlocal entropy contribution is a function of number of chain configurations (which increases with number of residues) and chain density (related to the occupied volume). Proteins in
29 their native, folded state are usually extremely compact, while the unfolded state is much expanded (favored by entropy). Important experimental evidence showing that entropy significantly opposes folding includes mutating residues to proline, thereby reducing configurational degrees of freedom in the unfolded state and observing increased protein stability [89, 90]. Additional support comes from observations that cross-linking and disulfide, which reduce the available configurations of the unfolded chain and therefore weakens the entropy contribution, results in significant increases in protein stability [58, 91].
30
E. Protein misfolding and natively unfolded proteins
The protein folding pathway in the cell includes a period during which hydrophobic regions of newly translated proteins are solvent-exposed and secondary structure elements are not yet formed. Chaperones and other cellular machinery have evolved to assist in proper protein folding, as well as detection and disposal of misfolded and aggregated proteins. Even with the extensive efforts by the cell to prevent misfolding, proteins can still elude quality-control, resulting in protein unfolding and/or aggregation that can lead to disease [92]. The first part of this section will focus on protein aggregation and one specific type of aggregation, amyloidogensis. The second part will focus on intrinsically disordered proteins having a native state lacking well-ordered structure seen in folded proteins.
i. Protein aggregation and amyloid formation
Protein aggregation is a generic term referring to the interaction of a large number of protein molecules, usually leading to visible, insoluble particles. Often, protein aggregation is nonspecific and results in loss of protein function. However, amyloidogenesis, or the formation of amyloid, is specific, ordered aggregation which may be associated with a gain or loss of protein function. Features of an amyloid traditionally include binding to dyes such as Congo Red or Thioflavin T, having primarily
β-sheet secondary structure, and showing a fibrillar morphology by electron microscopy
[92, 93]. Proteins which can form amyloids can also form non-ordered aggregates, termed amorphous or native-like aggregates [94, 95]. Amyloidogenesis typically shows a characteristic lag phase, where a monomer or base unit completely or partially unfolds
31 and takes on a conformation known as the nucleus. This nucleating species is the smallest unit which can initiate fibril elongation. The exponential or polymerization phase begins once the nucleating species is formed (or introduced via "seeding" - addition of pre-formed fibrils), and then aggregation into well-ordered fibrils occurs rapidly by the addition of monomers or single units. Following the exponential phase, saturation occurs and an equilibrium is reached where there is no net change in the length or number of fibrils [95, 96].
a. Amyloid stability
Once amyloid fibrils are formed, they are extremely stable, often more stable than the native state of the protein, and do not appear to be in equilibrium with non- aggregated states [97, 98]. The tensile strength of amyloid fibrils can approach that of steel [99]. The molecular basis for such stability is the extensive intermolecular hydrogen-bonding network along the protein backbone, as well as Van der Waals interactions [99-102]. Given the vast sequence diversity among amyloid-forming proteins, it is not surprising that the protein backbone is a major source of interactions which stabilize the amyloid [95], and it is in stark contrast to protein folding. As previously discussed, the primary determinant of protein folding is the hydrophobic effect, or the preference to bury hydrophobic sidechains. Specific sidechain contacts
[99], steric restrictions of proline [103], and amino acid identity [104], however, still play a notable role in amyloidogenesis. For example, hydrophobic residues tend to show higher aggregation propensities than polar residues [104].
32
b. Pathogenic vs. functional amyloid
Amyloids are often discussed in terms of human neurological diseases, such as
Alzheimer's (amyloid-β peptide), Huntington's (Huntingtin exon 1), and Parkinson's (α- synuclein) diseases, but amyloid deposits or inclusions are involved in about 70 different human diseases [95]. In the case of half of these diseases, the onset of disease correlates with aging, where gradual loss in the ability of cells to regulate protein misfolding and aggregation may lead to a greater amount of proteins passing through "quality control" unchecked [92, 95, 105]. In other words, the formation of amyloid appears to be accidental, and pathogenicity occurs as a result. Whether the amyloid fibrils or oligomeric intermediates are the toxic species is of particular interest for future therapeutic endeavors. Interestingly, many other cases have been documented in which amyloidogenesis is a highly regulated process which can be induced by the host organism for its own benefit. These amyloids are referred to as functional amyloids [95].
Functional amyloids have been described in bacterial [106-109], fungal [110], human [111], and archaeal [112] systems. Lower-level organisms, such as the bacteria, fungi, insects, and archaea tend to utilize amyloids for their physical strength, adding mechanical and chemical stability to structures such as biofilms, larvae or spores, and cell walls [112-114].
While functional amyloids share similar structural features with "traditional" or
"toxic" amyloids, the important difference is in the regulation of polymerization. The most well-understood example of a bacterial functional amyloid is curli produced by
Escherichia coli. Two separate operons are dedicated to curli assembly and regulation -
33 csgBAC and csgDEFG [106]. Curli fibrils themselves are composed from CsgA and
CsgB, where CsgB acts as the minor subunit which preferentially folds into a nucleating species on the surface of the bacterium. CsgA rapidly polymerizes in the presence of
CsgB. CsgC inhibits polymerization in the periplasm, allowing for CsgG to secrete the subunits into the extracellular space. CsgE and CsgF assist CsgG. CsgD is responsible for transcriptional activation of the csgBAC operon [106]. The function of curli fibrils includes colonization and biofilm formation, host tissue interaction, and immune evasion
[108, 109, 115]. Other bacterial functional amyloids act as adhesins, modulate surface properties, and attach to extracellular DNA to contribute to biofilm stability [109, 116,
117].
ii. Intrinsically disordered proteins
Intrinsically disordered proteins (IDPs) have taken many names during their exponential rise to fame through the 1990's and 2000's, including natively unfolded, intrinsically unstructured, dancing proteins, protein clouds, partially folded, etc. [118-
120]. Regardless of the specific terminology, IDPs are proteins which lack significant secondary structure and are often highly expanded or extended, lacking a compact, globular structure [118].
a. Factors determining conformational propensities
Considering the hydrophobic effect is the driving force leading to compact protein structure in well-folded proteins, it shouldn't be too surprising that hydrophobic residues are severely under-represented in IDPs [121]. The second strongest sequence-based
34 determinant of whether or not a protein is intrinsically disordered is net charge. Charge- hydropathy plots, especially one sometimes known as the "Uversky Plot," segregates
IDPs from folded proteins surprisingly well based on only two simple parameters [118].
Polar residues themselves are over-represented in IDPs, allowing for favorable interactions with water molecules in the solvent. In the case of sequences composed mostly of charged, polar residues, the main influence on compaction is actually the distribution or mixing of the charges. For instance, a well-mixed (i.e. positive-negative- positive-negative residues) sequence will remain highly extended - resembling self- avoiding random walks due to electrostatic repulsion, whereas a well-segregated sequence will be dominated by attractive electrostatic interactions, forming hairpins and a more compact ensemble of structures [122, 123]. The structural propensity of sequences which contain a lower number of overall charged residues are determined primarily by polyproline type-II helix propensity and weakly effected by electrostatic repulsions and α-helix propensity [124, 125].
IDPs have many conformations available to them - each with similarly favorable stability. This is very different from well-folded proteins, which usually have a single specific conformation with much higher stability than other possible conformations, causing that particular high stability conformation to be strongly preferred. The difference between these two cases is primarily due to the fact that IDPs lack the strong unfavorable interactions between the hydrophobic residues and solvent (i.e. the hydrophobic effect). Instead, IDPs rely heavily on (generally) weaker forces that must be well-balanced to avoid, on one hand, trapping a particular folded state (when not desired) and on the other hand, avoiding aggregation (e.g. α-synuclein and amyloid-β
35 are pathogenic, amyloid-forming IDPs). For example, many IDPs undergo folding upon binding, a process which demonstrates a favorable enthalpic contribution is able to overcome the entropic penalty of forming a more ordered structure or ensemble [126].
b. Functional roles of IDPs
The function of proteins has long been known to be closely tied to their structure
[127], and denaturation of folded proteins causing loss of activity was strong evidence for the case [128]. Evidence that unstructured regions could be functionally relevant started mounting when missing electron density in X-ray crystallography structures was observed for regions which had been shown to be important for function. NMR stepped in as a critical technique for examining these functionally important disordered regions
[121]. A revised hypothesis for the relationship between structure and function is called
"The Protein Trinity." The three states which compose the trinity are: ordered, molten globule and random coil. The ordered state refers to the well-folded, compact structure typically associated with function. The molten globule state is a partially folded state which has been proposed to be an intermediate in protein folding - with secondary structure similar to the ordered state, but a higher range of motion and a more expanded ensemble closer resembling random coil states. The random coil state is the least-structured state, able to exist in the greatest number of conformations. Each of these three states is proposed to be in equilibrium, and function can be related to a state or the transitions between [121]. The Protein Trinity has also been extended to
"The Protein Quartet" to accommodate both a molten globule and premolten globule
[129]. An important consideration when discussing disordered proteins is that "disorder
36
≠ disorder." IDPs can have different sequence compositions, degrees of compaction, responses to pH, salts, temperature, and co-solvents, and can even undergo folding upon binding to ligands [130, 131].
The function of IDPs is wide reaching and attempts have been made to organize classifications [131]. IDPs or IDRs (intrinsically disordered regions - often used interchangeably) in the entropic chains and springs category offer a way for proteins to keep domains positioned or spaced appropriately, and their disorder is directly important in this function. Some entropic chains are useful in harsh environments, where extreme temperatures or the presence of other denaturing conditions have no effect on the conformation of the protein/region, because the protein is already disordered [121, 132, 133]. Regions of disorder often are observed at sites of post- translation modifications or other areas where a particular motif needs to be easily accessible. Chaperones often contain disordered regions (over 1/3 disordered in the case of protein chaperones!), which can bind multiple different targets, have rapid association and disassociation, and fold upon binding. Effectors can be separate proteins, or they can be disordered regions of a protein, which will bind and modulate activity, often via allosteric mechanisms. Assemblers are usually IDRs which act as scaffolds to allow for protein binding and assembly of higher-order complexes. Finally, scavengers bind small ligands like ATP or tannin molecules, functioning as a sink for storage or to neutralize these ligands [131].
An analysis of the human proteome found that over 20% of all residues are located in regions predicted to be disordered. Furthermore, about 35% of proteins contain disordered regions longer than 30 residues, and 21.9% contain disordered
37 regions greater than 50 residues long [134]. Interestingly, bacteria and archaea average just 5.7% and 3.8% total residues disordered, respectively. This observation supports the importance of IDPs in signaling and regulation, given the increased networks of interaction found in humans [135]. Along with the important role of IDPs in signaling and important regulatory processes, comes the implication of IDPs in diseases when dysfunction occurs. In fact, over half of the proteins associated with cancer, cardiovascular disease, neurodegenerative diseases, and diabetes contain disordered regions at least 30 residues long [135]. IDPs have also been of recent interest as therapeutic targets due to their role in disease, ability to bind multiple partners, and the fact that amino acid sequence is the primary determinant of binding (as opposed to 3D structure in the case of folded proteins) [136, 137].
38
F. Goals of dissertation work
The Herr Lab has performed extensive biophysical and structural characterization of minimal B-repeat constructs containing one full B-repeat and the C- terminal half repeat cap (Brpt1.5) [36, 37, 56, 57]. Corrigan, et al. have demonstrated the importance of tandem B-repeats in S. aureus biofilm formation, by showing at least
5 B-repeats were required in SasG for biofilm formation to be observed [138].
Therefore, it was important to express constructs containing additional B-repeats.
Stefanie Johns, while in the Herr Lab, produced a construct which was originally believed to contain five and a half B-repeats, but was later found to be a Brpt3.5 construct after mass spectrometry analysis. The difficulty in working with multiple, nearly identical repeats, along with the increased accessibility of commercial gene synthesis, led to the decision to design well-defined Brpt3.5 and Brpt5.5 constructs to be ordered through LifeTechnologies' GeneArt Synthesis. Furthermore, the DNA sequence could be codon-optimized to introduce sequence uniqueness, allowing for easier mutagenesis downstream. These constructs were essential in creating a more biologically relevant study of the role of B-repeats. Particularly, we found that the Brpt3.5 and Brpt5.5 constructs were able to assemble beyond the monomer-dimer association observed using Brpt1.5 constructs, going on to form functional amyloid-like aggregates resembling extracellular material visible in S. epidermidis biofilms. The role of tandem
B-repeats in biofilm formation is the focus of Chapter II. An in-depth biophysical characterization of the early, reversible stages of Brpt5.5 assembly can be found in
Chapter III.
39
During the final years of dissertation work, a protein called small basic protein,
Sbp, was identified as playing an extensive role in S. epidermidis biofilm formation, from attachment to accumulation [24]. Sbp was isolated by running crude biofilm mixture over
B-repeat-coupled sepharose beads. Sbp, therefore, was predicted to be a binding partner of Aap. Additional experiments in this study provided convincing data to support such an interaction. Interestingly, a dissertation published by a lab member of a faculty involved in this initial study revealed a lack of Brpt1.5-Sbp interactions, based on gel filtration, native mass spectrometry, and microscale thermophoresis. At this point, we were well-aware of the fact that tandem B-repeats behave differently than the minimal
Brpt1.5 construct. Using our Brpt5.5 construct, we made a striking observation - Sbp rapidly induced aggregation of Brpt5.5 at Zn2+ concentrations nearly 10-fold lower than the concentration at which Brpt5.5 alone was expected to form this aggregate. Chapter
IV starts with a biophysical characterization of Sbp before diving into the mechanism of interaction between Sbp and Brpt5.5.
Despite the prevalence of "stalk-like' regions of low complexity among gram- positive, cell wall-anchored proteins, very little work has been done investigating the structure or function of these regions. The stalk-like region of Aap, the proline/glycine- rich region (PGR), will be a major focus of this dissertation work. In terms of the primary sequence, the 135-residue PGR has repeating patterns of AEPGKP, with some substitutions to AEPGTP, with more variation leading up to the LPXTG sortase motif.
Not surprisingly, given the frequency of Pro residues, there is no predicted secondary structure for this region, and a prediction of the hydrodynamic radius based on predicted polyproline type-II (PPII) helix results in a very elongated conformation due to extremely
40 high PPII propensity. This work is discussed in Chapter V. This work was furthered by investigating the PGR of SasG, the S. aureus ortholog of Aap, as well as the Ser/Asp- repeat regions of the Sdr family of proteins (see Chapter VI). In addition, we also performed a similar analysis of the A-repeat region of Aap, which is unstructured, but would presumably serve a different function than the stalk-like, PGR.
41
References
1. Otto M. Staphylococcus epidermidis--the 'accidental' pathogen. Nature reviews Microbiology. 2009;7(8):555-67. doi: 10.1038/nrmicro2182. PubMed PMID: 19609257; PubMed Central PMCID: PMC2807625. 2. Uckay I, Pittet D, Vaudaux P, Sax H, Lew D, Waldvogel F. Foreign body infections due to Staphylococcus epidermidis. Annals of medicine. 2009;41(2):109-19. Epub 2008/08/23. doi: 10.1080/07853890802337045. PubMed PMID: 18720093. 3. CDC. National Nosocomial Infections Surveillance (NNIS) system report. 4. Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infectious disease clinics of North America. 2009;23(1):73-98. Epub 2009/01/13. doi: 10.1016/j.idc.2008.10.001. PubMed PMID: 19135917. 5. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science (New York, NY). 1999;284(5418):1318-22. Epub 1999/05/21. PubMed PMID: 10334980. 6. Otto M. Staphylococcal biofilms. Current topics in microbiology and immunology. 2008;322:207-28. Epub 2008/05/06. PubMed PMID: 18453278; PubMed Central PMCID: PMCPmc2777538. 7. Arrecubieta C, Lee MH, Macey A, Foster TJ, Lowy FD. SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen. The Journal of biological chemistry. 2007;282(26):18767-76. Epub 2007/05/03. doi: 10.1074/jbc.M610940200. PubMed PMID: 17472965. 8. Dickinson GM, Bisno AL. Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices. Antimicrobial agents and chemotherapy. 1989;33(5):597-601. Epub 1989/05/01. PubMed PMID: 2665637; PubMed Central PMCID: PMCPMC172496. 9. Heilmann C, Hussain M, Peters G, Gotz F. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Molecular microbiology. 1997;24(5):1013-24. Epub 1997/06/01. PubMed PMID: 9220008. 10. Heilmann C, Thumm G, Chhatwal GS, Hartleib J, Uekotter A, Peters G. Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology (Reading, England). 2003;149(Pt 10):2769-78. Epub 2003/10/03. doi: 10.1099/mic.0.26527-0. PubMed PMID: 14523110. 11. Bowden MG, Chen W, Singvall J, Xu Y, Peacock SJ, Valtulina V, et al. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology (Reading, England). 2005;151(5):1453-64. doi: doi:10.1099/mic.0.27534-0. 12. Marraffini LA, Dedent AC, Schneewind O. Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiology and molecular biology reviews : MMBR. 2006;70(1):192-221. Epub 2006/03/10. doi: 10.1128/mmbr.70.1.192- 221.2006. PubMed PMID: 16524923; PubMed Central PMCID: PMCPmc1393253. 13. Herman P, El-Kirat-Chatel S, Beaussart A, Geoghegan JA, Foster TJ, Dufrene YF. The binding force of the staphylococcal adhesin SdrG is remarkably strong. Molecular microbiology. 2014;93(2):356-68. Epub 2014/06/06. doi: 10.1111/mmi.12663. PubMed PMID: 24898289.
42
14. Vanzieleghem T, Herman-Bausier P, Dufrene YF, Mahillon J. Staphylococcus epidermidis Affinity for Fibrinogen-Coated Surfaces Correlates with the Abundance of the SdrG Adhesin on the Cell Surface. Langmuir : the ACS journal of surfaces and colloids. 2015;31(16):4713-21. Epub 2015/03/31. doi: 10.1021/acs.langmuir.5b00360. PubMed PMID: 25821995. 15. Herman-Bausier P, Dufrene YF. Atomic force microscopy reveals a dual collagen-binding activity for the staphylococcal surface protein SdrF. Molecular microbiology. 2016;99(3):611-21. Epub 2015/10/21. doi: 10.1111/mmi.13254. PubMed PMID: 26481199. 16. Ponnuraj K, Bowden MG, Davis S, Gurusiddappa S, Moore D, Choe D, et al. A "dock, lock, and latch" structural model for a staphylococcal adhesin binding to fibrinogen. Cell. 2003;115(2):217-28. Epub 2003/10/22. PubMed PMID: 14567919. 17. Trivedi S, Uhlemann AC, Herman-Bausier P, Sullivan SB, Sowash MG, Flores EY, et al. The Surface Protein SdrF Mediates Staphylococcus epidermidis Adherence to Keratin. The Journal of infectious diseases. 2017;215(12):1846-54. Epub 2017/05/10. doi: 10.1093/infdis/jix213. PubMed PMID: 28482041; PubMed Central PMCID: PMCPMC5853823. 18. McCrea KW, Hartford O, Davis S, Eidhin DN, Lina G, Speziale P, et al. The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. Microbiology (Reading, England). 2000;146 ( Pt 7):1535-46. Epub 2000/07/06. doi: 10.1099/00221287-146-7-1535. PubMed PMID: 10878118. 19. Vacheethasanee K, Temenoff JS, Higashi JM, Gary A, Anderson JM, Bayston R, et al. Bacterial surface properties of clinically isolated Staphylococcus epidermidis strains determine adhesion on polyethylene. Journal of biomedical materials research. 1998;42(3):425-32. Epub 1998/10/27. PubMed PMID: 9788506. 20. Tormo MA, Knecht E, Gotz F, Lasa I, Penades JR. Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology (Reading, England). 2005;151(Pt 7):2465-75. Epub 2005/07/08. doi: 10.1099/mic.0.27865-0. PubMed PMID: 16000737. 21. Poxton IR. Chapter 5 - Teichoic Acids, Lipoteichoic Acids and Other Secondary Cell Wall and Membrane Polysaccharides of Gram-Positive Bacteria. In: Tang Y-W, Sussman M, Liu D, Poxton I, Schwartzman J, editors. Molecular Medical Microbiology (Second Edition). Boston: Academic Press; 2015. p. 91-103. 22. Weidenmaier C, Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nature reviews Microbiology. 2008;6(4):276-87. Epub 2008/03/11. doi: 10.1038/nrmicro1861. PubMed PMID: 18327271. 23. Gross M, Cramton SE, Gotz F, Peschel A. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infection and immunity. 2001;69(5):3423-6. Epub 2001/04/09. doi: 10.1128/iai.69.5.3423-3426.2001. PubMed PMID: 11292767; PubMed Central PMCID: PMCPMC98303. 24. Decker R, Burdelski C, Zobiak M, Buttner H, Franke G, Christner M, et al. An 18 kDa scaffold protein is critical for Staphylococcus epidermidis biofilm formation. PLoS pathogens. 2015;11(3):e1004735. Epub 2015/03/24. doi: 10.1371/journal.ppat.1004735. PubMed PMID: 25799153; PubMed Central PMCID: PMCPmc4370877.
43
25. Rohde H, Burdelski C, Bartscht K, Hussain M, Buck F, Horstkotte MA, et al. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Molecular microbiology. 2005;55(6):1883-95. doi: 10.1111/j.1365-2958.2005.04515.x. PubMed PMID: 15752207. 26. Macintosh RL, Brittan JL, Bhattacharya R, Jenkinson HF, Derrick J, Upton M, et al. The terminal A domain of the fibrillar accumulation-associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human corneocytes. Journal of bacteriology. 2009;191(22):7007-16. Epub 2009/09/15. doi: 10.1128/jb.00764-09. PubMed PMID: 19749046; PubMed Central PMCID: PMCPmc2772481. 27. Conlon BP, Geoghegan JA, Waters EM, McCarthy H, Rowe SE, Davies JR, et al. Role for the A domain of unprocessed accumulation-associated protein (Aap) in the attachment phase of the Staphylococcus epidermidis biofilm phenotype. Journal of bacteriology. 2014;196(24):4268-75. Epub 2014/10/01. doi: 10.1128/jb.01946-14. PubMed PMID: 25266380; PubMed Central PMCID: PMCPmc4248850. 28. Schaeffer CR, Woods KM, Longo GM, Kiedrowski MR, Paharik AE, Buttner H, et al. Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model. Infection and immunity. 2015;83(1):214-26. Epub 2014/10/22. doi: 10.1128/iai.02177- 14. PubMed PMID: 25332125; PubMed Central PMCID: PMCPmc4288872. 29. Paharik AE, Kotasinska M, Both A, Hoang TN, Buttner H, Roy P, et al. The metalloprotease SepA governs processing of accumulation-associated protein and shapes intercellular adhesive surface properties in Staphylococcus epidermidis. Molecular microbiology. 2016. Epub 2016/12/21. doi: 10.1111/mmi.13594. PubMed PMID: 27997732. 30. Gerke C, Kraft A, Sussmuth R, Schweitzer O, Gotz F. Characterization of the N- acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. The Journal of biological chemistry. 1998;273(29):18586-93. Epub 1998/07/11. PubMed PMID: 9660830. 31. Mack D, Nedelmann M, Krokotsch A, Schwarzkopf A, Heesemann J, Laufs R. Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infection and immunity. 1994;62(8):3244-53. Epub 1994/08/01. PubMed PMID: 8039894; PubMed Central PMCID: PMCPMC302952. 32. Hussain M, Herrmann M, von Eiff C, Perdreau-Remington F, Peters G. A 140- kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infection and immunity. 1997;65(2):519-24. Epub 1997/02/01. PubMed PMID: 9009307; PubMed Central PMCID: PMCPmc176090. 33. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials. 2007;28(9):1711-20. doi: 10.1016/j.biomaterials.2006.11.046. PubMed PMID: 17187854.
44
34. Hennig S, Nyunt Wai S, Ziebuhr W. Spontaneous switch to PIA-independent biofilm formation in an ica-positive Staphylococcus epidermidis isolate. International journal of medical microbiology : IJMM. 2007;297(2):117-22. Epub 2007/02/13. doi: 10.1016/j.ijmm.2006.12.001. PubMed PMID: 17292669. 35. Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR, et al. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. The Journal of biological chemistry. 2004;279(52):54881-6. Epub 2004/10/27. doi: 10.1074/jbc.M411374200. PubMed PMID: 15501828. 36. Conrady DG, Brescia CC, Horii K, Weiss AA, Hassett DJ, Herr AB. A zinc- dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(49):19456-61. doi: 10.1073/pnas.0807717105. PubMed PMID: 19047636; PubMed Central PMCID: PMC2592360. 37. Conrady DG, Wilson JJ, Herr AB. Structural basis for Zn2+-dependent intercellular adhesion in staphylococcal biofilms. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(3):E202-11. Epub 2013/01/02. doi: 10.1073/pnas.1208134110. PubMed PMID: 23277549; PubMed Central PMCID: PMCPmc3549106. 38. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. The Journal of infectious diseases. 2003;188(5):706-18. Epub 2003/08/23. doi: 10.1086/377239. PubMed PMID: 12934187. 39. Vuong C, Kocianova S, Yao Y, Carmody AB, Otto M. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. The Journal of infectious diseases. 2004;190(8):1498-505. Epub 2004/09/21. doi: 10.1086/424487. PubMed PMID: 15378444. 40. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus aureus biofilms. Journal of bacteriology. 2004;186(6):1838-50. Epub 2004/03/05. PubMed PMID: 14996815; PubMed Central PMCID: PMCPMC355980. 41. Teufel P, Gotz F. Characterization of an extracellular metalloprotease with elastase activity from Staphylococcus epidermidis. Journal of bacteriology. 1993;175(13):4218-24. Epub 1993/07/01. PubMed PMID: 8320236; PubMed Central PMCID: PMCPMC204852. 42. Dubin G, Chmiel D, Mak P, Rakwalska M, Rzychon M, Dubin A. Molecular cloning and biochemical characterisation of proteases from Staphylococcus epidermidis. Biological chemistry. 2001;382(11):1575-82. Epub 2002/01/05. doi: 10.1515/bc.2001.192. PubMed PMID: 11767947. 43. Ohara-Nemoto Y, Ikeda Y, Kobayashi M, Sasaki M, Tajika S, Kimura S. Characterization and molecular cloning of a glutamyl endopeptidase from Staphylococcus epidermidis. Microbial pathogenesis. 2002;33(1):33-41. Epub 2002/07/20. PubMed PMID: 12127798. 44. Kaplan JB, Ragunath C, Velliyagounder K, Fine DH, Ramasubbu N. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrobial agents and chemotherapy. 2004;48(7):2633-6. Epub 2004/06/25. doi: 10.1128/aac.48.7.2633- 2636.2004. PubMed PMID: 15215120; PubMed Central PMCID: PMCPMC434209. 45. Heilmann C, Schweitzer O, Gerke C, Vanittanakom N, Mack D, Gotz F. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus
45 epidermidis. Molecular microbiology. 1996;20(5):1083-91. Epub 1996/06/01. PubMed PMID: 8809760. 46. Cramton SE, Ulrich M, Gotz F, Doring G. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infection and immunity. 2001;69(6):4079-85. Epub 2001/05/12. doi: 10.1128/iai.69.6.4079-4085.2001. PubMed PMID: 11349079; PubMed Central PMCID: PMCPMC98472. 47. Rachid S, Ohlsen K, Witte W, Hacker J, Ziebuhr W. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm- forming Staphylococcus epidermidis. Antimicrobial agents and chemotherapy. 2000;44(12):3357-63. Epub 2000/11/18. PubMed PMID: 11083640; PubMed Central PMCID: PMCPMC90205. 48. Knobloch JK, Bartscht K, Sabottke A, Rohde H, Feucht HH, Mack D. Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress. Journal of bacteriology. 2001;183(8):2624-33. Epub 2001/03/29. doi: 10.1128/jb.183.8.2624-2633.2001. PubMed PMID: 11274123; PubMed Central PMCID: PMCPMC95180. 49. Tormo MA, Marti M, Valle J, Manna AC, Cheung AL, Lasa I, et al. SarA is an essential positive regulator of Staphylococcus epidermidis biofilm development. Journal of bacteriology. 2005;187(7):2348-56. Epub 2005/03/19. doi: 10.1128/jb.187.7.2348- 2356.2005. PubMed PMID: 15774878; PubMed Central PMCID: PMCPMC1065223. 50. Xu L, Li H, Vuong C, Vadyvaloo V, Wang J, Yao Y, et al. Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis. Infection and immunity. 2006;74(1):488-96. Epub 2005/12/22. doi: 10.1128/iai.74.1.488-496.2006. PubMed PMID: 16369005; PubMed Central PMCID: PMCPMC1346618. 51. Giormezis N, Kolonitsiou F, Foka A, Drougka E, Liakopoulos A, Makri A, et al. Coagulase-negative staphylococcal bloodstream and prosthetic-device-associated infections: the role of biofilm formation and distribution of adhesin and toxin genes. Journal of medical microbiology. 2014;63(Pt 11):1500-8. Epub 2014/08/02. doi: 10.1099/jmm.0.075259-0. PubMed PMID: 25082946. 52. Timmerman CP, Fleer A, Besnier JM, De Graaf L, Cremers F, Verhoef J. Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene. Infection and immunity. 1991;59(11):4187-92. Epub 1991/11/01. PubMed PMID: 1682256; PubMed Central PMCID: PMCPMC259015. 53. Pascual A, Fleer A, Westerdaal NA, Verhoef J. Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro. European journal of clinical microbiology. 1986;5(5):518-22. Epub 1986/10/01. PubMed PMID: 3096727. 54. Hogt AH, Dankert J, Hulstaert CE, Feijen J. Cell surface characteristics of coagulase-negative staphylococci and their adherence to fluorinated poly(ethylenepropylene). Infection and immunity. 1986;51(1):294-301. Epub 1986/01/01. PubMed PMID: 3940998; PubMed Central PMCID: PMCPMC261101. 55. Schumacher-Perdreau F, Heilmann C, Peters G, Gotz F, Pulverer G. Comparative analysis of a biofilm-forming Staphylococcus epidermidis strain and its
46 adhesion-positive, accumulation-negative mutant M7. FEMS microbiology letters. 1994;117(1):71-8. Epub 1994/03/15. PubMed PMID: 8181711. 56. Shelton CL, Conrady DG, Herr AB. Functional consequences of B-repeat sequence variation in the staphylococcal biofilm protein Aap: deciphering the assembly code. Biochemical Journal. 2017;474(3):427-43. doi: 10.1042/bcj20160675. 57. Chaton CT, Herr AB. Defining the metal specificity of a multifunctional biofilm adhesion protein. Protein science : a publication of the Protein Society. 2017. Epub 2017/07/15. doi: 10.1002/pro.3232. PubMed PMID: 28707417. 58. Dill KA. Dominant forces in protein folding. Biochemistry. 1990;29(31):7133-55. doi: 10.1021/bi00483a001. 59. Kauzmann W. Some factors in the interpretation of protein denaturation. Advances in protein chemistry. 1959;14:1-63. Epub 1959/01/01. PubMed PMID: 14404936. 60. Tanford C. How protein chemists learned about the hydrophobic factor. Protein Science. 1997;6(6):1358-66. doi: doi:10.1002/pro.5560060627. 61. Pace CN, Hermans J. The Stability of Globular Protein. CRC Critical Reviews in Biochemistry. 1975;3(1):1-43. doi: 10.3109/10409237509102551. 62. Pace CN, Trevino S, Prabhakaran E, Scholtz JM. Protein structure, stability and solubility in water and other solvents. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2004;359(1448):1225-34; discussion 34-5. Epub 2004/08/13. doi: 10.1098/rstb.2004.1500. PubMed PMID: 15306378; PubMed Central PMCID: PMCPMC1693406. 63. Pace CN, Fu H, Fryar KL, Landua J, Trevino SR, Shirley BA, et al. Contribution of Hydrophobic Interactions to Protein Stability. Journal of molecular biology. 2011;408(3):514-28. doi: https://doi.org/10.1016/j.jmb.2011.02.053. 64. Voet D, Voet JG, Pratt CW. Fundamentals of biochemistry: life at the molecular level. 3rd ed. Hoboken, N.J: Wiley; 2008. 65. Wertz DH, Scheraga HA. Influence of water on protein structure. An analysis of the preferences of amino acid residues for the inside or outside and for specific conformations in a protein molecule. Macromolecules. 1978;11(1):9-15. Epub 1978/01/01. PubMed PMID: 621952. 66. Lim WA, Sauer RT. Alternative packing arrangements in the hydrophobic core of lambda repressor. Nature. 1989;339(6219):31-6. Epub 1989/05/04. doi: 10.1038/339031a0. PubMed PMID: 2524006. 67. Laue T. Charge matters. Biophysical reviews. 2016;8(4):287-9. Epub 2017/05/17. doi: 10.1007/s12551-016-0229-3. PubMed PMID: 28510017; PubMed Central PMCID: PMCPMC5425809. 68. Nozaki Y, Tanford C. The solubility of amino acids and related compounds in aqueous urea solutions. The Journal of biological chemistry. 1963;238:4074-81. Epub 1963/12/01. PubMed PMID: 14086747. 69. Tanford C. Isothermal Unfolding of Globular Proteins in Aqueous Urea Solutions. J Am Chem Soc. 1964;86(10):2050-9. 70. Cohn EJ, Edsall JT. Proteins, amino acids and peptides as ions and dipolar ions. New York U6 - ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF- 8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt %3Akev%3Amtx%3Abook&rft.genre=book&rft.title=Proteins%2C+amino+acids+and+pe
47 ptides+as+ions+and+dipolar+ions&rft.au=Cohn%2C+Edwin+Joseph&rft.au=Edsall%2C +John+T&rft.series=American+Chemical+Society.+Monograph+series&rft.date=1943&rf t.pub=Reinhold+Publishing+Corporation&rft.volume=no.+90&rft.externalDocID=b18383 415¶mdict=en-US U7 - Book: Reinhold Publishing Corporation; 1943. 71. Robinson DR, Jencks WP. Effect of denaturing agents of the urea-guanidinium class on the solubility of acetyltetraglycine ethyl ester and related compounds. The Journal of biological chemistry. 1963;238:1558-60. Epub 1963/04/01. PubMed PMID: 13974427. 72. Kajander T, Kahn PC, Passila SH, Cohen DC, Lehtiö L, Adolfsen W, et al. Buried Charged Surface in Proteins. Structure. 2000;8(11):1203-14. doi: 10.1016/S0969- 2126(00)00520-7. 73. Auton M, Rosgen J, Sinev M, Holthauzen LM, Bolen DW. Osmolyte effects on protein stability and solubility: a balancing act between backbone and side-chains. Biophysical chemistry. 2011;159(1):90-9. Epub 2011/06/21. doi: 10.1016/j.bpc.2011.05.012. PubMed PMID: 21683504; PubMed Central PMCID: PMCPmc3166983. 74. Canchi Deepak R, García Angel E. Backbone and Side-Chain Contributions in Protein Denaturation by Urea. Biophysical Journal. 2011;100(6):1526-33. doi: https://doi.org/10.1016/j.bpj.2011.01.028. 75. Moeser B, Horinek D. Unified Description of Urea Denaturation: Backbone and Side Chains Contribute Equally in the Transfer Model. The Journal of Physical Chemistry B. 2014;118(1):107-14. doi: 10.1021/jp409934q. 76. Das A, Mukhopadhyay C. Urea-mediated protein denaturation: a consensus view. The journal of physical chemistry B. 2009;113(38):12816-24. Epub 2009/08/28. doi: 10.1021/jp906350s. PubMed PMID: 19708649. 77. Bolen DW, Baskakov IV. The osmophobic effect: natural selection of a thermodynamic force in protein folding. Journal of molecular biology. 2001;310(5):955- 63. Epub 2001/08/15. doi: 10.1006/jmbi.2001.4819. PubMed PMID: 11502004. 78. Yancey PH, Clark ME, Hand SC, Bowlus RD, Somero GN. Living with water stress: evolution of osmolyte systems. Science (New York, NY). 1982;217(4566):1214- 22. Epub 1982/09/24. PubMed PMID: 7112124. 79. Schaub LJ, Campbell JC, Whitten ST. Thermal unfolding of the N-terminal region of p53 monitored by circular dichroism spectroscopy. Protein science : a publication of the Protein Society. 2012;21(11):1682-8. Epub 2012/08/24. doi: 10.1002/pro.2146. PubMed PMID: 22915551; PubMed Central PMCID: PMCPmc3527704. 80. Baskakov I, Bolen DW. Forcing thermodynamically unfolded proteins to fold. The Journal of biological chemistry. 1998;273(9):4831-4. Epub 1998/03/28. PubMed PMID: 9478922. 81. Nozaki Y, Tanford C. The solubility of amino acids and two glycine peptides in aqueous ethanol and dioxane solutions. Establishment of a hydrophobicity scale. The Journal of biological chemistry. 1971;246(7):2211-7. Epub 1971/04/10. PubMed PMID: 5555568. 82. Cammers-Goodwin A, Allen TJ, Oslick SL, McClure KF, Lee JH, Kemp DS. Mechanism of Stabilization of Helical Conformations of Polypeptides by Water Containing Trifluoroethanol. Journal of the American Chemical Society. 1996;118(13):3082-90. doi: 10.1021/ja952900z.
48
83. Privalov PL, Khechinashvili NN. A thermodynamic approach to the problem of stabilization of globular protein structure: a calorimetric study. Journal of molecular biology. 1974;86(3):665-84. Epub 1974/07/05. PubMed PMID: 4368360. 84. Myers JK, Pace CN. Hydrogen bonding stabilizes globular proteins. Biophysical Journal. 1996;71(4):2033-9. doi: https://doi.org/10.1016/S0006-3495(96)79401-8. 85. Pace CN, Horn G, Hebert EJ, Bechert J, Shaw K, Urbanikova L, et al. Tyrosine hydrogen bonds make a large contribution to protein stability. Journal of molecular biology. 2001;312(2):393-404. Epub 2001/09/14. doi: 10.1006/jmbi.2001.4956. PubMed PMID: 11554795. 86. Stickle DF, Presta LG, Dill KA, Rose GD. Hydrogen bonding in globular proteins. Journal of molecular biology. 1992;226(4):1143-59. Epub 1992/08/20. PubMed PMID: 1518048. 87. Fitzkee NC, Fleming PJ, Gong H, Panasik N, Street TO, Rose GD. Are proteins made from a limited parts list? Trends in Biochemical Sciences. 2005;30(2):73-80. doi: https://doi.org/10.1016/j.tibs.2004.12.005. 88. Bertagna AM, Barrick D. Nonspecific hydrophobic interactions stabilize an equilibrium intermediate of apomyoglobin at a key position within the AGH region. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(34):12514-9. Epub 2004/08/18. doi: 10.1073/pnas.0404760101. PubMed PMID: 15314218; PubMed Central PMCID: PMCPMC515089. 89. Matthews BW, Nicholson H, Becktel WJ. Enhanced protein thermostability from site-directed mutations that decrease the entropy of unfolding. Proceedings of the National Academy of Sciences of the United States of America. 1987;84(19):6663-7. Epub 1987/10/01. PubMed PMID: 3477797; PubMed Central PMCID: PMCPMC299143. 90. Nicholson H, Tronrud DE, Becktel WJ, Matthews BW. Analysis of the effectiveness of proline substitutions and glycine replacements in increasing the stability of phage T4 lysozyme. Biopolymers. 1992;32(11):1431-41. Epub 1992/11/01. doi: 10.1002/bip.360321103. PubMed PMID: 1457724. 91. Pace CN, Grimsley GR, Thomson JA, Barnett BJ. Conformational stability and activity of ribonuclease T1 with zero, one, and two intact disulfide bonds. The Journal of biological chemistry. 1988;263(24):11820-5. Epub 1988/08/25. PubMed PMID: 2457027. 92. Dobson CM. Protein folding and misfolding. Nature. 2003;426(6968):884-90. Epub 2003/12/20. doi: 10.1038/nature02261. PubMed PMID: 14685248. 93. Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods (San Diego, Calif). 2004;34(1):151-60. Epub 2004/07/31. doi: 10.1016/j.ymeth.2004.03.012. PubMed PMID: 15283924. 94. Vetri V, Canale C, Relini A, Librizzi F, Militello V, Gliozzi A, et al. Amyloid fibrils formation and amorphous aggregation in concanavalin A. Biophysical chemistry. 2007;125(1):184-90. doi: http://doi.org/10.1016/j.bpc.2006.07.012. 95. Chiti F, Dobson CM. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annual review of biochemistry. 2017;86:27-68. Epub 2017/05/13. doi: 10.1146/annurev-biochem-061516-045115. PubMed PMID: 28498720.
49
96. Zhao R, So M, Maat H, Ray NJ, Arisaka F, Goto Y, et al. Measurement of amyloid formation by turbidity assay-seeing through the cloud. Biophysical reviews. 2016;8(4):445-71. Epub 2016/12/23. doi: 10.1007/s12551-016-0233-7. PubMed PMID: 28003859; PubMed Central PMCID: PMCPMC5135725. 97. Gazit E. The "Correctly Folded" state of proteins: is it a metastable state? Angewandte Chemie (International ed in English). 2002;41(2):257-9. Epub 2002/12/20. PubMed PMID: 12491403. 98. Baldwin AJ, Knowles TP, Tartaglia GG, Fitzpatrick AW, Devlin GL, Shammas SL, et al. Metastability of native proteins and the phenomenon of amyloid formation. J Am Chem Soc. 2011;133(36):14160-3. Epub 2011/06/10. doi: 10.1021/ja2017703. PubMed PMID: 21650202. 99. Knowles TP, Fitzpatrick AW, Meehan S, Mott HR, Vendruscolo M, Dobson CM, et al. Role of intermolecular forces in defining material properties of protein nanofibrils. Science (New York, NY). 2007;318(5858):1900-3. Epub 2007/12/22. doi: 10.1126/science.1150057. PubMed PMID: 18096801. 100. Fandrich M, Dobson CM. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. The EMBO journal. 2002;21(21):5682- 90. Epub 2002/11/02. PubMed PMID: 12411486; PubMed Central PMCID: PMCPMC131070. 101. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature. 2005;435(7043):773-8. doi: 10.1038/nature03680. PubMed PMID: 15944695; PubMed Central PMCID: PMC1479801. 102. Erskine E, MacPhee CE, Stanley-Wall NR. Functional Amyloid and Other Protein Fibers in the Biofilm Matrix. Journal of molecular biology. 2018;430(20):3642-56. doi: https://doi.org/10.1016/j.jmb.2018.07.026. 103. Williams AD, Portelius E, Kheterpal I, Guo J-t, Cook KD, Xu Y, et al. Mapping Aβ Amyloid Fibril Secondary Structure Using Scanning Proline Mutagenesis. Journal of molecular biology. 2004;335(3):833-42. doi: https://doi.org/10.1016/j.jmb.2003.11.008. 104. Sanchez de Groot N, Pallares I, Aviles FX, Vendrell J, Ventura S. Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC structural biology. 2005;5:18. Epub 2005/10/04. doi: 10.1186/1472-6807-5-18. PubMed PMID: 16197548; PubMed Central PMCID: PMCPMC1262731. 105. Csermely P. Chaperone overload is a possible contributor to 'civilization diseases'. Trends in genetics : TIG. 2001;17(12):701-4. Epub 2001/11/24. PubMed PMID: 11718923. 106. Deshmukh M, Evans ML, Chapman MR. Amyloid by Design: Intrinsic Regulation of Microbial Amyloid Assembly. Journal of molecular biology. 2018;430(20):3631-41. doi: https://doi.org/10.1016/j.jmb.2018.07.007. 107. Taglialegna A, Lasa I, Valle J. Amyloid Structures as Biofilm Matrix Scaffolds. Journal of bacteriology. 2016;198(19):2579-88. Epub 2016/05/18. doi: 10.1128/jb.00122-16. PubMed PMID: 27185827; PubMed Central PMCID: PMCPMC5019065. 108. Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science (New
50
York, NY). 2002;295(5556):851-5. Epub 2002/02/02. doi: 10.1126/science.1067484. PubMed PMID: 11823641; PubMed Central PMCID: PMCPmc2838482. 109. Romero D, Kolter R. Functional amyloids in bacteria. International microbiology : the official journal of the Spanish Society for Microbiology. 2014;17(2):65-73. Epub 2014/06/01. doi: 10.2436/20.1501.01.208. PubMed PMID: 26418850. 110. King CY, Tittmann P, Gross H, Gebert R, Aebi M, Wuthrich K. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(13):6618-22. Epub 1997/06/24. PubMed PMID: 9192614; PubMed Central PMCID: PMCPMC21207. 111. Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW. Functional amyloid formation within mammalian tissue. PLoS biology. 2006;4(1):e6. Epub 2005/11/23. doi: 10.1371/journal.pbio.0040006. PubMed PMID: 16300414; PubMed Central PMCID: PMCPMC1288039. 112. Dueholm MS, Larsen P, Finster K, Stenvang MR, Christiansen G, Vad BS, et al. The Tubular Sheaths Encasing Methanosaeta thermophila Filaments Are Functional Amyloids. The Journal of biological chemistry. 2015;290(33):20590-600. Epub 2015/06/26. doi: 10.1074/jbc.M115.654780. PubMed PMID: 26109065; PubMed Central PMCID: PMCPMC4536462. 113. Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid--from bacteria to humans. Trends Biochem Sci. 2007;32(5):217-24. Epub 2007/04/07. doi: 10.1016/j.tibs.2007.03.003. PubMed PMID: 17412596. 114. Larsen P, Nielsen JL, Dueholm MS, Wetzel R, Otzen D, Nielsen PH. Amyloid adhesins are abundant in natural biofilms. Environmental microbiology. 2007;9(12):3077-90. Epub 2007/11/10. doi: 10.1111/j.1462-2920.2007.01418.x. PubMed PMID: 17991035. 115. Blanco LP, Evans ML, Smith DR, Badtke MP, Chapman MR. Diversity, biogenesis and function of microbial amyloids. Trends in microbiology. 2012;20(2):66- 73. Epub 2011/12/27. doi: 10.1016/j.tim.2011.11.005. PubMed PMID: 22197327; PubMed Central PMCID: PMCPMC3278576. 116. Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS pathogens. 2012;8(6):e1002744. Epub 2012/06/12. doi: 10.1371/journal.ppat.1002744. PubMed PMID: 22685403; PubMed Central PMCID: PMCPMC3369951. 117. Zheng Y, Joo HS, Nair V, Le KY, Otto M. Do amyloid structures formed by Staphylococcus aureus phenol-soluble modulins have a biological function? International journal of medical microbiology : IJMM. 2017. Epub 2017/09/05. doi: 10.1016/j.ijmm.2017.08.010. PubMed PMID: 28867522. 118. Uversky VN, Gillespie JR, Fink AL. Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins. 2000;41(3):415-27. Epub 2000/10/12. PubMed PMID: 11025552. 119. Uversky VN. Intrinsically disordered proteins from A to Z. The international journal of biochemistry & cell biology. 2011;43(8):1090-103. Epub 2011/04/20. doi: 10.1016/j.biocel.2011.04.001. PubMed PMID: 21501695.
51
120. Oldfield CJ, Dunker AK. Intrinsically disordered proteins and intrinsically disordered protein regions. Annual review of biochemistry. 2014;83:553-84. Epub 2014/03/13. doi: 10.1146/annurev-biochem-072711-164947. PubMed PMID: 24606139. 121. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, et al. Intrinsically disordered protein. Journal of molecular graphics & modelling. 2001;19(1):26-59. Epub 2001/05/31. PubMed PMID: 11381529. 122. Das RK, Pappu RV. Conformations of intrinsically disordered proteins are influenced by linear sequence distributions of oppositely charged residues. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(33):13392-7. Epub 2013/08/01. doi: 10.1073/pnas.1304749110. PubMed PMID: 23901099; PubMed Central PMCID: PMCPmc3746876. 123. Mao AH, Crick SL, Vitalis A, Chicoine CL, Pappu RV. Net charge per residue modulates conformational ensembles of intrinsically disordered proteins. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(18):8183- 8. Epub 2010/04/21. doi: 10.1073/pnas.0911107107. PubMed PMID: 20404210; PubMed Central PMCID: PMCPmc2889596. 124. Tomasso ME, Tarver MJ, Devarajan D, Whitten ST. Hydrodynamic Radii of Intrinsically Disordered Proteins Determined from Experimental Polyproline II Propensities. PLoS computational biology. 2016;12(1):e1004686. Epub 2016/01/05. doi: 10.1371/journal.pcbi.1004686. PubMed PMID: 26727467. 125. English LR, Tilton EC, Ricard BJ, Whitten ST. Intrinsic alpha helix propensities compact hydrodynamic radii in intrinsically disordered proteins. Proteins. 2017;85(2):296-311. Epub 2016/12/10. doi: 10.1002/prot.25222. PubMed PMID: 27936491; PubMed Central PMCID: PMCPMC5258847. 126. Dyson HJ, Wright PE. Intrinsically unstructured proteins and their functions. Nature Reviews Molecular Cell Biology. 2005;6:197. doi: 10.1038/nrm1589. 127. Fischer E. Einfluss der Configuration auf die Wirkung der Enzyme. Berichte der deutschen chemischen Gesellschaft. 1894;27(3):2985-93. doi: 10.1002/cber.18940270364. 128. Mirsky AE, Pauling L. On the Structure of Native, Denatured, and Coagulated Proteins. Proceedings of the National Academy of Sciences of the United States of America. 1936;22(7):439-47. Epub 1936/07/01. PubMed PMID: 16577722; PubMed Central PMCID: PMCPMC1076802. 129. Uversky VN. Natively unfolded proteins: a point where biology waits for physics. Protein science : a publication of the Protein Society. 2002;11(4):739-56. Epub 2002/03/23. doi: 10.1110/ps.4210102. PubMed PMID: 11910019; PubMed Central PMCID: PMCPMC2373528. 130. Uversky VN. What does it mean to be natively unfolded? European journal of biochemistry / FEBS. 2002;269(1):2-12. Epub 2002/01/11. PubMed PMID: 11784292. 131. van der Lee R, Buljan M, Lang B, Weatheritt RJ, Daughdrill GW, Dunker AK, et al. Classification of intrinsically disordered regions and proteins. Chemical reviews. 2014;114(13):6589-631. Epub 2014/04/30. doi: 10.1021/cr400525m. PubMed PMID: 24773235; PubMed Central PMCID: PMCPmc4095912. 132. Uversky VN. Paradoxes and wonders of intrinsic disorder: Stability of instability. Intrinsically disordered proteins. 2017;5(1):e1327757. Epub 2018/09/27. doi:
52
10.1080/21690707.2017.1327757. PubMed PMID: 30250771; PubMed Central PMCID: PMCPMC6149434. 133. Yarawsky AE, English LR, Whitten ST, Herr AB. The Proline/Glycine-Rich Region of the Biofilm Adhesion Protein Aap Forms an Extended Stalk that Resists Compaction. Journal of molecular biology. 2017;429(2):261-79. Epub 2016/11/29. doi: 10.1016/j.jmb.2016.11.017. PubMed PMID: 27890783. 134. Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT. Prediction and Functional Analysis of Native Disorder in Proteins from the Three Kingdoms of Life. Journal of molecular biology. 2004;337(3):635-45. doi: https://doi.org/10.1016/j.jmb.2004.02.002. 135. Uversky VN, Oldfield CJ, Dunker AK. Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annual review of biophysics. 2008;37:215-46. Epub 2008/06/25. doi: 10.1146/annurev.biophys.37.032807.125924. PubMed PMID: 18573080. 136. Metallo SJ. Intrinsically disordered proteins are potential drug targets. Current opinion in chemical biology. 2010;14(4):481-8. Epub 2010/07/06. doi: 10.1016/j.cbpa.2010.06.169. PubMed PMID: 20598937; PubMed Central PMCID: PMCPmc2918680. 137. Uversky VN. Intrinsically disordered proteins and novel strategies for drug discovery. Expert opinion on drug discovery. 2012;7(6):475-88. Epub 2012/05/09. doi: 10.1517/17460441.2012.686489. PubMed PMID: 22559227. 138. Corrigan RM, Rigby D, Handley P, Foster TJ. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology (Reading, England). 2007;153(Pt 8):2435-46. Epub 2007/07/31. doi: 10.1099/mic.0.2007/006676- 0. PubMed PMID: 17660408.
53
Chapter II. The biofilm adhesion protein Aap from Staphylococcus epidermidis
forms zinc-dependent amyloid fibers*
Authors: Alexander E. Yarawsky1,2¶, Stefanie L. Johns1¶, Peter Schuck3, Deborah G.
Conrady1 and Andrew B. Herr2,4,5
¶These authors contributed equally to this work.
Affiliations: 1 - Graduate Program in Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
2 - Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
3 - Dynamics of Macromolecular Assembly Section, Laboratory of Cellular Imaging and Bioengineering, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA
4 - Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
5 - Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Author Contributions: A.E.Y. collected and analyzed data on Brpt5.5 and Brpt3.5-Cys, purified fibrils from biofilms for mass spectrometry, and performed biofilm assays and electron microscopy of biofilms S.L.J. collected and analyzed (HMBP-)Brpt3.5 data and performed confocal microscopy P.S. analyzed c(s,ff0) data D.G.C. designed and cloned the His-MBP-Brpt3.5 construct A.E.Y., S.L.J., and A.B.H. conceived experiments, directed the project and wrote the manuscript.
Funding: NIH R01-GM094363 and U19-AI070235, and funds from the Cincinnati Children’s Hospital Research Foundation awarded to A.B.H. supported this work.
*Notice of Previous Publication: Contributions from S.L.J., P.S. and D.G.C. have been previously published in Chapters 4 and 5 of the Ph. D. Dissertation entitled "Mechanistic insights for protein-dependent biofilm formation in Staphyloccocus epidermidis and beyond", by Stefanie L. Johns, 2011, University of Cincinnati. Major updates to the previously published text (primarily in the Results and Discussion sections) have been made in the current chapter by A.E.Y. and A.B.H.
54
Abstract
The skin-colonizing, commensal bacterium Staphylococcus epidermidis has emerged as a leading cause of hospital-acquired and device-related infections. The primary determinant for S. epidermidis pathogenesis is its ability to form biofilms, which are multi-layered, surface-adherent bacterial accumulations that show remarkable resistance to chemical and physical stresses. Accumulation-associated protein (Aap) from S. epidermidis and its S. aureus homolog SasG have been shown to be necessary and sufficient for mature biofilm formation. These proteins have a repetitive domain architecture, containing up to 17 tandem B-repeats; the presence of at least five tandem repeats in SasG has been shown to be critical for S. aureus biofilm formation. We previously demonstrated that Aap B-repeat constructs self-assemble in the presence of zinc to reversibly form twisted, rope-like filaments between staphylococcal cells in the biofilm. In this study, we demonstrate that longer Aap B-repeat constructs with three to five intact repeats form functional amyloid fibers in the presence of zinc. Fluorescence assays with amyloid-binding dyes, transmission electron microscopy, and confocal fluorescence microscopy experiments were used to analyze the time- and temperature- dependence of amyloid fiber formation. We have also utilized a recently developed analytical approach to resolve multiple amyloidogenic precursors using sedimentation velocity analytical ultracentrifugation. Furthermore, we have demonstrated the presence of amyloid fibers during both early and late stages of S. epidermidis biofilm formation using confocal microscopy and have confirmed that extracellular fibrils from biofilms primarily contain Aap. This work provides new insights into S. epidermidis biofilm
55 formation and architecture that will potentially lead to new therapeutic treatments for persistent staphylococcal infections.
56
Author summary
S. epidermidis has recently emerged as a leading cause of hospital-acquired infections, bloodstream infections, and medical device-related infections. While the majority of S. epidermidis strains are antibiotic-resistant, the actual basis for the propensity of S. epidermidis to cause persistent infections is its ability to form a biofilm.
A biofilm is a multi-layered bacterial aggregation that is typically encased in a polysaccharide-rich extracellular matrix. Once a mature biofilm-related infection has been established within the body, treatment often requires surgical removal of the biofilm and long-term intravenous antibiotic therapy. Here, we have determined that the accumulation-associated protein, which is critical for the establishment of S. epidermidis biofilms, forms a network of stable protein fibers in the presence of zinc. We determined that these fibers are amyloid, a type of highly stable, ordered protein aggregate that is resistant to chemical denaturants and has been implicated in the pathogenesis of a wide range of diseases. We have demonstrated the use of a new analytical technique to study the early protein assembly events leading to mature amyloid fiber formation that can potentially be applied to other amyloid-forming protein systems. Our study provides important insights into S. epidermidis biofilm formation that will potentially provide novel therapeutic treatments.
57
Introduction
Staphylococcus epidermidis is a critical component of the normal human flora that helps control the colonization and invasion of potentially dangerous microbial pathogens. However, S. epidermidis has emerged as a leading opportunistic pathogen due to its high prevalence on epithelial surfaces and ability to colonize prosthetic medical devices[1]. S. epidermidis specifically is the leading cause of nosocomial infections and device-related infections[2, 3], and is, along with its other coagulase- negative relatives, the leading cause of bacteremia[4, 5]. While S. epidermidis infections are typically non-aggressive, they are extremely resistant to antibiotic therapy[6].
Therefore, staphylococcal infections often require invasive treatment methods and frequently lead to chronic morbidity, mortality, and high healthcare costs[5, 7, 8]. S. epidermidis pathogenesis and chronic persistence is primarily associated with its ability to form a biofilm[9, 10], a multi-layered bacterial aggregation surrounded by an extracellular matrix[11]. Biofilm formation occurs in three general stages: primary adherence to a surface by individual staphylococcal cells; accumulation into multicellular colonies through intercellular adhesion events; and formation of a mature biofilm through cycles of remodeling that create characteristic cellular towers separated by channels that allow access to nutrients. The biofilm is typically surrounded by a secreted extracellular matrix comprised of macromolecular components that serve to anchor the staphylococcal cells together, including the polysaccharide poly-N- acetylglucosamine (PNAG) as well as proteins, extracellular DNA, or teichoic acid, depending on the strain and growth conditions[12-14]. Biofilm formation can occur through both polysaccharide-dependent and -independent pathways, the latter
58 mediated by protein-protein interactions[15]. The protein Aap (accumulation-associated protein) is primarily responsible for protein-dependent intercellular accumulation of S. epidermidis biofilm formation[16], and is also required for the polysaccharide-dependent mechanism[17]. Rohde et al and Corrigan et al described a protein-based mechanism for staphylococcal biofilm formation that is independent of PNAG; in several strains of S. epidermidis or S. aureus, the protein Aap or its ortholog SasG can mediate biofilm formation in the absence of polysaccharide secretion[18, 19]. Indeed, 39% of biofilm- positive clinical isolates are PNAG-negative while 90% are positive for Aap[15, 20, 21].
Recent work by Schaeffer et al[22] demonstrated the critical role of Aap in S. epidermidis infection in vivo. Under fluid shear, Aap-deficient strains formed significantly less biofilm than those expressing normal levels of Aap. A rat catheter model was then used to evaluate the biological implication of these results, which revealed that Aap, but not PNAG, was required for infection[22].
Aap is a multi-domain protein consisting of an N-terminal export signal followed by the A-repeat region (eleven partially-conserved 16-residue repeats), a lectin domain, the B-repeat region containing five to seventeen conserved repeats of a 128-amino acid sequence, a proline/glycine-rich (P/G-rich) region that forms a highly extended stalk that is resistant to compaction[23], and an LPXTG cell wall anchor motif, as shown in Fig 1A.
The N-terminal portion of Aap containing the A-repeat region and lectin domain
(collectively called the A-domain) can be proteolytically cleaved to expose the B-repeat region, which can then initiate bacterial accumulation into microcolonies[18]. The staphylococcal metalloprotease SepA is responsible for this proteolytic cleavage event, switching the role of Aap from A-domain-mediated surface adhesion to its namesake
59 role in biofilm accumulation[24]. Each B-repeat (Brpt) contains a 78-amino acid G5 domain and a 50-amino acid spacer domain (also called an E domain); the B-repeat sequences in Aap are highly conserved, with 83-100% sequence identity[25]. The final repeat in the B-repeat region is comprised of a single G5 domain without the spacer motif (Fig 1A); this C-terminal half-repeat “cap” plays a role in stabilizing the protein[25].
We have previously demonstrated that a single B-repeat domain with the half-repeat cap (Brpt1.5) will self-associate in the presence of Zn2+ to form an anti-parallel dimer, leading to a model for Zn2+-mediated protein-dependent intercellular accumulation between staphylococci in a nascent biofilm[25, 26]. Subsequent work demonstrated that
Brpt1.5 and longer B-repeat constructs can self-assemble in the presence of Zn2+ or
Cu2+, while other metals (Mn2+, Co2+, and Ni2+) can bind to B-repeats but do not induce assembly[27]. Recent work has shown similar Zn2+-dependent self-association behavior for the B-repeat region of SasG, the S. aureus ortholog of Aap[28, 29].
Full-length Aap contains 5-17 of these nearly identical B-repeats; Corrigan et al have demonstrated that at least five tandem B-repeats were required for S. aureus biofilm formation, suggesting that the biological function of SasG and, presumably, Aap relies on longer stretches of at least 5 consecutive B-repeats [19]. Therefore, the focus of this study is to characterize a biologically relevant construct of Aap consisting of five consecutive B-repeats and the C-terminal cap (called Brpt5.5; see Fig 1A), and to determine the role of tandem B-repeats in S. epidermidis biofilm formation. In the presence of Zn2+, tandem B-repeats assembled into a range of oligomeric states, including highly elongated fibers. We show that Zn2+-induced B-repeat fibers are functional amyloid fibers that assemble in a temperature- and time-dependent fashion.
60
Importantly, fibers formed in vitro by recombinant, tandem B-repeats show at least partial resistance to Zn2+ chelation and acidification, suggesting that these highly stable amyloid fibers may play a critical part in rendering the biofilm resistant to physical or chemical stresses. We apply a newly developed analytical approach to deconvolute the early-stage assembly of fibril intermediates using analytical ultracentrifugation. Finally, we show that amyloid fibers form during early and late stages of S. epidermidis biofilm growth, and we demonstrate that fibrils isolated from S. epidermidis biofilms are primarily composed of Aap. This is the first report demonstrating that Aap, an essential protein for S. epidermidis infectivity, forms amyloid fibrils; these findings could potentially lead to new therapeutic approaches to relieve the extensive morbidity and mortality caused by S. epidermidis infections.
61
Results
Solution characterization of tandem B-repeats from Aap
In order to determine the functional relationship between tandem copies of the
Aap B-repeat region and S. epidermidis biofilm formation, we have generated a construct containing the C-terminal five intact B-repeats, along with the C-terminal half- repeat (called Brpt5.5) (Fig 1A). The design of this construct was based on the minimum number of B-repeats previously shown to support biofilm formation by SasG, an Aap ortholog from S. aureus[19]. In addition, we utilized a Brpt3.5 construct, both in isolation and as an N-terminally His6-tagged maltose binding protein (MBP) fusion protein (called
HMBP-Brpt3.5). The HMBP-Brpt3.5 construct showed more efficient expression and was more stable in solution, so it was predominantly used for initial experiments.
Far-UV circular dichroism (CD) was used to verify proper folding of the B-repeats in these constructs (Fig 1B). Based on our previous studies of related Brpt1.5 constructs
[25, 26] and the high sequence identity between B-repeats (Fig S1)[25, 30], it was expected that the Brpt3.5 and Brpt5.5 constructs would have similar secondary structure content. Indeed, these constructs all contain high β-strand and coil content.
The increased negativity around 200 nm observed for the Brpt3.5 and Brpt5.5 constructs may be due to greater random coil contribution from the increased proportion of B-repeat spacer motifs compared to G5 domains in Brpt3.5 and Brpt5.5 (i.e. Brpt5.5 contains 5 spacer motifs vs 6 G5 domains (~45% spacer), whereas Brpt1.5 contains 1 spacer motif vs 2 G5 domains (~33% spacer) (see Fig 1A)). The CD spectrum for uncleaved HMBP-Brpt3.5 (Fig S2) revealed a combination of α-helical, β-strand, and coil secondary structure, consistent with the α-helical content of MBP[31].
62
Fig 1. Characterization of tandem B-repeats from S. epidermidis Aap. (A) Full length Aap domain organization including: the A-repeat region and putative lectin domain that are proteolytically cleaved (dashed line), the B-repeat region (5 – 17 B- repeats) ending with the conserved half-repeat cap, the proline/glycine-rich region (P/G- rich), and the cell wall anchor motif (LPXTG). The domain boundaries of the Brpt5.5, Brpt3.5, and Brpt1.5 constructs are shown underneath the cartoon. Each full B-repeat contains a G5 domain and a spacer region, while the half-repeat cap contains only the G5 domain. (B) Far-UV circular dichroism spectra demonstrating similar secondary structure characteristics of the previously characterized Brpt1.5 construct (green circle) and cleaved Brpt3.5 (blue triangle) and Brpt5.5 (red square). The far-UV CD spectrum of Brpt1.5 is adapted from[25], Copyright 2008 National Academy of Sciences, U.S.A. C) Sedimentation coefficient distribution plot c(s) of HMBP-Brpt3.5 (dashed blue line), cleaved Brpt3.5 (solid blue line), and Brpt5.5 (solid red line). All constructs sedimented as monomers in the absence of Zn2+.
63
Sedimentation velocity analytical ultracentrifugation (AUC) was used to characterize each construct in solution under native conditions (Fig 1C). Brpt3.5 and
Brpt5.5 sedimented as monomers with very high frictional ratios (2.58 and 3.55, respectively). Although these constructs have similar sedimentation coefficients, the difference in frictional ratios is an important indication of the increased mass of Brpt5.5 compared to Brpt3.5. Such high frictional ratios are indicative of highly elongated global conformations, such as what might be expected based on our prior characterization of
Brpt1.5[25, 26]. Furthermore, such an extended conformation for tandem B-repeats, in conjunction with the extended Pro/Gly-rich stalk[23], makes Aap well-suited to project itself out away from the S. epidermidis surface in order to more easily interact with adjacent cells and surfaces and avoid steric hindrance from other cell wall-anchored proteins. The HMBP-Brpt3.5 construct also sedimented as a monomer, but had a significantly increased sedimentation coefficient due to the additional 42 kDa mass contributed by the more globular HMBP fusion tag (Fig 1C).
Tandem B-repeats assemble into multiple higher-order species in the presence of
Zn2+
We previously reported that shorter Aap B-repeat constructs, Brpt1.5 and
Brpt2.5, specifically self-associate to form dimers in the presence of Zn2+[25-27, 30].
These data indicated that tandem B-repeats self-associate in a modular fashion, with each B-repeat capable of forming an adhesive contact with another B-repeat in the presence of approximately two Zn2+ ions, and that longer B-repeats constructs can dimerize at lower free Zn2+ concentrations[25, 32]. This phenomenon is known as the
64 chelate effect, in which the binding of Zn2+ and resulting self-association at the first site in each of two multi-site protomers reduces the entropic penalty for neighboring sites to self-assemble in the presence of Zn2+. Thus, the effective free Zn2+ concentration required for assembly of the entire multi-repeat protein becomes progressively lower as the number of repeats increases. Prior biophysical work on B-repeat constructs has focused on shorter constructs that were suitable for detailed thermodynamic analyses; these short constructs were limited to monomer-dimer equilibria[25-27, 30]. For the longer Brpt3.5 and Brpt5.5 constructs described here, self-association in the presence of Zn2+ could be significantly more complicated than a simple monomer-dimer equilibrium, due to the potential for multiple adhesive interactions within a stretch of three to five intact B-repeats. Indeed, we observed a dramatic change in the sedimentation coefficient distribution for HMBP-Brpt3.5 in the presence of Zn2+ compared to monomeric apo-HMBP-Brpt3.5 (Figs. 2A, 2B), consistent with the formation of a wide range of very large oligomeric states (Fig. 2C). In addition to the reaction boundaries visible in the 0-40 s* range, the increasing trend at 40 s* indicates the presence of even larger aggregated species. This aggregation behavior is quite distinct from previously observed oligomerization of B-repeat constructs in the presence of Zn2+. Although the HMBP fusion tag alone is able to dimerize in the presence of Zn2+
(data not shown), the formation of such enormous aggregates of HMBP-Brpt3.5 in the presence of Zn2+ is unexpected and suggests that a distinct mode of assembly or aggregation is occurring.
65
Fig 2. Sedimentation behavior of tandem B-repeats in the presence of Zn2+. (A) Raw sedimentation velocity data for 5 µM HMBP-Brpt3.5 in the absence of Zn2+ and (B) in the presence of 3 mM ZnCl2, both at 36,000 rpm and 20 °C. In both panels, scans 1- 100 (5 hours elapsed time) were loaded, with every 7th scan plotted. Note the dramatic increase in spacing between scans in panel B compared to panel A; the much faster- moving sedimentation boundaries of HMBP-Brpt3.5 in the presence of Zn2+ compared with HMBP-Brpt3.5 alone indicate the sedimentation of very large species. (C) Sedimentation coefficient distribution of HMBP-Brpt3.5 alone (grey line) and HMBP- Brpt3.5 in the presence of 3 mM ZnCl2 (blue line). The broad peak distribution in the presence of Zn2+ indicates that HMBP-Brpt3.5 sediments as a mixture of assembled oligomers; however, resolution of individual species is difficult due to overlapping sedimentation profiles. The inset of (C) shows the same data analyzed by Wide Distribution Analysis (WDA) in SEDANAL – note the x-axis is on the natural log scale, while the y-scale has been normalized by area. Here, the sample containing 3 mM ZnCl2 shows some material around the 5-10 s* range, with the majority of material sedimenting between 10-20 s*, in good agreement with the c(s) distribution calculated by SEDFIT.
66
2D size-and-shape sedimentation analysis indicates formation of fiber-like species
A recently developed AUC analysis method was used to better resolve the multiple sedimentation boundaries observed for HMBP-Brpt3.5 in the presence of Zn2+ and to provide additional information on the size and shape of the sedimenting species.
We utilized the 2D size-and-shape c(s,ff0) analysis in SEDFIT that characterizes each sedimenting species in terms of both sedimentation coefficient and frictional ratio[33].
This approach is particularly useful when analyzing co-sedimenting species that differ greatly in shape and therefore experience very different degrees of drag[34]. For these experiments, we used samples of 5 µM HMBP-Brpt3.5 alone or in the presence of 500
µM or 1 mM ZnCl2. The samples were analyzed at both 25 °C and 37 °C. In order to capture the earliest assembly events, the samples were incubated after addition of Zn2+ only for the time required to pull vacuum (approximately 30 minutes). As expected, the
HMBP-Brpt3.5 alone sample yielded a single predominant species corresponding to a highly elongated monomer, as seen in Fig 3A. Both samples incubated with Zn2+ formed similar oligomeric states, but the higher oligomeric species were more heavily populated for the sample incubated with 1 mM ZnCl2, allowing for easier resolution of the species involved (25 °C data not shown). The c(s,ff0) analysis yields a 3-dimensional plot (Fig
3A, B) that separates the species based on sedimentation coefficient on the x-axis, frictional ratio (f/f0; the frictional coefficient of the sedimenting species compared to that of an ideal sphere of identical volume) on the y-axis, and peak amplitude on the z-axis.
67
Fig 3. AUC c(s,ff0) analysis of early-stage HMBP-Brpt3.5 amyloidogenic intermediates. Sedimentation velocity data (36,000 rpm at 37 °C) were analyzed using the c(s,ff0) analysis model in Sedfit. (A) 3-D shape and size distribution plot for HMBP- Brpt3.5. Sedimenting species are distinguished based on sedimentation coefficient (plotted uncorrected for buffer conditions) along the x-axis and frictional (f/f0) along the y-axis. Increasing values of f/f0 correspond to more highly elongated or non-globular species. The heat map indicates species concentration, from lowest population density (blue) to highest (red). HMBP-Brpt3.5 alone sediments as a single dominant species of 4.53 S with an elongated frictional ratio (f/f0 = 2.3). (B) 3-D shape and size distribution plot for HMBP-Brpt3.5 in the presence of 1 mM Zn2+. In the presence of Zn2+, there is a broad distribution of species that vary both in sedimentation coefficient values as well as frictional ratios. Note in particular the series of extremely elongated species (f/f0) values of approximately 4 or higher) highlighted by the magenta oval. (C) To illustrate the putative species present, the three-dimensional plot from (B) has been simplified to a two-dimensional distribution of the sedimentation coefficient (x-axis) and frictional ratio (y-axis), labeled with the putative species present as implied by the given pairs of s- and f/f0-values. Elongated species with f/f0 values of approximately 3 or greater are highlighted by ovals and putative species labels in magenta. Compact species with f/f0 values between 1 and 2.5 are delineated by dark red lines along with putative species
68 labels under the distribution plot. The solid black line depicts a 2-dimensional representation of c(s,*), showing the relative total amount of material at any sedimentation coefficient.
69
We also show a top-down view of the 3D distribution plot (Fig 3C) superimposed on the standard sedimentation coefficient distribution that has been labeled with the approximate oligomeric states, estimated by Sedfit based on the sedimentation coefficient and apparent frictional ratio values. The data show that HMBP-Brpt3.5 incubated with 1 mM ZnCl2 at 37 °C forms multiple species including: monomeric
HMBP-Brpt3.5, several mostly compact oligomeric species (dimer, trimer, and tetramer or pentamer), followed by large oligomers of ever-increasing degrees of elongation. In the presence of Zn2+, peaks for both elongated and compact monomer species are observed (f/f0 values of 3.1 and 1.2, respectively), in contrast to the HMBP-Brpt3.5 alone data that shows only elongated monomer (Fig 3A). The dimer and trimer species are mostly compact, with frictional ratios comparable to those of globular proteins
(between 1.2 and 1.4). The putative pentamer species is moderately elongated, with a frictional ratio of 1.7, but all higher oligomers are highly elongated. The putative 9-mer and 14-mer species show frictional ratios of 2.2 or 2.5, respectively, while the 15-mer through 65-mer peaks (circled in magenta ovals in Fig 3C) gave f/f0 values between 3.9 and 4.7. (As a control, the analysis of the same sedimentation data with an upper limit of 2.5 for f/f0 values resulted in a worse fit to the measured sedimentation boundaries.)
These f/f0 values of 3.9 or greater indicate extremely elongated fiber-like morphologies, with approximate axial ratios that range from 72-108 (assuming prolate ellipsoids), suggesting that these species may be nascent amyloid fibers. The HMBP-Brpt3.5 sample incubated with 1 mM ZnCl2 analyzed at 25 °C showed a very similar distribution of oligomeric species, although the slower sedimentation rates (due to lower
70 temperature) allowed resolution of a few higher-order oligomeric species, such as putative 75-mer and 115-mer fibers (data not shown).
Tandem B-repeats form amyloid fibers in the presence of Zn2+
To characterize the nature of these extremely large, fiber-like B-repeat species, samples of HMBP-Brpt3.5 incubated with Zn2+ for 2, 4, or 7 days were visualized by transmission electron microscopy (TEM) (Fig 4A). Negative-stained TEM images revealed large assemblies of protein fibers. One possibility raised by the TEM images is that HMBP-Brpt3.5 can form amyloid fibers in the presence of Zn2+. Amyloid fibers are highly stable protein fibers that have a characteristic β-strand-based fibril architecture[35]. Formation of amyloid fibers was initially linked to protein misfolding implicated in disease states; however, a number of “functional” amyloid proteins required for specific cell processes have recently been characterized in organisms ranging from archaea[36] and bacteria to humans[37]. Functional amyloid proteins from bacterial species, such as Escherichia coli, Bacillus subtillis, Enterobacteriaceae, and
Pseudomonas spp., have recently been implicated in biofilm formation; specifically, these functional amyloid fibers are integral to the overall stability of the biofilm[38-41].
To confirm that these HMBP-Brpt3.5 protein fibers were amyloid, samples were incubated with Thioflavin T (ThT) and characterized by fluorescence spectroscopy.
Thioflavin T is a small-molecule fluorophore that can intercalate within amyloid fibers, which restricts rotation about an internal bond and results in a dramatic increase in quantum yield and characteristic fluorescence emission at 482 nm[42, 43].
71
Fig 4. Amyloid properties of tandem B-repeat constructs in the presence of Zn2+. (A) Negative-stained TEM image of HMBP-Brpt3.5 protein fibers generated 7 days post- incubation with 500 µM ZnCl2. (B) Fluorescence emission spectra of 10 µM Thioflavin T (ThT) alone (black) or ThT in the presence of: HMBP-Brpt3.5 with 500 µM ZnCl2 (red), HMBP-Brpt3.5 alone (dark blue), and HMBP-Brpt3.5 with 10% formic acid (FA, cyan) after excitation at 432 nm. HMBP-Brpt3.5 without ThT (green) did not produce fluorescence. The HMBP-Brpt3.5 alone and HMBP-Brpt3.5 + Zn2+ samples were pre- treated with 10% FA to remove aggregates, followed by dialysis back into working buffer and addition of ZnCl2. (C) ThT fluorescence of cleaved Brpt3.5 tagged with Cys added to the C-terminus (Brpt3.5-Cys). At 1 mM ZnCl2, there is negligible fluorescence of incubated samples of 0.5 mg/ml (10 µM) Brpt3.5-Cys under reducing (M, monomer) and oxidizing (D, dimer) conditions. However, at 5 mg/ml (100 µM) and 10 mg/ml (200 µM)
72
Brpt3.5-Cys, strong ThT fluorescence indicates a high propensity for amyloid fibers in the presence of Zn2+. This clearly demonstrates the dependence of amyloid formation on local B-repeat concentration. (D) TEM image of native, cleaved Brpt5.5 (20 µM, 1.5 mg/ml) incubated at 37 °C with 5 mM ZnCl2 showing similar fiber morphology as HMBP- Brpt3.5 in panel A. (E) shows the absorbance and fluorescence of Brpt5.5 (20 µM, 1.5 mg/ml) incubated with different ZnCl2 concentrations. At 5 and 10 mM ZnCl2, there is an increased fluorescence of ThT and Proteostat dyes, indicating amyloid-like aggregates in the native, untagged Brpt5.5 construct. (F) Far-UV CD spectrum of Brpt5.5 (6.5 µM, 0.5 mg/ml) with or without Zn2+, at 20 °C or 40 °C. Only in the presence of Zn2+ and at higher temperatures does the CD spectrum indicate the rich β-sheet structure observed for amyloid-like aggregate. (G) Brpt5.5 samples were tested for recognition by the anti- amyloid antibody OC using a dot blot assay. Antibody binding was observed for samples incubated at temperatures and Zn2+ concentrations conducive of the CD spectral change to a minimum near 225 nm. Natively folded Brpt5.5 (without Zn2+) also showed binding, but this was lost when Brpt5.5 was unfolded.
73
To ensure that the ThT fluorescence produced was truly from Zn2+-dependent amyloid fibers, HMBP-Brpt3.5 was first pretreated with 10% formic acid (FA) to depolymerize any fibers that may have spontaneously formed[44]. As seen with other amyloid proteins, HMBP-Brpt3.5/Zn2+ produced minimal ThT fluorescence in the presence of FA
(Fig 4B). This effect was not due to FA-induced structural changes in the HMBP-Bprt3.5 monomer, since the secondary structure of the protein was unchanged upon addition of
FA (Fig S2). Upon removal of FA and incubation for 24 hours, HMBP-Brpt3.5/Zn2+ protein fibers demonstrated strong ThT fluorescence (Fig 4B). However, after removal and incubation, HMBP-Brpt3.5 alone also produced a low level of ThT fluorescence, suggesting that some fibers could potentially form in the absence of Zn2+. Based on quantification of monomeric HMBP-Brpt3.5 in the Zn2+-free AUC data, the proportion of protein that forms fibers in the absence of Zn2+ is 3% or less (Figs 1 and 2). A separate construct was additionally tested to better replicate the natural setting of Aap tethered in dense tufts to the cell wall of S. epidermidis. This construct was Brpt3.5 (cleaved from
HMBP) with a C-terminal Cys residue added (Brpt3.5-Cys). Under non-reducing conditions, a disulfide bond would link two Brpt3.5 molecules in a parallel fashion, similar to their orientation on the cell surface, while raising the local B-repeat concentration – a well-known factor in amyloidogenesis. In Fig 4C, there is not only an overall protein concentration threshold required for amyloidogenesis, but there is also a clear dependence on local B-repeat concentration, with disulfide-linked samples (“D” for dimer) yielding higher ThT fluorescence than reduced samples (“M” for monomer).
To ensure that amyloid formation was not due to the presence of the His6-MBP tag (or the C-terminal Cys tag), native Brpt5.5 (tag-free) was incubated with Zn2+, then
74 visualized by TEM. Brpt5.5 formed fibers (Fig 4D) primarily of the “branched” morphology seen with HMBP-Brpt3.5 (Fig 4A). This morphology resembles one often observed with light chain amyloid [45], but that is also observable with Aβ peptide [46].
Analyzing these Brpt5.5 fibers spectroscopically (Fig 4E) revealed that incubation with amyloid-binding dyes led to increases in both ThT and Proteostat fluorescence[47].
These samples also showed an increase in Congo Red absorbance at 540 nm[48] (data not shown). Because amyloid fibers have characteristic structures rich in β-strand, we examined the far-UV CD spectrum under conditions which promote these amyloid-like aggregates. It should be noted that based on X-ray crystallography and NMR studies[26, 30, 49], along with CD data presented here and elsewhere[25, 30], natively folded B-repeats contain β-sheet and random coil content. Importantly, however, Fig 4F demonstrates that when Brpt5.5 is incubated with 5 mM Zn2+ at near-physiological temperature (40 °C), there is a significant change in the CD spectrum, resulting in a strong, broad minimum near 225 nm. This is similar to CD spectra observed with insulin fibrils[50] and glucagon fibrils[51]. Together, these spectroscopic results and TEM observations are consistent with amyloid-like fibril formation by native, tandem B- repeats.
A number of antibodies have been raised against amyloid-forming peptides or proteins. Kayed, et al.[52] reported an antibody (OC antibody) which could specifically recognize Aβ42 fibers, but not monomers or oligomers. Further, it appeared to be recognizing generic amyloid fiber conformation(s), irrespective of protein sequence, as it was able to also detect amyloid fibers from IAPP and α-synuclein[52]. Due to the ability for OC antibody to specifically recognize fibers and be apparently independent of
75 protein sequence, we chose this antibody to test against Brpt5.5 amyloid fibers (Fig 4G.
By dot blot assays, OC antibody recognized Brpt5.5 that had been incubated with Zn2+ at temperatures which resulted in the significant change in the CD signal in Fig 4F.
Interestingly, OC antibody recognized native, monomeric Brpt5.5 as well. This suggests that conformations present in the amyloid fiber are also present in the natively folded protein. Incubating Brpt5.5 in the absence of Zn2+ and at a temperature high enough to unfold the protein resulted in loss of OC antibody binding. Collectively, Brpt5.5 and
HMBP-Brpt3.5 both share features characteristic of amyloid fibers.
B-repeat fiber assembly is time- and temperature-dependent
Metal ions, namely Zn2+ and Cu2+, play complex roles in the aggregation and amyloidogenesis of amyloid-β peptide important in Alzheimer’s disease[53-56].
However, functional amyloid-forming proteins from bacteria assemble into amyloid fibers without a known requirement for zinc ions or other triggering molecules. Rather, these amyloid proteins form as a result of the coordinated action of accessory proteins expressed within operons, including nucleator proteins and chaperones to prevent aberrant polymerization in the cytoplasm[38, 41, 57, 58], or amyloidogenesis can require proteolytic activity to release the amyloidogenic regions of the protein, such as with Bap[59]. Thus, the mechanism of Zn2+-dependent amyloid formation by the B- repeat region of Aap is of significant interest for comparison to other systems. We have therefore used a combination of HPLC, TEM, confocal microscopy, and AUC to analyze the assembly of Aap B-repeat amyloid formation as a function of time, temperature, and solution conditions.
76
Fig 5. HPLC and turbidity assays to monitor time and temperature dependence of amyloidogenesis. (A) C4 reverse-phase HPLC elution profiles of 10 µM HMBP-Brpt3.5 alone (black) or incubated with 500 µM ZnCl2 for 1 (red), 4 (blue), or 30 (green) days at 37 °C. Samples were centrifuged at 13,000 rpm for 1 hour prior to HPLC separation to remove insoluble aggregates. (B) Samples of 10 µM HMBP-Brpt3.5 with 500 µM ZnCl2 were incubated for 4 days at 37 °C prior to addition of Tris-buffer saline (red trace); sufficient dilute HCl to lower the pH to 5 (blue trace); or 2 mM DTPA (green trace). Separation by HPLC revealed that oligomer/soluble fiber species were maintained in the presence of both acid (blue) and DTPA (green) when compared to the buffer-treated control samples (red) at both temperatures. TEM images of these samples are in Supporting Information (S3 Fig). (C) Samples of 5 µM Brpt5.5 incubated at 37 °C and followed by absorbance at 400 nm, showing turbidity in the presence of ZnCl2 with maximal turbidity reached by 5 days. Data points are shown as symbols connected by straight lines for clarity. The lines do not represent fits.
77
To assess the effect of temperature on the rate and morphology of amyloid fiber formation, we used a HPLC quantification assay previously shown to effectively differentiate between monomer and oligomer or soluble fiber species[60]. A relative time course for HMBP-Brpt3.5 fiber formation was established by incubating 10 µM HMBP-
Brpt3.5 with 500 µM ZnCl2 for 0, 2, and 6 hours and 1, 4 and 30 days at both 20 °C (Fig
S3) and 37 °C (Fig 5A). Samples were first centrifuged for one hour at 13,000 rpm to remove any insoluble aggregates prior to separation by a C4 HPLC column; therefore, the elution profile only reports on monomer, oligomer, and/or soluble amyloid fiber species. The HPLC elution profile of HMBP-Brpt3.5 alone (Fig 5A, black trace) gives a peak eluting at 28.5 ml, which corresponds to a single monomeric species, as shown by its sedimentation coefficient distribution (Fig 1B). Upon addition of Zn2+ to HMBP-
Brpt3.5, samples gradually showed a shift in the distribution of peaks toward higher elution volumes that represent higher-order oligomer or fiber species. The elution profiles at 2 and 6 hours were unchanged from time point zero (data not shown), indicating slow assembly kinetics. As time progressed, the monomer peak decreased and shifted to the right as the oligomer peak increased. The transition from monomer to putative fiber species was more pronounced after 1, 4, or 30 days for samples incubated at 37 °C (Fig 5A) compared to the samples incubated at 20 °C (Fig S3), indicating accelerated HMBP-Brpt3.5 self-assembly at higher temperature.
We verified that our observations were not an artifact of the His6-MBP tag, using an orthogonal approach. Because the HPLC assay is limited to only oligomers and soluble fiber species, we used a turbidity assay which follows light scattering by large assemblies and aggregates, including amyloid fibers[61]. With the Brpt5.5 construct, we
78 observed significant increases in the turbidity of the samples containing Zn2+ when incubated at 37 °C (Fig 5C), but no visible change in turbidity when incubated at 20 °C under the same Zn2+ concentrations (data not shown). These data demonstrate the
Zn2+-, time-, and temperature- dependence of B-repeat fiber assembly using native, untagged B-repeats.
B-repeat fibers are resistant to acid and chelator treatment
Our previous work on Brpt1.5 revealed that this shorter construct formed a reversible Zn2+-dependent dimer that was sensitive to removal of Zn2+ (via the chelator
DTPA) or to even a modest decrease in pH (from 7.4 to 6.0)[25]. To assess the stability of mature amyloid fibers, we allowed HMBP-Brpt3.5 fibers to form in the presence of
Zn2+ over a period of 24 hours or 4 days at 20 °C or 37 °C. We then treated the samples by addition of a sufficient volume of dilute HCl to lower the pH to 5, addition of 2 mM
DTPA, or addition of buffer as a control. The samples were incubated for 2 hours before loading onto a C4 reverse-phase HPLC column, without spinning out the fibrous aggregates. The elution profile for the 20 °C sample at 4 days resembled the 24-hour samples (Fig S3) in terms of the monomer vs oligomer distribution and showed evidence of limited remodeling upon incubation with DTPA or HCl. In contrast, the elution profile for the 37 °C sample (Fig 5B) showed that the oligomer/fiber peak predominated, and that it was more resistant to the action of DTPA or HCl. TEM was performed on each sample to confirm that fiber structure was maintained (Fig S4).
Furthermore, although some conformational rearrangement of the fibers may occur at
79 lower temperatures and early time points[62], mature fibers at 37 °C are highly resistant to these environmental conditions.
The initial Zn2+-dependent assembly of untagged Brpt5.5 was reversible with addition of DTPA or HCl, as shown by sedimentation velocity AUC data in Fig S5.
These results coincide with the reversible assembly of Brp1.5[25], suggesting tandem
B-repeats still undergo an initial phase of reversible assembly. While Brpt5.5 aggregates from Fig 5C showed sensitivity to DTPA, turbidity was not completely abolished after the addition of DTPA (data not shown). This result suggests that while some higher-order oligomers or non-amyloid aggregate may have been reversed or solubilized by DTPA, there is a fraction of material that remained in an aggregate form, as indicated by the remaining turbidity. It is possible the DTPA-sensitive material had not yet developed into mature amyloid fibers, or that a higher local concentration of the tandem B-repeats (e.g., as seen with HMBP-Brpt3.5 or with native cell wall-anchored
Aap) is required for complete DTPA resistance. DTPA-resistance is an important feature of Aap functional amyloid, in that we previously reported the addition of Zn2+ chelator could prevent biofilm formation, but not disrupt mature biofilms[25], a phenomenon likely caused by these newly observed amyloid fibers.
Amyloid fibers are structural components in S. epidermidis biofilms
While it has been well established that Aap is critical for S. epidermidis biofilm formation[15, 16, 22, 25], the mechanism by which Aap promotes stable, long-term intercellular adhesion is not well understood. Others have shown that bundles of Aap fibrils extend outward from the cell wall on planktonic S. epidermidis cells[63, 64], but
80 these were presumably free-standing proteins attached to the cell wall rather than amyloid fibrils. We sought to explore the significance of our findings in the context of S. epidermidis biofilms. S. epidermidis strain RP62A biofilms were grown in tryptic soy broth (TSB) supplemented without additional Zn2+ (Fig 6A) or with additional Zn2+ (Fig
6B) and visualized by TEM. Large networks of extracellular fibrils were observed around clusters of cells in the biofilm. This morphology closely resembles the fiber morphology observed by native Brpt5.5 when examined at the same magnification (see Fig 6G for
Brpt5.5 incubated at 37 °C with 5 mM ZnCl2, compared to Fig 6H for RP62A biofilm + 20
µM ZnCl2). These extracellular fibers were observed in biofilms grown in TSB with or without addition of Zn2+, although the presence of Zn2+ increased the prevalence of the fibers. TSB contains Zn2+, which allows for Aap-based, Zn2+-dependent accumulation and biofilm formation[25, 26, 65]. Addition of the Zn2+ chelator, DTPA, at the start of growth inhibits biofilm formation[25]; by TEM, these S. epidermidis cells showed no evidence of the extracellular fibrous networks seen in the mature biofilms (Fig 6C). The addition of DTPA at the start of growth would prevent the initial reversible self-assembly of Aap B-repeat regions (Fig S5), presumably preventing subsequent nucleation of amyloid. However, once a mature biofilm is formed, DTPA can be added with no resulting effect[25] (Fig 6D), similar to the observation that adding DTPA to mature amyloid fibers formed in vitro does not result in depolymerization (Fig 5B). The highly resistant nature of these amyloid fibers would contribute to the strength and stability of the mature biofilm, as shown previously for other systems, including TasA from B. subtilis[40]. In Fig 4B, we demonstrated that B-repeat fibers formed in vitro are sensitive to formic acid (FA).
81
Fig 6. Amyloid fibers composed of Aap are important structural components in S. epidermidis biofilms. S. epidermidis biofilms were examined by TEM when grown on dialysis membrane on (A) TSA, (B) + 20 µM ZnCl2, (C) 100 µM DTPA added at the start of growth (t = 0 hr) or (D) 100 µM DTPA at the end of growth and incubated for 1 hour (t = 24 hr), (E) 50% FA (t = 24 hr), (F) pH lowered to pH 5 (t = 24 hr). This series of TEM images displays the resistance of fibers to DTPA and acidification in the setting of a mature biofilm. (G) and (H) compare the fibers observed by Brpt5.5 incubated at 37 °C with 5 mM ZnCl2 (from Fig 3) (G) and RP62A biofilms + 20 µM ZnCl2 (H) at similar magnification demonstrating similar morphologies. (I) examines the ability of S. epidermidis to form biofilms under various conditions. Biofilm formation can be inhibited by addition of DTPA (t = 0 hr), but not after biofilm formation has already occurred (t = 24 hr), while addition of FA can significantly disrupt mature biofilms. Acidification to pH 5, like adding DTPA at t=24 hr, had no significant effect compared to RP62A without treatment. The * symbol denotes statistical difference (P < 0.05) to RP62A biofilm formation without treatment, as determined by a two-tailed Student’s t test. (J) Bacteria
82 from biofilms shown in (B) were digested with lysostaphin to remove cell wall-anchored proteins. The supernatant from this mixture was then examined by SDS-PAGE, which revealed a large amount of material unable to migrate beyond the stacking gel. This material (red rectangle) was identified primarily as Aap by nanoLC-MS/MS.
83
Based on this result, Aap fibers in biofilms should also show sensitivity to FA. Indeed, addition of FA to mature biofilms demonstrated the ability to disrupt the majority of the extracellular fibers in the biofilm (Fig 6E). Furthermore, we examined the effect of pH on biofilm stability. As with DTPA, we previously observed that mildly acidic pH disrupts the reversible assembly of B-repeat proteins[25, 32] but low pH has no effect on pre-formed
B-repeat amyloid fibrils (Fig 5B). Consistent with these in vitro results, we observed that lowering the pH of an established biofilm to 5.0 had no effect on the extracellular amyloid fiber network (Fig 6F).
A biofilm formation assay (Fig 6I) was performed to complement the TEM observations and evaluate the role of Aap functional amyloid fibers in biofilm formation in a more quantitative way. We once again observed the ability of DTPA to inhibit amyloid formation, but only when present before biofilm formation; when DTPA or pH
5.0 buffer was added after biofilm maturation (t = 24 hr), neither was able to disrupt the biofilm, likely due to the resistance of the amyloid fibers (Fig 6D, F, I). Furthermore, addition of FA to mature biofilm was able to significantly disrupt the biofilm, as expected due to its ability to depolymerize the functional amyloid (Fig 6E). The correlation between depolymerization of amyloid fibrils and weakening of the biofilm structure is a key observation which supports the idea of functional amyloid fibrils contributing strength and stability to the biofilms.
S. epidermidis amyloid fibers are composed of processed Aap
As a final characterization of the extracellular amyloid fibers we observed in S. epidermidis biofilms, we determined the composition of these fibers by a combination of
84
SDS-PAGE and mass spectrometry (MS). Biofilms were collected as they were for TEM characterization (Fig 6B). The biofilm mixtures were then centrifuged to separate the bacteria from extracellular material and media. After removing the supernatant, we used lysostaphin to digest the polyglycine crosslinks of the cell wall peptidoglycan. The soluble proteins released from the cell wall were examined by SDS-PAGE. We observed SDS-insoluble aggregate trapped in the well and stacking gel (Fig 6J). This aggregated material contained primarily Aap when examined by nanoLC-MS/MS after in-gel tryptic digestion (Fig S6, Table S1). In addition to Aap, peptides from several cytoplasmic proteins were identified, but with sparse coverage, suggesting these proteins are present in small quantities and are likely irrelevant to the amyloid fibers.
Peptides were observed from the B-repeats and the lectin region of Aap, with one peptide including Leu601, which is one of two SepA cleavage sites (the other being
Leu335)[24], suggesting the lectin domain is still attached to Aap. The Aap A-repeats also contain tryptic sites, so the fact that no A-repeat peptides were detected by MS/MS is highly suggestive that SepA cleavage occurred at Leu335, downstream of the A- repeat region. This observation is in agreement with Rohde et al, who demonstrated that proteolytic processing of the N-terminus of Aap is required for biofilm formation[18], and with Paharik et al, who observed SepA-processed Aap molecules that retained the lectin domain, but not the A-repeat region in the context of biofilms[24]. This suggests the lectin need not be removed for biofilm formation (accumulation and amyloidogenesis specifically) to occur, but that it is the A-repeat region which inhibits biofilm formation.
85
Amyloid fibers form early in biofilm formation and correlate with DTPA resistance of biofilms
To further explore the importance of Aap amyloidogenesis in the context of developing biofilms, we followed biofilm formation by S. epidermidis strain RP62A at distinct time points throughout the first 24 hours of biofilm formation. The addition of ThT to the media during the initial inoculation of the bacteria allowed us to follow amyloid formation by CFM (Fig 7A). In parallel, biofilms were stained with LIVE/DEAD fluorescent dye to ensure ThT was not affecting cell growth or biofilm formation (Fig
7B). As early as 2 hours post-inoculation, punctate ThT fluorescence was visible on planktonic cells. This suggests that fibers start to form to a limited degree prior to cellular accumulation or biofilm assembly (Fig 7B). At 6 hours, the formation of microcolonies, and therefore intercellular accumulation, begins to occur. At this stage,
ThT fluorescence is located at the boundaries between associating cells, which is consistent with the role of Aap as the critical factor for intercellular adhesion. ThT fluorescence increases throughout the biofilm over time, with a predominance of fluorescence in the core of the biofilm with the highest cellular densities.
To understand the implications of the observed ThT fluorescence in the developing biofilm, we tested the ability of DTPA to inhibit biofilm formation when added at distinct time points along a similar time frame. Addition of DTPA during the first hour of incubation was able to prevent biofilm formation from occurring, whereas by 2 hours,
DTPA was significantly less effective. The DTPA resistance of the biofilm correlates with the time-frame of amyloid formation in growing biofilms (Fig 7A). To ensure that the lack of biofilm formation at early time-points was not due to mixing of the cultures upon
86 adding DTPA, a duplicate experiment (Fig 7D) was performed where DTPA was not added, but wells were mixed in the same way as in Fig 7C. Each of the conditions were still able to grow very strong biofilms, similar to the untreated control (“RP62A”), indicating that the mixing does not significantly affect biofilm formation. Therefore, these results support our hypothesis that Aap is important both for intercellular accumulation, by the formation of amyloid fibers between bacteria, and for stabilizing mature biofilms due to the remarkable resistance of amyloid fibers to physical and chemical insults.
87
Fig 7. The formation of amyloid fibers is well correlated to DTPA resistance in S. epidermidis biofilms. (A) Biofilm formation by S. epidermidis was characterized 2, 6, 12, 18, and 24 hours post-inoculation by confocal microscopy, staining with 10 µM ThT (cyan) over brightfield. In the 2-hour panel, a zoomed inset is shown with increased contrast and brightness to highlight punctate ThT fluorescence visible around planktonic S. epidermidis cells. ThT fluorescence is seen primarily at cell-cell junctions at the 6- hour time point. Mature biofilms (24 hours) show ThT throughout the biofilm as a major structural component. (B) S. epidermidis biofilms at 2, 6, 12, 18, and 24 hours post- inoculation were stained in parallel with LIVE/DEAD stain (green/red) as a control. (scale bar = 10 µm). Images were generated in Zen 2009 Light Edition. (C) Biofilm formation assays show DTPA resistance develops within 2 – 6 hours, with full DTPA resistance reached within 24 hrs. (D) demonstrates these observations are in fact, due to addition of DTPA, not mixing. The * symbol denotes statistical difference (P < 0.05) to DTPA added at t = 0 hr, while the # indicates no significant difference to RP62A without treatment, as determined by a two-tailed Student’s t test.
88
Discussion
Our previous work established that the B-repeat region of Aap can undergo Zn2+- mediated self-association to form protein-based ‘ropes’ between staphylococcal cells in the biofilm and that Zn2+ chelation was able to inhibit biofilm formation by both S. epidermidis and S. aureus[25-27, 30]. This initial work was carried out with the short B- repeat constructs Brpt1.5 and Brpt2.5, which showed reversible self-association that could be inhibited upon addition of chelator or moderate reduction in pH. Given that staphylococcal biofilms typically undergo acidification over time, it was unclear how this
Zn2+-mediated self-assembly mechanism could be maintained within the biofilm in vivo.
The results presented here using a more biologically relevant construct (Brpt5.5) and a Brpt3.5 fusion protein (HMBP-Brpt3.5) demonstrate that the B-repeat region of
Aap is capable of two distinct Zn2+-dependent assembly processes, forming both reversible oligomers and functional amyloid fibers within biofilms. While the formation of amyloid fibers in biofilms has been established in several bacterial species, the mechanism of Aap amyloid fiber assembly displays some unique features among this group of bacterial biofilm proteins. Unlike the amyloidogenic biofilm proteins curli (E. coli and Salmonella spp.)[57, 66] TasA (B. subtilis)[40, 58] or FapC (Pseudomonas spp.)[41] that require additional chaperones or initiator proteins for amyloid fiber assembly, our data suggest that Aap utilizes Zn2+ as a catalyst to drive amyloid fiber formation. This mechanism for metal-dependent amyloid nucleation is instead reminiscent of several mammalian amyloid-forming proteins including amyloid-β[54, 67, 68], prions[69, 70], and β2-microglobulin[71, 72]. Our proposed mechanism of Aap amyloid assembly has some similarities to that reported for S. aureus Bap[59]. The N-terminal region of this
89 cell wall-anchored protein is cleaved and released into the local environment, where it can self-assemble into amyloid-like structures in the presence of low Ca2+ concentrations or at acidic pH. Bap, like Aap, can therefore act as both a sensor and a scaffold protein[59]. Aap requires cleavage of the N-terminal A-repeat region by staphylococcal proteases or human proteases in order to support biofilm formation[18,
24]. With the N-terminal region of Aap removed, the B-repeat region is unmasked and allowed to facilitate intercellular contact and amyloidogenesis in the presence of Zn2+.
As previously mentioned, the S. aureus cell wall-associated protein, Bap (Biofilm associated protein) is capable of forming amyloid fibers in biofilms and seems to be critical for infection in a mouse catheter model[59]. Bap has a similar domain arrangement and function to SasG and Aap. However, the bap gene has not been found in S. aureus or S. epidermidis human clinical isolates[59]. A Bap homologue, Bhp, is present in human isolates of S. epidermidis[73], but no experimental evidence exists regarding its role in biofilm formation or ability to form amyloid fibers, with the exception of a study by Lembre et al, who showed a six-residue peptide from Bhp was able to form amyloid fibers in vitro[74]. The bhp gene was found in less than half of S. epidermidis strains isolated from prosthetic knee joint and hip infections, while aap was found in 89% of isolates[15].
A recently identified S. epidermidis protein, Sbp, was shown to form amyloid fibers both in vitro and when expressed in intracellular inclusions in E. coli[75]. Wang, et al.[75] also showed that an sbp knockout of S. epidermidis strain 1457 did not show
Thioflavin S (ThS) fluorescence by confocal microscopy, nor did it form a biofilm - an observation consistent with the initial study by Decker, et al.[76]. The wild-type strain
90
1457 did show biofilm formation, as expected, along with ThS fluorescence indicative of amyloid-like fibers. However, the authors did not identify Sbp as a component of purified amyloid fibers derived from biofilms, so there is uncertainty as to whether Sbp directly forms amyloid fibers in the biofilm, or if Sbp plays an indirect role in the nucleation of
Aap amyloid fibers. If the latter case were true, then genetic knockout of either aap or sbp would abrograte biofilms as well as eliminate ThT fluorescence. Until there are well- defined mutations identified in either Aap or Sbp that specifically eliminate interactions, it will be difficult to establish the exact role played by Sbp. For this reason, we utilized mass spectrometry to confirm that the fibers we observed were indeed composed of
Aap.
The molecular characteristics of diverse types of amyloid fiber architecture have been well described in multiple studies using a combination of structural and biophysical techniques[77-85]. AUC approaches have also been used to characterize mature amyloid fibers in solution[86, 87]. However, there have been few studies about the assembly of early oligomers and proto-fibril intermediates that produce mature amyloid fibers[88-90], particularly in terms of resolving discrete intermediate species. For example, pre-amyloid oligomerization of transthyretin has been characterized by AUC but without resolution of individual species[91]. We have applied the c(s,ff0) analysis to sedimentation velocity AUC data to resolve the broad array of species present at early stages of Aap amyloidogenesis, including the oligomeric complexes and nascent fibers.
This is one of the first uses of this 2D size-and-shape analysis approach to an amyloid- forming protein, and its ability to separate many species with differing sizes and shapes in solution holds promise for resolving assembly intermediates in other amyloid systems
91 as well. A similar approach, based on the van Holde-Weischet method[92] and implemented in Ultrascan[93] (http://www.ultrascan.uthscsa.edu) designed to resolve size and shape information from sedimentation velocity data has been applied to mature amyloid fibers formed by Abeta peptides[94, 95], but here we examined amyloidogenesis of a much larger protein. The c(s,ff0) analysis model is capable of distinguishing species of different size and shape that are sedimenting at the same rate[34], which can occur in amyloid assembly systems due to the complicated nature of the assembly process and the number of species to be resolved. This analysis works particularly well in systems such as this one with slow kinetics, which allows resolution of discrete assembly intermediates rather than simply showing broad reaction boundaries representing multiple species in rapid exchange. The c(s,ff0) analysis of Aap presented here clearly discriminates between compact oligomers and fibers that show similar sedimentation coefficients due to the increased drag and resulting slower sedimentation of the highly elongated fibers. This analytical approach could prove useful in providing mechanistic details for how amyloid nucleation occurs by this or other proteins.
Biofilm formation is the primary characteristic responsible for pathogenicity and it contributes to antibiotic resistance in chronic infections caused by S. epidermidis. One of the biggest challenges with recurrent infections caused by biofilms is their highly adhesive and cohesive nature and their resistance to chemical and physical insults. Our data indicate that intercellular amyloid fibers appear early during the accumulation phase of nascent biofilms, and they continue to increase until they are ubiquitous throughout the mature biofilm. Using highly purified tandem B-repeats in solution, we
92 show that mature amyloid fibers are highly resistant to chemical stresses such as Zn2+ chelation or acidic pH, suggesting that the amyloid fibers forming the intercellular network are one reason S. epidermidis biofilms are so resistant to harsh environmental conditions. We have previously shown[25] that addition of Zn2+ chelators to staphylococcal cultures prevents biofilm formation. However, addition of these same chelators to pre-formed mature staphylococcal biofilms does not appreciably disperse the biofilm, which is now explained by the presence of resistant amyloid fibers between cells. Furthermore, we predict that homologous surface proteins containing tandem B- repeats in S. aureus (i.e., SasG and Pls) and other gram-positive bacteria will form similar Zn2+-dependent amyloid fibers between cells in biofilms. The data presented here will provide new insights for both potential prevention and treatment of chronic staphylococcal infections, particularly with regard to methods that could depolymerize amyloid fibers and thus destabilize the biofilm.
93
Methods
Bacterial Strains and Media
S. epidermidis strain RP62A (ATCC 35984) was purchased directly from ATCC as a glycerol stock and was cultured in tryptic soy broth (TSB).
Expression Construct Generation
The Brpt3.5 construct (amino acids 1761-2223) of Aap (NCBI AAW53239.1) was
PCR amplified from RP62A genomic DNA and inserted into the expression vector pHisMBP-DEST (kindly provided by Dr. Artem Evdokimov) using Gateway technology, which adds an N-terminal hexahistidine-maltose binding protein (His-MBP) fusion to the
Brpt3.5 construct, with an intervening tobacco etch virus protease site. The Brpt5.5 construct (amino acids 1505-2223) of Aap (NCBI AAW53239.1) was synthesized by
LifeTechnologies GeneArt®, also containing an intervening tobacco etch virus protease site for removal of the His-MBP tag. The plasmids were then transformed into the E. coli expression cell line BLR(DE3) (Novagen). The Brpt3.5-Cys mutant was synthesized by
LifeTechnologies GeneArt® as well, containing amino acids 1761-2223 of Aap (NCBI
AAW53239.1), followed by a single cysteine residue inserted before the stop codon.
Protein Expression and Purification
One-liter cultures were inoculated with 10 ml of His-MBP-Brpt3.5/BLR(DE3) culture at an OD600 of 0.6-0.8, and then allowed to incubate overnight with shaking at 37
°C. Protein expression was then induced using 250 µM IPTG for 6 hours at 25 °C. The cells were then harvested, re-suspended, frozen and thawed prior to lysis by French
94 press. The cell lysate was centrifuged, and the soluble fraction was decanted onto a nickel-NTA gravity column. The Brpt3.5 protein was eluted by imidazole step gradient.
Fractions confirmed by SDS gel to contain Brpt3.5 were then further purified by anion exchange using a 5 ml anionQ fast-flow column (GE Healthcare) followed by size- exclusion chromatography using a Superdex 200 column (GE Healthcare). The presence of the His-MBP fusion tag improved solubility and behavior in solution and was therefore left attached to enhance protein stability, except for initial CD and AUC experiments (Fig 1).
The Brpt5.5 construct was induced overnight at 20 °C with 200 µM IPTG, lysed by sonication, then ran over a homemade 50 ml NiNTA column containing 50 ml of
IMAC Sepharose Fast Flow resin (GE Healthcare) charged with Ni2+ and housed inside a XK 16/40 column. After elution by an imidazole linear gradient, the fractions containing Brpt5.5 were dialyzed into 20 mM Tris pH 7.4, 300 mM NaCl and cleaved by
TEV for at least 6 hours under reducing conditions. Another 50 ml NiNTA column was run, this time collected the flow-through (cleaved Brpt5.5). Finally, a Superdex 200 (GE
Healthcare) column was run to separate remaining contaminants and truncations of
Brpt5.5.
Circular Dichroism
Brpt3.5 and HMBP-Brpt3.5 samples were dialyzed into 10 mM Tris pH 7.4 and
150 mM NaF. Far-UV VD spectra were obtained using an Aviv 215 spectrometer. The concentration of cleaved Brpt3.5 (fusion tag removed) was determined using the molar extinction coefficient of 10,430 M-1 cm-1, as calculated using the online server
95
PrtoParam (web.expasy.org/protparam), and the concentration of HMBP-Brpt3.5 was determined using the molar extinction coefficient of 78,270 M-1 cm-1 calculated by
ProtParam. An additional sample of HMBP-Brpt3.5 was treated with 10% formic acid
(FA) to depolymerize amyloid fibers, followed by dialysis of the sample into 10 mM Tris pH 7.4 and 150 mM NaF. The concentration of Brpt5.5 was based on the molar extinction coefficient of 16,390 M-1 cm-1, and the spectrum was collected in 10 mM Tris pH 7.4 and 50 mM NaF. Data were analyzed using the CDSSTR program on the online
Dichroweb server with reference set 4 (http://dichroweb.cryst.bbk.ac.uk)[96]. Data are plotted as mean residue ellipticity, [θ], which is in units of degrees cm2 dmol-1 residue-1.
Analytical Ultracentrifugation
Experiments were performed with a Beckman XL-I analytical ultracentrifuge using absorbance optics at 280 nm. Sedimentation velocity experiments were performed at 36,000 rpm at 20 °C with and without 3 mM ZnCl2 (Fig 2) or at 25 °C and
37 °C with or without 500 µM or 1 mM ZnCl2 as indicated (Fig 3). Data were analyzed using Sedfit software[97] and the c(s) (Figs 1 and 2) or c(s,ff0) models (Fig 3). The c(s,ff0) model describes the sedimentation behavior of the species in solution as a two- dimensional distribution based on both sedimentation coefficient and frictional ratio, which allows resolution of multiple species of widely differing size and shape sedimenting at the same sedimentation coefficients[33, 34]. Parameters of buffer density and viscosity and the partial specific volume of constructs were calculated using
SEDNTERP[98] at all relevant experimental temperatures. The data described in Fig 3B and Fig 3C were analyzed using several different models in SEDFIT; the c(s,ff0) model
96 yielded fits with the lowest value for the summed square of the residuals (SSR). The standard c(s) model fit gave an SSR value of 0.5140; the best-fit worm-like chain model gave an SSR value of 0.5102; the c(s,ff0) model gave an SSR value of 0.5029 when setting the frictional ratio limits from 1 to 5.
In order to show reversibility of Brpt5.5 initial assembly (Fig S5), 6 µM Brpt5.5 was dialyzed overnight into 50 mM MOPS pH 7.2, 50 mM NaCl, 3.5 mM ZnCl2. A sample was analyzed by sedimentation velocity AUC with the addition of buffer (Brpt5.5
+ Zn), 7 mM DTPA (+ Zn + DTPA), or enough HCl to reach pH near 6 (+ Zn + HCl). As a control, Brpt5.5 was also dialyzed into 20 mM MES pH 5.0, 50 mM NaCl, 3.5 mM
ZnCl2. This sample sedimented as a monomer near 2 s* (data not shown). The absorbance at 280 nm was used for the c(s) distribution analysis.
Transmission Electron Microscopy
5 µl samples of 10 µM HMBP-Brpt3.5 incubated with 500 µM ZnCl2 were applied to 200 mesh formvar carbon/copper grids for 2 minutes, washed with diH2O, stained by
1% uranyl acetate drop-wise for 30 seconds, and washed a second time with diH2O.
Samples were then dried for 1 hour prior to viewing on a Hitachi 7600 transmission electron microscope at an accelerating voltage of 80 kV. Images were captured using an AMT 2k CCD camera. Brpt5.5 was incubated at 20 µM with 5 mM Zn2+ and incubated at 37 °C for 3 weeks. Samples were stained using the same protocol as
HMBP-Brpt3.5, but with 2% uranyl acetate (Electron Microscopy Sciences). To stain biofilms, they were washed off of the dialysis tubing as described in “Bacterial Strains and Media.” The washes were treated with DTPA, FA, or buffer and incubated for 1
97 hour at room temperature while shaking. A 3 µl sample was added to grids for negative staining as described above. For extracellular biofilm material, washes were centrifuged at 17 k x g for 5 minutes before collecting the supernatant.
Harvesting Biofilms
This protocol was based on an approach used by Sun, et al. [17] to isolate extracellular and cell wall-associated proteins from S. epidermidis biofilms. RP62A was grown overnight on tryptic soy agar (TSA) with Sheep Blood (Thermo ScientificTM
R01202). Colonies were scraped from the agar plate and suspended in TSB to an OD of 0.1. A piece of 3,500 MWCO dialysis tubing was cut down the edge and opened to be arranged over a TSA agar plate. A 2 ml aliquot (with the addition of ZnCl2, DTPA, FA, or
100 mM MES pH 5.0) was added to the dialysis tubing on top of the TSA agar. After 16 hours of growth at 37 °C, the biofilm was washed off of the dialysis tubing using 1 ml of
H2O. For lysostaphin digestion of the cell wall, mixtures were centrifuged for 10 minutes at 17 k x g and the pellet resuspended in 50 mM Tris pH 7.4, 150 mM NaCl, 30% raffinose. Samples were then incubated at 37 °C for 1 hr with 1 mg/ml of lysostaphin
(Sigma L3876).
Thioflavin T Protein Fluorescence Assay
10 µM HMBP-Brpt3.5 and 20 µM Brpt5.5 samples were treated with 10% formic acid (FA) to depolymerize amyloid fibers[44], followed by dialysis into standard buffer.
The FA-treated protein was then incubated with or without 500 µM ZnCl2 for 24 hours at
20 °C prior to adding thioflavin T (Sigma) to a final concentration of 10 µM. In parallel,
98 one sample of HMBP-Brpt3.5 was treated with 10% FA and was tested for ThT fluorescence without removing the FA (Labeled “FA + HMBP-Brpt3.5 + ThT” in Fig 4B).
Fluorescence was measured using a Perkin Elmer LS50B Luminescence
Spectrophotometer or a Biotek Synergy at an excitation of 434 nm or 440 nm and collecting the complete emission spectrum between 450 and 600 nm. Congo Red absorbance was measured from 400 to 600, and the absorbance at 540 nm plotted in
Fig 4E. Proteostat fluorescence was measured using an excitation wavelength of 500 nm and collecting the emission spectrum from 500 to 700 nm. The emission at 600 nm was plotted in Fig 4F, along with the emission of ThT at 482 nm (Fig 4C, F).
HPLC Assays
For the HPLC fiber/oligomer quantification assay, 10 µM HMBP-Brpt3.5 samples were incubated with or without 500 µM ZnCl2 for 1, 4, or 30 days at 20 °C or 37 °C.
Samples were prepared based on a protocol previously described by O’Nuallain et al[60]. Briefly, samples were centrifuged for 1 hour at 13,500 rpm and then 250 µl of 5% acetonitrile. Samples were loaded on a C4 reverse-phase column (Phenomenex) and run on an Äkta purifier with a linear gradient of 0-95% acetonitrile over 10 column volumes. Peaks were integrated using the Unicorn software, normalizing the peak area to a standardized elution volume for monomer and oligomer peaks. To determine the stability of the Zn2+-induced amyloid fibers, samples of 10 µM HMBP-Brpt3.5 were incubated with 500 µM ZnCl2 for 1 or 4 days at 20 °C or 37 °C, followed by the addition of an equal volume of: 1) buffer (20 mM sodium citrate pH 7.4, 150 mM NaCl); 2) dilute hydrochloride acid sufficient to lower the pH 5.0; or 3) 2 mM Na5-
99 diethylenetriaminepentacetic acid (DTPA). Samples were further incubated for 2 hours, mixed with equal volume of 5% acetonitrile and then separated on a C4 column.
Turbidity Assays
5 µM Brpt5.5 in 2 ml 20 mM MOPS pH 7.2, 50 mM NaCl was incubated with 3, 5, or 8 mM ZnCl2 at 37 °C in a shaking incubator. The sample was transferred to a cuvette and the absorbance at 280, 400, and 700 nm was measured in a BioMate 3S
(ThermoFisher). The reported turbidity value is the absorbance measured at 400 nm
(Fig 5C). To evaluate the resistance of Brpt5.5 fibers to DTPA and HCl, samples were taken from the turbidity assay in Fig 5C, then DTPA or HCl were titrated in, with turbidity measurements taken after each addition.
Confocal Microscopy
For analysis of Brpt5.5 protein fibers, 10 µM samples were incubated with 500
µM ZnCl2 for 2, 6, 12, 18, or 24 hours prior to addition of thioflavin T (10 µM final concentration). Samples were then added to 8-well borosilicate glass slides (Nunc) and viewed using a Zeiss LSM 710 inverted microscope using an Apochromat 63x/1.40 oil
DIC M27 objective for brightfield and a laser set to 458 nm with emission filters at 469-
580 nm to measure thioflavin T fluorescence. For analysis of amyloid formations in biofilms, overnight cultures of S. epidermidis RP62A were diluted 1:200 and 400 µl aliquots were added to 8-well borosilicate glass slides. The slides were incubated 18 hours at 37 °C without shaking, followed by addition of thioflavin T to 10 µM as indicated. The media was aspirated and each well washed 3x with diH2O. The biofilms
100 were viewed using a Zeiss LSM 510 inverted microscope as described above. Control biofilm samples were alternatively labeled with the LIVE/DEAD stain kit (Invitrogen), using 3 µl stain diluted in 1 ml of sterile saline.
Biofilm Formation Assay
To quantify the ability for RP62A to form biofilms under varying conditions, a crystal violet-based biofilm formation assay was utilized[25]. An overnight culture grown in TSB was diluted 1:200 into TSB. To wells of a 96 well plate (Corning 351172), 200 µl of culture were added, along with initial treatments of ZnCl2 or DTPA (t = 0 hr). DTPA,
FA, or 100 mM MES pH 5.0 were added at the specified time points and incubated for an additional 1 hour at 37 °C. The liquid was then removed from the wells, followed by two washes of 200 µl H2O before being allowed to dry. Next, 100 µl of 0.1 % crystal violet was added and allowed to stain the biofilms for 10 minutes at room temperature.
The crystal violet solution was then removed, followed by two more washes with 200 µl
H2O. The plates were allowed to dry before being scanned. Finally, 200 µl 33 % acetic acid was added and plates incubated at 4 °C for 30 min to remove crystal violet stain from the adherent biofilms. The solution in the wells was then transferred to new wells, and then diluted 1:1 (100 µl solution to 100 µl H2O) before scanning at 520 nm.
Statistical analysis was performed in Microsoft Excel, using the two-tailed, two-sample unequal variance Student’s t test. Significant difference was identified when P < 0.05.
101
Mass spectrometry
Biofilms were prepared as described in “Harvesting Biofilms,” with the exception that no H2O was added to the dialysis membrane during collection. This kept the material in the biofilm at a reasonable concentration to be visualized by SDS-PAGE.
The section outlined in Fig 6 was reduced with DTT, alkylated with iodoacetamide and digested with trypsin. The resultant peptides were recovered and dried in a speed vac, before analysis by nanoLC-MS/MS.
Acknowledgements
The authors thank Georgianne Ciralo and Cincinnati Children’s Department of
Pathology for assistance and use of the electron microscopy facility, Dr. Dan Hassett and lab members and Dr. Birgit Ehmer for assistance with the confocal microscope, Dr.
Andy Deng and Dr. Tom Thompson’s lab members for help with the HPLC experiments and analysis, Dr. Nicolas Nassar for use of their fluorescence spectrophotometer, and the University of Cincinnati Cancer Biology Proteomics Core Facility for mass spectrometry services. The authors would also like to thank Dr. Rhett Kovall and Dr.
Tom Thompson for comments on the manuscript and Dr. Catherine Chaton for helpful discussions. This project was supported by NIH grants R01-GM094363 and U19-
AI070235, and by funds from the Cincinnati Children’s Hospital Research Foundation
(to ABH).
102
Supporting Information
S1 Fig. Sequence identity comparison of the tandem Brpt domains of Aap. S. epidermidis strain RP62A contains 12 tandem B-repeats. Each B-repeat amino acid sequence was aligned, using the most N-terminal repeat as the reference sequence with the online ISREC-Server program LALIGN, version 2.1.30 (http://www.ch.embnet.org/software/LALIGN_form.html). Sequence alignment of each B-repeat demonstrates a highly conserved sequence identity for each repeat with minor amino acid differences. In addition, several internal repeats are up to 98-100% identical to one another (such as repeats 4 and 5 or 9, 10, and 11) despite sequence differences with the N-terminal reference B-repeat.
103
S2 Fig. Secondary structure analysis of Brpt3.5. Circular dichroism spectra of uncleaved Brpt3.5 (black) and uncleaved Brpt3.5 treated with formic acid (FA, grey) demonstrates that the secondary structure of Brpt3.5 was not affected by treatment with FA. The secondary structure profile of Brpt3.5 (13% α-helix, 33% β-sheet, 22% turn, 31% coil) is almost identical to Brpt3.5 treated with formic acid (13% α-helix, 34% β- sheet, 23% turn, 30% coil). Secondary structure content was determined using CDSSTAR (reference set 4) on Dichroweb (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml).
104
S3 Fig. B-repeat fibers are resistant to acid and metal chelator treatment. A) C4 reverse-phase HPLC elution profiles of 10 µM HMBP-Brpt3.5 alone (black) or incubated with 500 µM ZnCl2 for 1 (red), 4 (blue), or 30 (green) days at 20 °C. Samples were centrifuged at 13,000 rpm for 1 hour prior to HPLC separation to remove insoluble aggregates. B) Samples of 10 µM HMBP-Brpt3.5 with 500 µM ZnCl2 were incubated for 4 days at 20 °C prior to addition of Tris-buffer saline (red trace); sufficient dilute HCl to lower the pH to 5 (blue trace); or 2 mM DTPA (green trace). Separation by HPLC revealed that oligomer/soluble fiber species were maintained in the presence of both acid (blue) and DTPA (green) when compared to the buffer-treated control samples (red) at both temperatures. TEM images of these samples are in Supporting Information (S4 Fig).
105
S4 Fig. Stability of HMBP-Brpt3.5/Zn2+ fibers after incubation with HCl or the metal chelator DTPA. Representative TEM images of the 4 day-Zn2+ incubated HPLC samples (see Fig 4) at 20 °C (A) and 37 °C (B) treated with TBS buffer, acid, and DTPA, respectively. The fiber morphology is maintained upon each treatment, with minor fiber assembly rearrangements visible for the 20 °C acid-treated fibers (shown in image), although other rod-like fibers can still be found in this sample. Scale bars = 1 µm.
106
S5 Fig. Initial assembly of Brpt5.5 is sensitive to acidification and the metal chelator DTPA. 6 µM Brpt5.5 was incubated with 3.5 mM ZnCl2 overnight, then analyzed by sedimentation velocity AUC with the addition of buffer (black), 7 mM DTPA (blue) or HCl to pH 5 (red). This experiment indicates that tandem B-repeats undergo an initial, reversible assembly.
107
S6 Fig. Mass spectrometry results of SDS-resistant aggregate present in S. epidermidis RP62A biofilms. Biofilms were collected from dialysis membrane on TSA grown in the presence of 20 µM ZnCl2. Collected material was centrifuged and the supernatant removed. The bacterial pellet was incubated with lysostaphin, resulting in the digestion of the cell wall and release of cell wall anchored proteins. After another centrifugation step, the supernatant was run on SDS-PAGE, revealing aggregate trapped in the well and stacking gel when stained with coomassie (Fig 6J). Results from nanoLC-MS/MS performed using the material within the red rectangle in Fig 6J are displayed above. Aap is the primary protein identified. The three other proteins, each of which is cystoplasmic, have very little coverage, suggesting these are likely present in very small amounts, and may therefore be insignificant to the amyloid fibers. Table S1 displays all peptides observed.
108
Protein Sequence Observed Accumulation-associated protein ADLDGATLTYTPK Accumulation-associated protein DNYDFYGR Accumulation-associated protein EFDPNLAPGTEK Accumulation-associated protein EFDPNLAPGTEKVVQK Accumulation-associated protein EFNPDLKPGEER Accumulation-associated protein GSQEDVPGKPGVK Accumulation-associated protein GSQEDVPGKPGVKNPDTGEVVTPPVDDVTK Accumulation-associated protein GTPSAAGFR Accumulation-associated protein GYGTFVKNDSQGNTSK Accumulation-associated protein IDTGYYNNDPLDK Accumulation-associated protein NPDTGEVVTPPVDDVTK Accumulation-associated protein NPLTGEKVGEGEPTEK Accumulation-associated protein NTIDIPPTTVK Accumulation-associated protein QPVDEIVEYGPTK Accumulation-associated protein TITTPTTKNPLTGEK Accumulation-associated protein VGEGEPTEKITK Accumulation-associated protein YNASNQTFTATYAGK Accumulation-associated protein YNYGQPPGTTTAGAVQFK Accumulation-associated protein PITSTEEIPFDK Accumulation-associated protein TGEVVTPPVDDVTK Arginine deiminase DVLAIGISER Arginine deiminase VVAIEIPTSR L-lactate dehydrogenase DAAYDIIQAK L-lactate dehydrogenase VIGSGTVLDSAR Probable malate:quinone IDEGTDVNYGALTR oxidoreductase Probable malate:quinone YSIDQMIK oxidoreductase
S1 Table. Mass spectrometry results of SDS-resistant aggregate present in S. epidermidis RP62A biofilms. Listed in this table are the peptides observed by mass spectrometry.
109
References 1. Uckay I, Pittet D, Vaudaux P, Sax H, Lew D, Waldvogel F. Foreign body infections due to Staphylococcus epidermidis. Annals of medicine. 2009;41(2):109-19. Epub 2008/08/23. doi: 10.1080/07853890802337045. PubMed PMID: 18720093. 2. NNIS. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American journal of infection control. 2004;32(8):470-85. Epub 2004/12/02. doi: 10.1016/s0196655304005425. PubMed PMID: 15573054. 3. Fey PD, Olson ME. Current concepts in biofilm formation of Staphylococcus epidermidis. Future microbiology. 2010;5(6):917-33. Epub 2010/06/05. doi: 10.2217/fmb.10.56. PubMed PMID: 20521936; PubMed Central PMCID: PMCPMC2903046. 4. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2004;39(3):309-17. Epub 2004/08/13. doi: 10.1086/421946. PubMed PMID: 15306996. 5. Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infectious disease clinics of North America. 2009;23(1):73-98. Epub 2009/01/13. doi: 10.1016/j.idc.2008.10.001. PubMed PMID: 19135917. 6. Fey PD. Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Current opinion in microbiology. 2010;13(5):610-5. Epub 2010/10/05. doi: 10.1016/j.mib.2010.09.007. PubMed PMID: 20884280; PubMed Central PMCID: PMCPMC2966470. 7. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase- negative staphylococci. The Lancet Infectious diseases. 2002;2(11):677-85. Epub 2002/11/01. PubMed PMID: 12409048. 8. Otto M. Staphylococcus epidermidis--the 'accidental' pathogen. Nature reviews Microbiology. 2009;7(8):555-67. doi: 10.1038/nrmicro2182. PubMed PMID: 19609257; PubMed Central PMCID: PMC2807625. 9. Kristian SA, Birkenstock TA, Sauder U, Mack D, Gotz F, Landmann R. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. The Journal of infectious diseases. 2008;197(7):1028-35. Epub 2008/04/19. doi: 10.1086/528992. PubMed PMID: 18419540. 10. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin- resistant Staphylococcus epidermidis strain. Journal of bacteriology. 2005;187(7):2426- 38. Epub 2005/03/19. doi: 10.1128/jb.187.7.2426-2438.2005. PubMed PMID: 15774886; PubMed Central PMCID: PMCPMC1065214. 11. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science (New York, NY). 1999;284(5418):1318-22. Epub 1999/05/21. PubMed PMID: 10334980. 12. Sadovskaya I, Vinogradov E, Flahaut S, Kogan G, Jabbouri S. Extracellular carbohydrate-containing polymers of a model biofilm-producing strain, Staphylococcus
110 epidermidis RP62A. Infection and immunity. 2005;73(5):3007-17. Epub 2005/04/23. doi: 10.1128/iai.73.5.3007-3017.2005. PubMed PMID: 15845508; PubMed Central PMCID: PMCPMC1087347. 13. Izano EA, Amarante MA, Kher WB, Kaplan JB. Differential roles of poly-N- acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Applied and environmental microbiology. 2008;74(2):470-6. Epub 2007/11/28. doi: 10.1128/aem.02073-07. PubMed PMID: 18039822; PubMed Central PMCID: PMCPMC2223269. 14. Mack D, Haeder M, Siemssen N, Laufs R. Association of biofilm production of coagulase-negative staphylococci with expression of a specific polysaccharide intercellular adhesin. The Journal of infectious diseases. 1996;174(4):881-4. Epub 1996/10/01. PubMed PMID: 8843236. 15. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials. 2007;28(9):1711-20. doi: 10.1016/j.biomaterials.2006.11.046. PubMed PMID: 17187854. 16. Hussain M, Herrmann M, von Eiff C, Perdreau-Remington F, Peters G. A 140- kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infection and immunity. 1997;65(2):519-24. Epub 1997/02/01. PubMed PMID: 9009307; PubMed Central PMCID: PMCPmc176090. 17. Sun D, Accavitti MA, Bryers JD. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clinical and diagnostic laboratory immunology. 2005;12(1):93-100. Epub 2005/01/12. doi: 10.1128/cdli.12.1.93-100.2005. PubMed PMID: 15642991; PubMed Central PMCID: PMCPMC540198. 18. Rohde H, Burdelski C, Bartscht K, Hussain M, Buck F, Horstkotte MA, et al. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Molecular microbiology. 2005;55(6):1883-95. doi: 10.1111/j.1365-2958.2005.04515.x. PubMed PMID: 15752207. 19. Corrigan RM, Rigby D, Handley P, Foster TJ. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology (Reading, England). 2007;153(Pt 8):2435-46. Epub 2007/07/31. doi: 10.1099/mic.0.2007/006676- 0. PubMed PMID: 17660408. 20. Kogan G, Sadovskaya I, Chaignon P, Chokr A, Jabbouri S. Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS microbiology letters. 2006;255(1):11-6. Epub 2006/01/27. doi: 10.1111/j.1574- 6968.2005.00043.x. PubMed PMID: 16436056. 21. Jabbouri S, Sadovskaya I. Characteristics of the biofilm matrix and its role as a possible target for the detection and eradication of Staphylococcus epidermidis associated with medical implant infections. FEMS immunology and medical microbiology. 2010;59(3):280-91. Epub 2010/06/10. doi: 10.1111/j.1574- 695X.2010.00695.x. PubMed PMID: 20528930. 22. Schaeffer CR, Woods KM, Longo GM, Kiedrowski MR, Paharik AE, Buttner H, et al. Accumulation-associated protein enhances Staphylococcus epidermidis biofilm
111 formation under dynamic conditions and is required for infection in a rat catheter model. Infection and immunity. 2015;83(1):214-26. Epub 2014/10/22. doi: 10.1128/iai.02177- 14. PubMed PMID: 25332125; PubMed Central PMCID: PMCPmc4288872. 23. Yarawsky AE, English LR, Whitten ST, Herr AB. The Proline/Glycine-Rich Region of the Biofilm Adhesion Protein Aap Forms an Extended Stalk that Resists Compaction. Journal of molecular biology. 2017;429(2):261-79. Epub 2016/11/29. doi: 10.1016/j.jmb.2016.11.017. PubMed PMID: 27890783. 24. Paharik AE, Kotasinska M, Both A, Hoang TN, Buttner H, Roy P, et al. The metalloprotease SepA governs processing of accumulation-associated protein and shapes intercellular adhesive surface properties in Staphylococcus epidermidis. Molecular microbiology. 2017;103(5):860-74. Epub 2016/12/21. doi: 10.1111/mmi.13594. PubMed PMID: 27997732; PubMed Central PMCID: PMCPMC5480372. 25. Conrady DG, Brescia CC, Horii K, Weiss AA, Hassett DJ, Herr AB. A zinc- dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(49):19456-61. doi: 10.1073/pnas.0807717105. PubMed PMID: 19047636; PubMed Central PMCID: PMC2592360. 26. Conrady DG, Wilson JJ, Herr AB. Structural basis for Zn2+-dependent intercellular adhesion in staphylococcal biofilms. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(3):E202-11. Epub 2013/01/02. doi: 10.1073/pnas.1208134110. PubMed PMID: 23277549; PubMed Central PMCID: PMCPmc3549106. 27. Chaton CT, Herr AB. Defining the metal specificity of a multifunctional biofilm adhesion protein. Protein science : a publication of the Protein Society. 2017;26(10):1964-73. Epub 2017/07/15. doi: 10.1002/pro.3232. PubMed PMID: 28707417; PubMed Central PMCID: PMCPMC5606542. 28. Geoghegan JA, Corrigan RM, Gruszka DT, Speziale P, O'Gara JP, Potts JR, et al. Role of surface protein SasG in biofilm formation by Staphylococcus aureus. Journal of bacteriology. 2010;192(21):5663-73. Epub 2010/09/08. doi: 10.1128/jb.00628-10. PubMed PMID: 20817770; PubMed Central PMCID: PMCPMC2953683. 29. Formosa-Dague C, Speziale P, Foster TJ, Geoghegan JA, Dufrene YF. Zinc- dependent mechanical properties of Staphylococcus aureus biofilm-forming surface protein SasG. Proceedings of the National Academy of Sciences of the United States of America. 2016;113(2):410-5. Epub 2015/12/31. doi: 10.1073/pnas.1519265113. PubMed PMID: 26715750; PubMed Central PMCID: PMCPmc4720321. 30. Shelton CL, Conrady DG, Herr AB. Functional consequences of B-repeat sequence variation in the staphylococcal biofilm protein Aap: deciphering the assembly code. The Biochemical journal. 2017;474(3):427-43. Epub 2016/11/23. doi: 10.1042/bcj20160675. PubMed PMID: 27872164. 31. Spurlino JC, Lu GY, Quiocho FA. The 2.3-A resolution structure of the maltose- or maltodextrin-binding protein, a primary receptor of bacterial active transport and chemotaxis. The Journal of biological chemistry. 1991;266(8):5202-19. Epub 1991/03/15. PubMed PMID: 2002054.
112
32. Herr AB, Conrady DG. Thermodynamic analysis of metal ion-induced protein assembly. Methods in enzymology. 2011;488:101-21. Epub 2011/01/05. doi: 10.1016/b978-0-12-381268-1.00005-7. PubMed PMID: 21195226. 33. Brown PH, Schuck P. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophysical journal. 2006;90(12):4651-61. Epub 2006/03/28. doi: 10.1529/biophysj.106.081372. PubMed PMID: 16565040; PubMed Central PMCID: PMCPMC1471869. 34. Chaton CT, Herr AB. Elucidating Complicated Assembling Systems in Biology Using Size-and-Shape Analysis of Sedimentation Velocity Data. Methods in enzymology. 2015;562:187-204. Epub 2015/09/29. doi: 10.1016/bs.mie.2015.04.004. PubMed PMID: 26412652. 35. Sunde M, Blake C. The structure of amyloid fibrils by electron microscopy and X- ray diffraction. Advances in protein chemistry. 1997;50:123-59. Epub 1997/01/01. PubMed PMID: 9338080. 36. Dueholm MS, Larsen P, Finster K, Stenvang MR, Christiansen G, Vad BS, et al. The Tubular Sheaths Encasing Methanosaeta thermophila Filaments Are Functional Amyloids. The Journal of biological chemistry. 2015;290(33):20590-600. Epub 2015/06/26. doi: 10.1074/jbc.M115.654780. PubMed PMID: 26109065; PubMed Central PMCID: PMCPMC4536462. 37. Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid--from bacteria to humans. Trends in biochemical sciences. 2007;32(5):217-24. Epub 2007/04/07. doi: 10.1016/j.tibs.2007.03.003. PubMed PMID: 17412596. 38. Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science (New York, NY). 2002;295(5556):851-5. Epub 2002/02/02. doi: 10.1126/science.1067484. PubMed PMID: 11823641; PubMed Central PMCID: PMCPMC2838482. 39. Larsen P, Nielsen JL, Dueholm MS, Wetzel R, Otzen D, Nielsen PH. Amyloid adhesins are abundant in natural biofilms. Environmental microbiology. 2007;9(12):3077-90. Epub 2007/11/10. doi: 10.1111/j.1462-2920.2007.01418.x. PubMed PMID: 17991035. 40. Romero D, Aguilar C, Losick R, Kolter R. Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(5):2230-4. Epub 2010/01/19. doi: 10.1073/pnas.0910560107. PubMed PMID: 20080671; PubMed Central PMCID: PMCPMC2836674. 41. Dueholm MS, Petersen SV, Sonderkaer M, Larsen P, Christiansen G, Hein KL, et al. Functional amyloid in Pseudomonas. Molecular microbiology. 2010;77(4):1009-20. Epub 2010/06/25. doi: 10.1111/j.1365-2958.2010.07269.x. PubMed PMID: 20572935. 42. LeVine H, 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta- amyloid peptides: detection of amyloid aggregation in solution. Protein science : a publication of the Protein Society. 1993;2(3):404-10. Epub 1993/03/01. doi: 10.1002/pro.5560020312. PubMed PMID: 8453378; PubMed Central PMCID: PMCPMC2142377. 43. Wolfe LS, Calabrese MF, Nath A, Blaho DV, Miranker AD, Xiong Y. Protein- induced photophysical changes to the amyloid indicator dye thioflavin T. Proceedings of the National Academy of Sciences of the United States of America.
113
2010;107(39):16863-8. Epub 2010/09/10. doi: 10.1073/pnas.1002867107. PubMed PMID: 20826442; PubMed Central PMCID: PMCPMC2947910. 44. Collinson SK, Emody L, Muller KH, Trust TJ, Kay WW. Purification and characterization of thin, aggregative fimbriae from Salmonella enteritidis. Journal of bacteriology. 1991;173(15):4773-81. Epub 1991/08/01. PubMed PMID: 1677357; PubMed Central PMCID: PMCPMC208156. 45. Blancas-Mejia LM, Hammernik J, Marin-Argany M, Ramirez-Alvarado M. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans. The Journal of biological chemistry. 2015;290(8):4953-65. Epub 2014/12/30. doi: 10.1074/jbc.M114.615401. PubMed PMID: 25538238; PubMed Central PMCID: PMCPMC4335233. 46. Kodali R, Williams AD, Chemuru S, Wetzel R. Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. Journal of molecular biology. 2010;401(3):503-17. Epub 2010/07/06. doi: 10.1016/j.jmb.2010.06.023. PubMed PMID: 20600131; PubMed Central PMCID: PMCPMC2919579. 47. Navarro S, Carija A, Munoz-Torrero D, Ventura S. A fast and specific method to screen for intracellular amyloid inhibitors using bacterial model systems. European journal of medicinal chemistry. 2016;121:785-92. Epub 2015/11/27. doi: 10.1016/j.ejmech.2015.10.044. PubMed PMID: 26608003. 48. Howie AJ, Brewer DB. Optical properties of amyloid stained by Congo red: history and mechanisms. Micron (Oxford, England : 1993). 2009;40(3):285-301. Epub 2008/11/21. doi: 10.1016/j.micron.2008.10.002. PubMed PMID: 19019688. 49. Gruszka DT, Wojdyla JA, Bingham RJ, Turkenburg JP, Manfield IW, Steward A, et al. Staphylococcal biofilm-forming protein has a contiguous rod-like structure. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(17):E1011-8. Epub 2012/04/12. doi: 10.1073/pnas.1119456109. PubMed PMID: 22493247; PubMed Central PMCID: PMCPmc3340054. 50. Pedersen JS, Dikov D, Flink JL, Hjuler HA, Christiansen G, Otzen DE. The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. Journal of molecular biology. 2006;355(3):501-23. Epub 2005/12/03. doi: 10.1016/j.jmb.2005.09.100. PubMed PMID: 16321400. 51. Macchi F, Eisenkolb M, Kiefer H, Otzen DE. The effect of osmolytes on protein fibrillation. International journal of molecular sciences. 2012;13(3):3801-19. Epub 2012/04/11. doi: 10.3390/ijms13033801. PubMed PMID: 22489184; PubMed Central PMCID: PMCPMC3317744. 52. Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M, et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Molecular Neurodegeneration. 2007;2(1):18. doi: 10.1186/1750-1326-2-18. 53. Tougu V, Karafin A, Zovo K, Chung RS, Howells C, West AK, et al. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. Journal of neurochemistry. 2009;110(6):1784-95. Epub 2009/07/22. doi: 10.1111/j.1471- 4159.2009.06269.x. PubMed PMID: 19619132.
114
54. Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, Gusella JF, et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (New York, NY). 1994;265(5177):1464-7. Epub 1994/09/02. PubMed PMID: 8073293. 55. Adlard PA, Bush AI. Metals and Alzheimer's disease. Journal of Alzheimer's disease : JAD. 2006;10(2-3):145-63. Epub 2006/11/23. PubMed PMID: 17119284. 56. Faller P. Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer. Chembiochem : a European journal of chemical biology. 2009;10(18):2837-45. Epub 2009/10/31. doi: 10.1002/cbic.200900321. PubMed PMID: 19877000. 57. Hammer ND, Schmidt JC, Chapman MR. The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerization. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(30):12494-9. Epub 2007/07/20. doi: 10.1073/pnas.0703310104. PubMed PMID: 17636121; PubMed Central PMCID: PMCPMC1941497. 58. Romero D, Vlamakis H, Losick R, Kolter R. An accessory protein required for anchoring and assembly of amyloid fibres in B. subtilis biofilms. Molecular microbiology. 2011;80(5):1155-68. Epub 2011/04/12. doi: 10.1111/j.1365-2958.2011.07653.x. PubMed PMID: 21477127; PubMed Central PMCID: PMCPMC3103627. 59. Taglialegna A, Navarro S, Ventura S, Garnett JA, Matthews S, Penades JR, et al. Staphylococcal Bap Proteins Build Amyloid Scaffold Biofilm Matrices in Response to Environmental Signals. PLoS pathogens. 2016;12(6):e1005711. Epub 2016/06/22. doi: 10.1371/journal.ppat.1005711. PubMed PMID: 27327765; PubMed Central PMCID: PMCPMC4915627. 60. O'Nuallain B, Thakur AK, Williams AD, Bhattacharyya AM, Chen S, Thiagarajan G, et al. Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay. Methods in enzymology. 2006;413:34-74. Epub 2006/10/19. doi: 10.1016/s0076-6879(06)13003-7. PubMed PMID: 17046390. 61. Zhao R, So M, Maat H, Ray NJ, Arisaka F, Goto Y, et al. Measurement of amyloid formation by turbidity assay-seeing through the cloud. Biophysical reviews. 2016;8(4):445-71. Epub 2016/12/23. doi: 10.1007/s12551-016-0233-7. PubMed PMID: 28003859; PubMed Central PMCID: PMCPMC5135725. 62. Plakoutsi G, Bemporad F, Calamai M, Taddei N, Dobson CM, Chiti F. Evidence for a mechanism of amyloid formation involving molecular reorganisation within native- like precursor aggregates. Journal of molecular biology. 2005;351(4):910-22. Epub 2005/07/19. doi: 10.1016/j.jmb.2005.06.043. PubMed PMID: 16024042. 63. Banner MA, Cunniffe JG, Macintosh RL, Foster TJ, Rohde H, Mack D, et al. Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein. Journal of bacteriology. 2007;189(7):2793-804. Epub 2007/02/06. doi: 10.1128/jb.00952-06. PubMed PMID: 17277069; PubMed Central PMCID: PMCPMC1855787. 64. Macintosh RL, Brittan JL, Bhattacharya R, Jenkinson HF, Derrick J, Upton M, et al. The terminal A domain of the fibrillar accumulation-associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human corneocytes. Journal of bacteriology. 2009;191(22):7007-16. Epub 2009/09/15. doi: 10.1128/jb.00764-09. PubMed PMID: 19749046; PubMed Central PMCID: PMCPMC2772481.
115
65. Damo SM, Kehl-Fie TE, Sugitani N, Holt ME, Rathi S, Murphy WJ, et al. Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(10):3841-6. Epub 2013/02/23. doi: 10.1073/pnas.1220341110. PubMed PMID: 23431180; PubMed Central PMCID: PMCPMC3593839. 66. Nenninger AA, Robinson LS, Hultgren SJ. Localized and efficient curli nucleation requires the chaperone-like amyloid assembly protein CsgF. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(3):900-5. Epub 2009/01/10. doi: 10.1073/pnas.0812143106. PubMed PMID: 19131513; PubMed Central PMCID: PMCPMC2630086. 67. Dong J, Shokes JE, Scott RA, Lynn DG. Modulating amyloid self-assembly and fibril morphology with Zn(II). Journal of the American Chemical Society. 2006;128(11):3540-2. Epub 2006/03/16. doi: 10.1021/ja055973j. PubMed PMID: 16536526; PubMed Central PMCID: PMCPMC3555692. 68. Talmard C, Leuma Yona R, Faller P. Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1-28). Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry. 2009;14(3):449-55. Epub 2008/12/17. doi: 10.1007/s00775-008-0461-9. PubMed PMID: 19083027. 69. Edgeworth JA, Gros N, Alden J, Joiner S, Wadsworth JD, Linehan J, et al. Spontaneous generation of mammalian prions. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(32):14402-6. Epub 2010/07/28. doi: 10.1073/pnas.1004036107. PubMed PMID: 20660771; PubMed Central PMCID: PMCPMC2922516. 70. Jobling MF, Huang X, Stewart LR, Barnham KJ, Curtain C, Volitakis I, et al. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry. 2001;40(27):8073-84. Epub 2001/07/04. PubMed PMID: 11434776. 71. Calabrese MF, Eakin CM, Wang JM, Miranker AD. A regulatable switch mediates self-association in an immunoglobulin fold. Nature structural & molecular biology. 2008;15(9):965-71. Epub 2009/01/28. PubMed PMID: 19172750; PubMed Central PMCID: PMCPMC2680708. 72. Eakin CM, Knight JD, Morgan CJ, Gelfand MA, Miranker AD. Formation of a copper specific binding site in non-native states of beta-2-microglobulin. Biochemistry. 2002;41(34):10646-56. Epub 2002/08/21. PubMed PMID: 12186550. 73. Tormo MA, Knecht E, Gotz F, Lasa I, Penades JR. Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology (Reading, England). 2005;151(Pt 7):2465-75. Epub 2005/07/08. doi: 10.1099/mic.0.27865-0. PubMed PMID: 16000737. 74. Lembre P, Vendrely C, Martino PD. Identification of an amyloidogenic peptide from the Bap protein of Staphylococcus epidermidis. Protein and peptide letters. 2014;21(1):75-9. Epub 2013/12/21. PubMed PMID: 24354773. 75. Wang Y, Jiang J, Gao Y, Sun Y, Dai J, Wu Y, et al. Staphylococcus epidermidis small basic protein (Sbp) forms amyloid fibrils, consistent with its function as a
116 scaffolding protein in biofilms. The Journal of biological chemistry. 2018;293(37):14296- 311. Epub 2018/07/28. doi: 10.1074/jbc.RA118.002448. PubMed PMID: 30049797; PubMed Central PMCID: PMCPMC6139570. 76. Decker R, Burdelski C, Zobiak M, Buttner H, Franke G, Christner M, et al. An 18 kDa scaffold protein is critical for Staphylococcus epidermidis biofilm formation. PLoS pathogens. 2015;11(3):e1004735. Epub 2015/03/24. doi: 10.1371/journal.ppat.1004735. PubMed PMID: 25799153; PubMed Central PMCID: PMCPmc4370877. 77. Pedersen JS, Otzen DE. Amyloid-a state in many guises: survival of the fittest fibril fold. Protein science : a publication of the Protein Society. 2008;17(1):2-10. Epub 2007/11/29. doi: 10.1110/ps.073127808. PubMed PMID: 18042680; PubMed Central PMCID: PMCPMC2144592. 78. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature. 2005;435(7043):773-8. Epub 2005/06/10. doi: 10.1038/nature03680. PubMed PMID: 15944695; PubMed Central PMCID: PMCPMC1479801. 79. Shewmaker F, McGlinchey RP, Thurber KR, McPhie P, Dyda F, Tycko R, et al. The functional curli amyloid is not based on in-register parallel beta-sheet structure. The Journal of biological chemistry. 2009;284(37):25065-76. Epub 2009/07/04. doi: 10.1074/jbc.M109.007054. PubMed PMID: 19574225; PubMed Central PMCID: PMCPMC2757210. 80. Andersen CB, Hicks MR, Vetri V, Vandahl B, Rahbek-Nielsen H, Thogersen H, et al. Glucagon fibril polymorphism reflects differences in protofilament backbone structure. Journal of molecular biology. 2010;397(4):932-46. Epub 2010/02/17. doi: 10.1016/j.jmb.2010.02.012. PubMed PMID: 20156459. 81. Morris K, Serpell L. From natural to designer self-assembling biopolymers, the structural characterisation of fibrous proteins & peptides using fibre diffraction. Chemical Society reviews. 2010;39(9):3445-53. Epub 2010/07/30. doi: 10.1039/b919453n. PubMed PMID: 20668734. 82. Zhang R, Hu X, Khant H, Ludtke SJ, Chiu W, Schmid MF, et al. Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(12):4653-8. Epub 2009/03/07. doi: 10.1073/pnas.0901085106. PubMed PMID: 19264960; PubMed Central PMCID: PMCPMC2660777. 83. Sikorski P, Atkins ED, Serpell LC. Structure and texture of fibrous crystals formed by Alzheimer's abeta(11-25) peptide fragment. Structure (London, England : 1993). 2003;11(8):915-26. Epub 2003/08/09. PubMed PMID: 12906823. 84. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature. 2007;447(7143):453-7. Epub 2007/05/01. doi: 10.1038/nature05695. PubMed PMID: 17468747. 85. Liu C, Sawaya MR, Cheng PN, Zheng J, Nowick JS, Eisenberg D. Characteristics of amyloid-related oligomers revealed by crystal structures of macrocyclic beta-sheet mimics. Journal of the American Chemical Society. 2011;133(17):6736-44. Epub 2011/04/09. doi: 10.1021/ja200222n. PubMed PMID: 21473620; PubMed Central PMCID: PMCPMC3124511.
117
86. MacRaild CA, Hatters DM, Lawrence LJ, Howlett GJ. Sedimentation velocity analysis of flexible macromolecules: self-association and tangling of amyloid fibrils. Biophysical journal. 2003;84(4):2562-9. Epub 2003/04/02. doi: 10.1016/s0006- 3495(03)75061-9. PubMed PMID: 12668464; PubMed Central PMCID: PMCPMC1302822. 87. Pham Cle L, Mok YF, Howlett GJ. Sedimentation velocity analysis of amyloid fibrils. Methods in molecular biology (Clifton, NJ). 2011;752:179-96. Epub 2011/06/30. doi: 10.1007/978-1-60327-223-0_12. PubMed PMID: 21713638. 88. Smith DP, Radford SE, Ashcroft AE. Elongated oligomers in beta2-microglobulin amyloid assembly revealed by ion mobility spectrometry-mass spectrometry. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(15):6794-8. Epub 2010/03/31. doi: 10.1073/pnas.0913046107. PubMed PMID: 20351246; PubMed Central PMCID: PMCPMC2872402. 89. Binger KJ, Pham CL, Wilson LM, Bailey MF, Lawrence LJ, Schuck P, et al. Apolipoprotein C-II amyloid fibrils assemble via a reversible pathway that includes fibril breaking and rejoining. Journal of molecular biology. 2008;376(4):1116-29. Epub 2008/01/22. doi: 10.1016/j.jmb.2007.12.055. PubMed PMID: 18206908. 90. Ryan TM, Teoh CL, Griffin MD, Bailey MF, Schuck P, Howlett GJ. Phospholipids enhance nucleation but not elongation of apolipoprotein C-II amyloid fibrils. Journal of molecular biology. 2010;399(5):731-40. Epub 2010/05/04. doi: 10.1016/j.jmb.2010.04.042. PubMed PMID: 20433849; PubMed Central PMCID: PMCPMC2887044. 91. Lashuel HA, Lai Z, Kelly JW. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. Biochemistry. 1998;37(51):17851-64. Epub 1999/01/28. PubMed PMID: 9922152. 92. Van Holde KE, Weischet WO. Boundary analysis of sedimentation-velocity experiments with monodisperse and paucidisperse solutes. Biopolymers. 1978;17(6):1387-403. doi: 10.1002/bip.1978.360170602. 93. Demeler B, van Holde KE. Sedimentation velocity analysis of highly heterogeneous systems. Analytical biochemistry. 2004;335(2):279-88. Epub 2004/11/24. doi: 10.1016/j.ab.2004.08.039. PubMed PMID: 15556567. 94. Demeler B, Brookes E, Nagel-Steger L. Analysis of heterogeneity in molecular weight and shape by analytical ultracentrifugation using parallel distributed computing. Methods in enzymology. 2009;454:87-113. Epub 2009/02/17. doi: 10.1016/s0076- 6879(08)03804-4. PubMed PMID: 19216924. 95. Nagel-Steger L, Demeler B, Meyer-Zaika W, Hochdörffer K, Schrader T, Willbold D. Modulation of aggregate size- and shape-distributions of the amyloid-β peptide by a designed β-sheet breaker. European Biophysics Journal. 2010;39(3):415-22. doi: 10.1007/s00249-009-0416-2. 96. Whitmore L, Wallace BA. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic acids research. 2004;32(Web Server issue):W668-73. Epub 2004/06/25. doi: 10.1093/nar/gkh371. PubMed PMID: 15215473; PubMed Central PMCID: PMCPMC441509. 97. Schuck P, Perugini MA, Gonzales NR, Howlett GJ, Schubert D. Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model
118 systems. Biophysical journal. 2002;82(2):1096-111. Epub 2002/01/25. doi: 10.1016/s0006-3495(02)75469-6. PubMed PMID: 11806949; PubMed Central PMCID: PMCPMC1301916. 98. Laue TM SB, Ridgeway SL. Computer aided interpretation of analytical sedimentation data for proteins. SE H, editor1992.
119
Chapter III. Tandem B-repeats from Aap show reversible zinc-dependent
assembly beyond dimer
Authors: Alexander E. Yarawsky1,2 and Andrew B. Herr2,3
Affiliations: 1 - Graduate Program in Molecular Genetics, Biochemistry & Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
2 - Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA
3 - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA
Author Contributions: A.E.Y. collected data.
A.E.Y. and A.B.H. analyzed data, conceived experiments and directed the project.
A.E.Y. wrote this draft.
Funding: Work was performed using funding from R01-GM094363 and U19-AI070235 awarded to A.B.H. and the University of Cincinnati Graduate School Dean's Fellowship awarded to A.E.Y. (2018-2019 AY).
120
Abstract The accumulation-associated protein (Aap) from Staphylococcus epidermidis is a critical factor for infection. The B-repeat superdomain of Aap, composed of 5 to 17 B- repeats containing a Zn2+-binding G5 domain and spacer region, is responsible for Zn2+- dependent assembly leading to accumulation of bacteria during biofilm formation. The importance of this assembly has been demonstrated in biofilm formation assays, where chelation of Zn2+ will prevent biofilm formation from occurring. Recently, we have found the presence of functional amyloid-like structures composed of Aap within biofilms. In vitro, we have used a construct containing the first 5 and a half B-repeats (Brpt5.5) from
Aap to examine amyloid fibril formation. While previous studies using minimal B-repeat constructs have described the formation of an antiparallel dimer in the presence of Zn2+, we sought to understand the initial assembly events leading up to amyloid formation using the more biologically relevant Brpt5.5 construct. In order to characterize these assembly events, we have utilized analytical ultracentrifugation (AUC) to determine hydrodynamic parameters of each species and perform linked equilibrium studies.
Interestingly, Brpt5.5 assembles beyond the expected dimer, forming a novel tetramer.
Linkage studies indicate 1-2 Zn2+ ions are bound during the tetramerization event. In characterizing the tetramer, we took advantage of this knowledge and searched for potential Zn2+ binding sites outside of the known sites involved in dimerization, as well as probing surface regions of the dimer by chemical modification of tyrosine and arginine residues. Based on these results, we developed a Brpt5.5 mutant which was unable to form the tetramer species, and was concordantly unable to form the Zn2+- induced amyloid fibrils that Brpt5.5 wild-type forms. We complemented AUC data with circular dichroism and dynamic light scattering to gain additional information in order to
121 propose models of the B-repeat assembly states prior to nucleation of amyloid fibrils. An improved understanding of the mechanistic details of tandem B-repeat assembly will pave the way for new therapeutic approaches to combat problematic staphylococcal infections.
122
Introduction
The human skin commensal, Staphylococcus epidermidis, has been referred to as the 'accidental pathogen' [1]. Its primary virulence factor is its apt ability to form biofilms on a variety of surfaces [2]. It is this feature that has allowed S. epidermidis to take its place as a leading cause of hospital-acquired infections [3]. Biofilms are well- organized communities which offer mechanical and chemical resistance upon its populations [4]. Biofilm formation begins with attachment of bacteria to a biotic (ie. corneocytes or collagen-coated implant) or abiotic surface (ie. catheter or artificial joint).
Following attachment is accumulation of bacteria mediated by protein-protein interactions and/or secretion of an extracellular polysaccharide. As the biofilm matures, its characteristic 3-dimensional structure takes shape. Eventually, shedding or dispersal of bacteria from the biofilm occurs, allowing for biofilm formation (and infection) to occur elsewhere [2].
One of the key determinants of biofilm formation, specifically in the context of infection, is the accumulation-associated protein (Aap) [5-8]. This protein is anchored to the peptidoglycan layer of the bacterial cell wall at its C-terminus. Starting at the N- terminus, furthest from the cell wall, is a series of short A-repeats, followed by a putative lectin domain flanked by a proteolytic cleavage site on either side, the B-repeat superdomain containing up to 17 B-repeats composed of Zn2+-binding G5 domains and spacer regions, and, lastly, a highly extended proline/glycine-rich stalk region [9].
Studies have shown that while the A-repeats and/or lectin domain are required for Aap's role in attachment to a surface, removal of these regions via cleavage by SepA or other proteases is required for the accumulation of bacteria in the biofilm via the B-repeat
123 region [10, 11]. Biophysical studies and x-ray crystallography have been performed on multiple minimal B-repeat constructs containing one and a half B-repeats (Brpt1.5).
These studies have shown that B-repeats are highly extended, rich in β-sheet and random coil secondary structure, and monomeric in the absence of Zn2+ [8, 12, 13].
When Zn2+ (or to some extent, Cu2+) is present, Brpt1.5 dimerizes in a mostly overlapping, anti-parallel fashion with no observable change in secondary structure. In the crystal structure, one Zn2+ ion is bound to the G5 domain and interacts with both protomers [14, 15]. The residues involved in Zn2+ binding have been identified by crystallography and mutagenesis. Another interesting aspect is that while the B-repeats are 89-100% identical, there exists two variations of B-repeats. These two variations differ in a set of eight residues in the G5 domain, which are located near the Zn2+- binding site, dimer interface and hydrophobic "stack" in the Brpt1.5 dimer structure.
Interestingly, the B-repeats with the less common variation (termed the variant repeats - as opposed to the consensus repeats) show weaker Zn2+-dependent dimerization, but higher thermal stability in Brpt1.5 constructs [12].
While the Zn2+-dependent assembly of Brpt1.5 constructs has been well- explored, Aap is believed to require at least 5 B-repeats to support biofilm formation, given results observed in its S. aureus ortholog, SasG [16]. Our lab has previously sought to characterize the Zn2+-dependent assembly of longer, more biologically relevant constructs (namely a Brpt5.5 construct), and we identified the formation of larger species leading up to amyloid fibril formation. The presence of amyloid fibrils in S. epidermidis biofilms was demonstrated, and we also showed the fibrils are composed primarily of proteolytically processed Aap. These fibrils offer the biofilm resistance
124 against DTPA, a Zn2+-chelator which can prevent biofilm formation from occurring when introduced prior to accumulation, but has no effect on mature biofilms. During this process, we found that Brpt5.5 assembled beyond dimer, before forming large, irreversible amyloid-like aggregate.
In this report, we focus on characterizing the initial, reversible assemblies formed by Brpt5.5 in the presence of Zn2+. First, we perform detailed analyses of analytical ultracentrifugation data to demonstrate the formation of the expected dimer and a novel tetramer, the latter which is not observed with Brpt1.5 constructs. By analysis of the linked equilibria between Zn2+-binding and Zn2+-mediated B-repeat assembly, we report the number of Zn2+ ions bound upon dimerization, which is consistent with the 1-2 Zn2+ ions per G5 domain we have reported for Brpt1.5 and Brpt2.5 dimerization. This is highly suggestive that the mechanism of dimerization is consistent between the larger
Brpt5.5 construct and the Brpt1.5 construct which has solved crystal structures.
Interestingly, the tetramer requires the addition of 1-2 Zn2+ ions per dimer. This suggested there were additional Zn2+-binding sites than what we had observed in crystallography studies. We performed chemical modification of tyrosine and arginine residues to narrow down our search of the tetramer interface and additional Zn2+- binding sites. Mutagenesis of a single histidine in the spacer region of each B-repeat completely abolished tetramer formation. Using data from dynamic light scattering and circular dichroism, we characterized a temperature-dependent conformational change in the presence of Zn2+ which correlated with rapid aggregation. The tetramer-negative mutant did not undergo the conformational change or the subsequent aggregation, revealing this higher-order assembly could be a critical step in amyloidogenesis. Finally,
125 we propose models of the dimer and tetramer assembly states formed by Brpt5.5. An understanding of the mechanism of assembly of longer, more biologically relevant B- repeat constructs will provide important details to inhibit amyloidogenesis in these biofilms.
126
Results
Brpt5.5 exhibits monomer-dimer-tetramer equilibrium
To begin investigating the assembly of Brpt5.5, we performed sedimentation velocity analytical ultracentrifugation (AUC) experiments at increasing ZnCl2 concentrations at a constant Brpt5.5 concentration (Figure 1A). As expected based on the dimerization of shorter B-repeat constructs [8, 12, 14, 15, 17], we observed a shift in the sedimentation coefficient as the ZnCl2 concentration was increased. Figure 1B shows the relationship between the weight-averaged sedimentation coefficient (sw) and the Zn2+ concentration. It appears here as though there may be two separate sigmoidal transitions, with the first midpoint near 3 mM ZnCl2, and the second near 5 mM ZnCl2.
This would indicate there are actually three species participating in this equilibrium, not just a monomer and dimer. Beyond 8 mM ZnCl2, there is significant loss of protein due to aggregation, but no further shift in sw.
In order to better define these three species, a sedimentation equilibrium AUC experiment was performed at 3 mM ZnCl2, where all species should be populated to an observable degree, based on the sedimentation velocity data. A global fit was performed on samples at three different protein concentrations, all in 3 mM ZnCl2, and the data was best fitted by a monomer-dimer-tetramer (1-2-4) equilibrium. Figure 1C shows the raw data and species fits for the middle concentration of 1.8 µM (0.15 mg/ml) sample, with residuals shown in the upper plot. This is the first official data that confirmed a novel tetramer state. Using the fitted association constants, a species plot
(Figure 1D) was produced. It is evident from the overlapping populations that it will not be possible to selectively populate the dimer species without having contamination from
127 monomer or dimer. Species plots at other Zn2+ concentrations show a similar trend
(data not shown). Therefore, biophysical characterization of the dimer species might require special considerations.
128
(A) (B)
(C) (D )
Figure 1. Brpt5.5 exhibits a monomer-dimer-tetramer equilibrium in the presence of Zn2+. (A) Wide Distribution Analysis (WDA) of 0.50 mg/ml Brpt5.5 in the presence of increasing ZnCl2 concentrations. (B) The weight-averaged sedimentation coefficient (sw) at increasing ZnCl2 concentrations. Data plotted were analyzed by separate programs, as designated in the key. Panel (C) shows a representative sedimentation equilibrium AUC dataset at 3 mM Zn2+, 0.15 mg/ml Brpt5.5, at 13000 rpm. This dataset is part of a global fit of 6 or more curves (at least 3 protein concentrations and at least 3 speeds). Empty circles are raw absorbance data at 236 nm, and the solid grey line represents the best fit, with residuals shown in the upper plot. Individual species are represented by lines in black (monomer), green (dimer) and red (tetramer). Panel (D) shows the distribution of each species based on Brpt5.5 concentration (13 µM = 0.50 mg/ml) and is calculated from the determined association constants at 3 mM Zn2+. The x-axis extends until saturation of monomer or tetramer.
129
Analysis of linked equilibria indicates a similar mechanism of Brpt5.5 dimerization to shorter constructs
We have previously analyzed the linked equilibria between Zn2+-binding and
Zn2+-mediated Brpt1.5 and Brpt2.5 dimerization, finding good agreement with the X-ray crystal structure of the Brpt1.5 dimer (no structural data is available for Brpt2.5) [8, 14,
17]. Sedimentation equilibrium AUC experiments were performed with Brpt5.5 at fifteen
ZnCl2 concentrations and the dimerization and tetramer assembly constants were calculated. For the dimerization assembly constant, K12, the slope of the Wyman Plot
(also referred to as a log-log plot) indicated 9.3 (±1.3) Zn2+ ions are bound upon dimerization (Figure 2A). Given that there are 6 G5 domains in the Brpt5.5 construct
(the half-repeat is a G5 domain), we compared the number of Zn2+ ions per G5 domain to that of Brpt1.5 and Brpt2.5, which were previously published [8, 17]. The slope of this plot indicates 1.6 Zn2+ ions bound per G5 domain, consistent with the 1-2 Zn2+ ions per
G5 domain previously reported (Figure 2D).
Formation of the tetramer requires additional Zn2+ ions
We then produced a Wyman Plot for the overall tetramerization constant, K14,
(Figure 2B) determined in the linked equilibria analysis, along with the more easily interpretable dimer-tetramer assembly constant, K24, (Figure 2C) which shows larger error bars due to the conversion from K14 to K24 resulting in the smaller absolute Y-axis
2+ values. The slope of the K24 Wyman Plot indicates 1-2 Zn ions bound upon formation of the tetramer from two dimers.
130
While we have previously reported that there is no change in the secondary structure upon Brpt1.5 dimerization [8], we tested for the presence of any changes that might occur in the secondary structure of Brpt5.5 upon assembly. In the presence of 5 mM ZnCl2, where Brpt5.5 should exist as a mix of dimer and tetramer, there was little to no change in the secondary structure by CD (Supplemental Figure 1).
131
(A) (B) (C) (D)
Figure 2. Analysis of linked equilibria reveals the number of Zn2+ ions bound during each assembly event. Panel (A) shows the Wyman Plot of linked equilibria for the dimer. The slope of the linear regression indicates the number of Zn2+ ions bound during dimerization (ΔZn = 9.3 ± 1.3). The Wyman Plot for the tetramer is shown based on the overall monomer-tetramer association constant (K14) in panel (B) and the dimer- tetramer association constant (K24) in panel (C). (D) A comparison of the ΔZn values per G5 domain for Brpt5.5 (determined in this study), Brpt2.5 and Brpt1.5 (previously published by Conrady, et al. 2008 [8]).
132
Chemical modification and sequence mutation to define tetramer assembly
Further characterization of this novel tetramer could provide useful insights into the amyloidogenesis pathway of Aap. To probe for the dimer surfaces important in tetramer formation, we chemically modified residues which we expected to be outside of the dimer interface, based on the Brpt1.5 dimer structure solved by X-ray crystallography (Figure 3) [14]. Because our analysis of linked equilibria suggested a similar dimerization mechanism across these B-repeat constructs, we expect this to be a useful representation of the repeating units of the Brpt5.5 dimer. We performed chemical modifications of tyrosines and arginines. Both residues are completely conserved across all B-repeats of Brpt5.5 (and all 12.5 B-repeats of Aap in RP62A).
Chemical modification of all tyrosine residues (Figure 3, orange residues) resulted in a significant decrease in the sedimentation coefficient in the presence of Zn2+, compared to that of the unmodified Brpt5.5 (Figure 4A). Modification of arginine residues (Figure 3, purple), which flank the tyrosine residues on the opposite face of the Zn2+-binding site involved in dimerization, resulted in a slightly weaker shift toward lower sedimentation coefficients. Modification of both types of residues resulted in a sedimentation profile very similar to tyrosine modification alone. Nonetheless, modified tyrosines and arginines are able to significantly inhibit tetramer formation. Based on the location of these residues, it seems likely that the tetramer is formed via side-by-side mechanisms as opposed to end-to-end mechanisms.
133
D87 H85
Y126 D122
E100
Figure 3. Chemical modification targets and potential Zn2+-binding residues are highlighted on a structure of Brpt1.5 (PDB: 4FUN). Tyrosine residues are colored orange, arginine residues are colored magenta, and hypothesized Zn2+-binding residues important in tetramer formation are colored red. The bottom left inset shows higher detail in the region within the black square.
134
After determining that additional Zn2+ ions are required for tetramer formation, we began searching for another Zn2+-binding site. Figure 3 (inset) shows our hypothesized
Zn2+-binding site, based on similar residues and orientations observed in the known dimer Zn2+-binding site [14]. Their location near Y126, which showed an ability to inhibit tetramer formation when chemically modified (Figure 4A), was a promising piece of evidence. Also, residues in position H85, D87, and D122 are completely conserved across all spacer regions in Brpt5.5, and the 12.5 B-repeats of Aap from S. epidermidis
RP62A. We chose the histidine in position 85 (H85) of each B-repeat spacer region for further investigation.
To test our hypothesis that H85 is involved in the Zn2+-binding site of tetramerization, we produced a mutant containing a H85A mutation in all spacer regions of Brpt5.5 (i.e. H85A, H213A, H341A, H469A, and H597A) - which we will refer to as
Brpt5.5 H85A for simplicity. Note that there are only 5 spacer regions, while there are 6
G5 domains in Brpt5.5, because of the half-repeat being composed of only a G5 domain. The H85A mutant appeared similar in secondary structure to the native Brpt5.5 construct by CD (Supplemental Figure 2A), and had a slight shift in the monomer sedimentation coefficient from 2.20 s* for wild-type (Figure 4B, solid line) to 2.26 s* for
H85A (Figure 4B, dashed line), but a high frictional ratio characteristic of folded B- repeats (wild-type = 3.46 and H85A = 3.46). Further, sedimentation velocity experiments in the presence of Zn2+ indicated limited assembly of Brpt5.5 H85A and there was no indication of aggregation around 8 mM ZnCl2 like we observed with
Brpt5.5 wild-type. The distribution of H85A + 8.00 mM ZnCl2 resembles closely the
135
(A) (B)
(C) (D)
Figure 4. Chemical modifications and H85A mutations inhibit tetramer formation. Panels (A) and (B) show sedimentation velocity AUC data analyzed by WDA. Chemical modification of Tyr, Arg, and both residues reduces assembly (A). In (B), mutating all H85A positions results in decreased assembly. (C) and (D) By sedimentation equilibrium AUC, Brpt5.5 H85A has similar dimerization characteristics as wild-type, but no tetramer was observed for H85A. Empty circles are raw absorbance data (WT = black, H85A = grey), which were normalized to 1.0 across (C) and (D). Solid lines represent total and species fits for Brpt5.5 WT (total = black), while dashed lines represent fits for H85A (total = grey). Monomer is shown in black, labeled with a 1. Dimer is shown in green line, while tetramer is in red.
Sample logK12 logK14 Brpt5.5 WT + 3.50 mM ZnCl2 10.41 (9.98 - 10.85) 30.46 (29.88 - 31.07) Brpt5.5 H85A + 3.50 mM ZnCl2 10.22 (9.92 - 10.54) Table 1. Measured equilibrium constants from sedimentation equilibrium experiments shown in Figure 4C and 4D.
136 distribution of the tyrosine and arginine + tyrosine chemical modification samples, suggesting that perhaps in both cases, the tetramer is unable to form. To further investigate this hypothesis, equilibrium AUC experiments were performed with Brpt5.5 wild-type and H85A in the presence of Zn2+. Raw data and species fits, displayed in
Figure 4C, indicated there was very little change in the dimerization constants, as evident by the overlap in the data and fits. Figure 4D shows a condition capable of producing mostly tetramer in the wild-type construct, but there was no tetramer detectable for the H85A mutant. Global fitting produced a logK12 = 10.41 (9.98 - 10.85) and logK14 = 30.46 (29.88 - 31.07) for wild-type and logK12 = 10.22 (9.92 - 10.54) for
H85A, with no significant improvement in the fit when incorporating a tetramer species.
We therefore are inclined to believe that H85 in the spacer region is absolutely critical for tetramer formation, while not playing a role in dimerization.
Tetramer assembly is required for Zn2+-dependent amyloidogenesis
Because we did not observe aggregation at high Zn2+ concentrations during initial characterization of the Brpt5.5 H85A construct, we were interested in testing the ability for Brpt5.5 H85A to form Zn2+-induced amyloid fibrils. With wild-type Brpt5.5, we observe a major change in the circular dichroism (CD) spectrum at ~225nm as temperature is increased (Figure 5A). The temperature depends heavily on the amount of Zn2+ present, but interestingly, Brpt5.5 H85A under the same conditions appears to simply unfold as the temperature is increased (Figure 5B). The strong minimum observed near 40°C for wild-type is likely representative of major rearrangement or twisting of β-sheets [18] into a nucleating species on the pathway to amyloidogenesis,
137
(A) (B)
(C) (D)
WT + 3.50 mM Zn H85A + 3.50 mM Zn
Figure 5. Inhibiting tetramer formation results in weaker aggregation propensity. Panel (A) shows a significant change in the Brpt5.5 CD signal at ~40°C in the presence of Zn2+, whereas the H85A mutant does not show this behavior. Panel (B) examines the turbidity of a Brpt5.5 WT or H85A sample upon Zn2+ additions. The black, filled circles show raw data for WT, while the solid line is the fit using a 4 parameter logistic curve. The horizontal dashed line is the turbidity at the WT EC50 (Turbidity = 0.218). Vertical dashed lines drop down from the intersection of the horizontal dashed line to show the EC50 along the x-axis, which is plotted on the log scale. Panel (C) and (D) show the Rh measured by DLS (black, filled circles) overlaid with CD data collected at a single wavelength (red, filled circles - wavelength specified on right y-axis).
138 as the signal is quickly lost due to aggregation in the cuvette settling or light scattering.
We have previously shown that Brpt5.5 under these conditions forms fibers which could be detected by the anti-amyloid OC antibody [See Dissertation Chapter II]. We evaluated the ability for Brpt5.5 H85A to form Zn2+-induced aggregates via two other methods as well. We monitored light scattering as Zn2+ was titrated into a cuvette of
Brpt5.5 wild-type or Brpt5.5 H85A (Figure 5C), and we observed a sigmoidal transition with a midpoint near 16 mM ZnCl2 for wild-type. For Brpt5.5 H85A, the apparent midpoint appears to be around 43 mM ZnCl2, however, there is no sigmoidal transition observed in this case, and we do not have a well-defined "maximum" signal. The solubility of ZnCl2 is severely limited at high concentrations, but does not cause significant turbidity at 400 nm (data not shown). Based on these data alone, we cannot say with certainty if this observed turbidity is related to a very weak propensity for amyloid-like aggregation, or if this is non-ordered or non-specific aggregation.
We used a third complementary technique to once again better clarify our observations. Dynamic light scattering is a hydrodynamic technique useful for measuring particle size. One can monitor for aggregation as the temperature is increased. This approach, in parallel with CD measurements, can provide us with two separate perspectives - secondary structure changes and aggregation. In good agreement with our CD observations (Figure 5A), we observe aggregation of Brpt5.5 wild-type near 37°C, consistent with the appearance of the ~225 nm minimum by CD
(Figure 5C). In the case of Brpt5.5 H85A, there is instead a significant decrease in the hydrodynamic radius (Rh) which is mirrored by the unfolding to random coil observed by
CD near 50°C (Figure 5D). Due to the highly elongated nature of the B-repeats,
139 unfolding of Brpt5.5 H85A to a random coil is expected to be described by a decrease in
Rh - contrary to the unfolding of a compact, globular protein. We therefore conclude that formation of the tetramer is critically linked to Zn2+-induced B-repeat amyloidogenesis.
140
Discussion
Based on the results presented in this study, we can propose models for the
Brpt5.5 dimer and tetramer assembly. Linkage equilibria studies suggested a consistent mechanism of dimerization between minimal Brpt1.5 constructs, a Brpt2.5 construct, and Brpt5.5 presented here. The number of Zn2+ ions bound upon dimerization was found to be a consistent 1-2 Zn2+ ions per G5 domain. X-ray crystallography structures for Brpt1.5 [14] show an "overlapping," anti-parallel dimer, where there are sufficient
Zn2+-dependent contacts to accommodate the appropriate amount of Zn2+ ions. We propose Brpt5.5 assembles into a similar "overlapping" dimer (Figure 6 middle, center) as opposed to a more offset dimer (Figure 6 middle, left) In the case of Brpt5.5 from
Aap from S. epidermidis RP62A, this is also reasonable due to the identity of the B- repeats. For example, all consensus (high Zn2+-affinity) B-repeats can make contact, while the variant (low Zn2+-affinity) B-repeat overlaps with the half-repeat cap.
Due to the number of B-repeats, one could imagine a variety of orientations or configurations for the tetramer (a dimer of dimers). In Figure 6, we evaluate the plausibility of different configurations of each assembly state. Based on our hydrodynamic data from sedimentation velocity AUC experiments, the frictional ratio decreases from monomer to tetramer for wild-type Brpt5.5. Because we cannot isolate the dimer using wild-type Brpt5.5, we cannot accurately estimate the frictional ratio of this species. However, using the H85A mutant which dimerizes similarly, we can in fact saturate the dimer population, giving us a frictional ratio smaller than that of the monomer. The "overlapping" dimer we proposed based on linkage studies would indeed exhibit a smaller frictional ratio than the monomer, as it is essentially twice as thick in
141 the z-direction, but similar along the other two axes. In contrast, if the protomers were not overlapping, but more offset from each other, a higher frictional ratio would be expected, since the length in the x-direction would increase significantly. More importantly, there would not be enough Zn2+-binding sites in contact to satisfy the 1-2
Zn2+ ions per G5 domain.
From the overlapping dimer to the wild-type tetramer, there is another decrease in the frictional ratio. If dimers attached end-to-end to form the tetramer, there would be a significant extension along the x-axis, while the other axes are unchanged. This would result in a much higher frictional ratio of the tetramer compared to the dimer. Similarly, a
"top-to-bottom" dimer of dimers would also result in a higher frictional ratio, again due to the extension along one axis - the y-axis in this case. A third option for the tetramer is a side-by-side dimer of dimers. This configuration would, in fact, yield a lower frictional ratio like what was observed, due to the extension along the z-direction which offsets the highly extended x-coordinate. The bottom rightmost option, a tilted side-by-side dimer of dimers, could also be plausible, as we only observed the addition of 1-2 Zn2+ ions upon formation of the tetramer. These latter two configurations also are logical in a biological sense, as adjacent cells with cell wall-anchored Aap extending outward from the cell surface might interact with neighboring Aap molecules.
142
Figure 6. Models of tandem B-repeat reversible assembly. The B-repeat identity is described as "Consensus" or "Variant" according to Shelton, et al. 2017 [12]. Based on the results of this study, we can eliminate several models based on biophysical data. However, we will require additional data to distinguish between the two bottom right tetramer configurations.
143
This study presents the first data demonstrating that tandem B-repeats from Aap exhibit a monomer-dimer-tetramer equilibrium. Our previous demonstration of the ability of the B-repeats of Aap to form a functional amyloid in the presence of Zn2+ was an early indication that tandem B-repeats (beyond one and a half B-repeats) behave differently in some ways than shorter B-repeat constructs. Importantly, we have now begun to understand the pathway of Zn2+-induced amyloidogenesis using biophysical analyses of Brpt5.5, a construct which represents the expected minimum number of B- repeats required for biofilm formation. Indeed, by inhibiting the formation of the tetramer via a set of point mutations in a predicted Zn2+-binding site, Zn2+-induced aggregation was inhibited.
144
Materials and methods
Protein expression and purification
Brpt5.5 cloning, expression, and purification was described previously [See
Dissertation Chapter II]. The Brpt5.5 H85A mutant was produced via the Agilent
QuikChange II Site-Directed Mutagenesis Kit. Mutated residues include H85, H213,
H341, H469, and H597, all of which were mutated to alanine. Brpt5.5 H85A was purified using the same procedures as wild-type.
Analytical ultracentrifugation
A Beckman Coulter XL-I analytical ultracentrifuge was used for AUC experiments. For sedimentation velocity experiments, two-sector epon-charcoal 1.2 cm centerpieces were used with sapphire windows. Data were collected via absorbance optics (interference optics in the case of chemical modification experiments) at 48 k rpm at 20°C in an An-60 Ti. Experiments were run overnight, usually around 20 hours. Data were analyzed using SEDFIT's continuous c(s) distribution model [19], SEDANAL's wide distribution analysis (WDA) [20], or DCDT+ version 2.4.3 by John Philo [21, 22].
Sedimentation equilibrium experiments were performed using protein dialyzed into the specified ZnCl2 concentration in 50 mM MOPS pH 7.2, 50 mM NaCl. After dialysis, protein concentrations were adjusted to approximately 0.50, 0.15, and 0.05 mg/ml and loaded into a six-channel 1.2 cm centerpiece. Samples were centrifuged at
10 k, 13 k, 17 k, 24 k, and 37 k rpm for 24 hours each, which provided ample time for equilibration of the monomer species to occur at each speed. Raw data were trimmed using WinReedit V0.999 and then fit using WinNonlin V1.080. Data from at least three
145 speeds and three loading concentrations were used for analysis of each Zn2+ concentration. Partial specific volumes, buffer densities, and buffer viscosities were estimated using SEDNTERP [23].
Analysis of linked equilibria
Experiments were designed and analyzed based on analysis of linked equilibria for Brpt1.5 and Brpt2.5, discussed elsewhere [8, 17]. Datasets were collected at ZnCl2 concentrations at 1.50, 2.00, 2.25, 2.50, 2.75, 3.00, 3.25, 3.50, 3.75, 4.00, 4.25, 4.50,
5.00, 5.50 and 6.00 mM, but 1.50 and 6.00 mM ZnCl2 were excluded due to the lack of sufficient dimer or tetramer species, which prevented accurate measurements of both logK12 and logK14 within WinNonlin. In other words, only datasets which produced both logK12 and logK14 measurements were used.
To determine the number of ligand molecules, bound or released upon a ligand- dependent equilibrium event, the following equation can be used [24]: